{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "a0f93f3c-638a-47a0-a8df-28c6f3d0aed7",
   "metadata": {},
   "source": [
    "## This is a sample notebook to identify patient's medical conditions and ICD-10 codes from the patient notes."
   ]
  },
  {
   "attachments": {
    "0c44c6fa-4e7a-4f68-9c64-faf6f3c57f5f.png": {
     "image/png": "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"
    },
    "4f457829-132d-450d-82b9-dabb4c1390da.png": {
     "image/png": "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"
    },
    "64191be6-4b9d-4189-9bf2-764be737a945.png": {
     "image/png": "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"
    },
    "83bd77be-e771-4efa-bb6d-39d41475b469.png": {
     "image/png": "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"
    }
   },
   "cell_type": "markdown",
   "id": "c766d488-1ad5-43bb-a4de-093a5d1caca0",
   "metadata": {},
   "source": [
    "There are <b>4 different options</b> shown to extract the patient's medical conditions and ICD-10 codes from the patient notes:\n",
    "- <b>Option 1:</b> one can share the patient notes and use prompt engineering with LLM to extract the patient's medical conditions and ICD-10 codes\n",
    "![Screenshot 2024-07-10 at 10.36.46PM.png](attachment:0c44c6fa-4e7a-4f68-9c64-faf6f3c57f5f.png)\n",
    "\n",
    "- <b>Option 2:</b> one can use Amazon Comprehend Medical to extract an initial set of recommednation on the patient's medical conditions and ICD-10 codes from the patient notes. Then use that as an input to LLM and fine tune the response on the patient's medical conditions and ICD-10 codes\n",
    "![Screenshot 2024-07-10 at 10.35.00PM.png](attachment:83bd77be-e771-4efa-bb6d-39d41475b469.png)\n",
    "\n",
    "- <b>Option 3:</b> one can use LLM to extract an initial set of recommednation on the patient's medical conditions and ICD-10 codes from the patient notes. Then use organization's guidlines from the internal Knowledge Base (KB) to find any nuances on the ICD-10 codes based on the medical conditions. Finally use the initial set of recommendations and the KB input to fine tune the response on the patient's medical conditions and ICD-10 codes\n",
    "![Screenshot 2024-07-10 at 10.35.56PM.png](attachment:4f457829-132d-450d-82b9-dabb4c1390da.png)\n",
    "\n",
    "- <b>Option 4:</b> one can use Amazon Comprehend Medical to extract an initial set of recommednation on the patient's medical conditions and ICD-10 codes from the patient notes. Then use that as an input to LLM and fine tune the response on the patient's medical conditions and ICD-10 codes. This can further be enhanced by looking up the organization's guidlines from the internal Knowledge Base (KB) to find any nuances on the ICD-10 codes based on the identified medical conditions. Finally use the initial set of recommendations and the KB input to get the response on the patient's medical conditions and ICD-10 codes\n",
    "![Screenshot 2024-07-10 at 10.31.22PM.png](attachment:64191be6-4b9d-4189-9bf2-764be737a945.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4e8bb622-f2fa-4c9a-9ad6-4be6d71d9212",
   "metadata": {
    "tags": []
   },
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Install latest packages\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "f03a4bbf-c14d-4dba-8c45-3d4120d2bb1b",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: pip in /opt/conda/lib/python3.11/site-packages (24.2)\n",
      "Note: you may need to restart the kernel to use updated packages.\n",
      "\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\n",
      "autogluon-multimodal 1.1.1 requires nvidia-ml-py3==7.352.0, which is not installed.\n",
      "aiobotocore 2.13.2 requires botocore<1.34.132,>=1.34.70, but you have botocore 1.34.162 which is incompatible.\n",
      "amazon-sagemaker-sql-magic 0.1.3 requires sqlparse==0.5.0, but you have sqlparse 0.5.1 which is incompatible.\n",
      "autogluon-core 1.1.1 requires scikit-learn<1.4.1,>=1.3.0, but you have scikit-learn 1.4.2 which is incompatible.\n",
      "autogluon-features 1.1.1 requires scikit-learn<1.4.1,>=1.3.0, but you have scikit-learn 1.4.2 which is incompatible.\n",
      "autogluon-multimodal 1.1.1 requires omegaconf<2.3.0,>=2.1.1, but you have omegaconf 2.3.0 which is incompatible.\n",
      "autogluon-multimodal 1.1.1 requires scikit-learn<1.4.1,>=1.3.0, but you have scikit-learn 1.4.2 which is incompatible.\n",
      "autogluon-tabular 1.1.1 requires scikit-learn<1.4.1,>=1.3.0, but you have scikit-learn 1.4.2 which is incompatible.\n",
      "autogluon-timeseries 1.1.1 requires gluonts==0.15.1, but you have gluonts 0.14.3 which is incompatible.\n",
      "sagemaker 2.227.0 requires boto3<2.0,>=1.34.142, but you have boto3 1.34.138 which is incompatible.\n",
      "sparkmagic 0.21.0 requires pandas<2.0.0,>=0.17.1, but you have pandas 2.2.2 which is incompatible.\u001b[0m\u001b[31m\n",
      "\u001b[0mNote: you may need to restart the kernel to use updated packages.\n",
      "\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\n",
      "aiobotocore 2.13.2 requires botocore<1.34.132,>=1.34.70, but you have botocore 1.34.139 which is incompatible.\n",
      "sagemaker 2.227.0 requires boto3<2.0,>=1.34.142, but you have boto3 1.34.138 which is incompatible.\n",
      "sparkmagic 0.21.0 requires pandas<2.0.0,>=0.17.1, but you have pandas 2.2.2 which is incompatible.\u001b[0m\u001b[31m\n",
      "\u001b[0mNote: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "%pip install --upgrade pip\n",
    "%pip install boto3==1.34.138 --force-reinstall --quiet\n",
    "%pip install botocore==1.34.139 --force-reinstall --quiet"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6ab52332-afb6-41f6-980f-abf9518e7e64",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Import libraries, declare global variables \n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "d9df3c0e-8a52-4416-b20d-8da9199d0f7b",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "import boto3\n",
    "import json\n",
    "import re\n",
    "from botocore.client import Config\n",
    "from botocore.exceptions import ClientError\n",
    "\n",
    "region = 'us-east-1'\n",
    "model_id = 'anthropic.claude-3-sonnet-20240229-v1:0'\n",
    "\n",
    "s3_bucket = '' ## bucket name where you are uploading the patient's note. The CDK deployment will create S3 bucket for use usage. You can get bucket name from AWS S3 console. \n",
    "s3_input_object_key = 'gen-ai/icd-10/input/patient_note.json'\n",
    "s3_output_object_key = 'gen-ai/icd-10/output/patient_medical_conditions.json'\n",
    "\n",
    "use_comprehend_medical = 'Y'\n",
    "cm_threshold = 0.70\n",
    "use_knowledge_base = 'Y'\n",
    "kb_id = '' ## Bedrock Knowledgebase ID. The CDK deployment will create bedrock knowledge base. You can get knowledge base ID from AWS Bedrock console. \n",
    "kb_number_of_results = 5\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e6db431a-d6e3-4bef-8cae-0bc6c5319ef7",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Setup Bedrock client and define the function\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "a8437700-8718-47cb-b3c1-50f165f415f2",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "bedrock_client = boto3.client(service_name='bedrock-runtime', region_name=region)\n",
    "bedrock_config = Config(connect_timeout=120, read_timeout=120, retries={'max_attempts': 0})\n",
    "bedrock_agent_client = boto3.client(\"bedrock-agent-runtime\",\n",
    "                              config=bedrock_config, region_name = region)\n",
    "\n",
    "def get_completion(prompt, system_prompt=None, prefill=None):\n",
    "    inference_config = {\n",
    "        \"temperature\": 0.0,\n",
    "         \"maxTokens\": 4096\n",
    "    }\n",
    "    converse_api_params = {\n",
    "        \"modelId\": model_id,\n",
    "        \"messages\": [{\"role\": \"user\", \"content\": [{\"text\": prompt}]}],\n",
    "        \"inferenceConfig\": inference_config\n",
    "    }\n",
    "    if system_prompt:\n",
    "        converse_api_params[\"system\"] = [{\"text\": system_prompt}]\n",
    "    if prefill:\n",
    "        converse_api_params[\"messages\"].append({\"role\": \"assistant\", \"content\": [{\"text\": prefill}]})\n",
    "    try:\n",
    "        response = bedrock_client.converse(**converse_api_params)\n",
    "        text_content = response['output']['message']['content'][0]['text']\n",
    "        # Print token usage.\n",
    "        token_usage = response['usage']\n",
    "        print(\"Input tokens: %s\", token_usage['inputTokens'])\n",
    "        print(\"Output tokens: %s\", token_usage['outputTokens'])\n",
    "        print(\"Total tokens: %s\", token_usage['totalTokens'])\n",
    "        print(\"Stop reason: %s\", response['stopReason'])\n",
    "        return text_content\n",
    "\n",
    "    except ClientError as err:\n",
    "        message = err.response['Error']['Message']\n",
    "        print(f\"A client error occured: {message}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "445cec7f-715f-44dd-a18b-24de853022df",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Patient Notes\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "61ca843e-e154-4981-aac9-5d51468c98bc",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------\n",
      "------ Patient Notes: ------\n",
      "----------------------------\n",
      "{\n",
      "  \"name\": \"Patient 1\",\n",
      "  \"age\": \"57 years\",\n",
      "  \"sex\": \"Male\",\n",
      "  \"encounters\": [\n",
      "    {\n",
      "      \"Date\": \"2016-01-21\",\n",
      "      \"ICD10 diagnoses\": \"R01.1\",\n",
      "      \"Procedure codes\": \"93306\",\n",
      "      \"note\": []\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-02-25\",\n",
      "      \"Lab results\": \"potassium: 4 mmol/L, Body temperature: 97 degree Fahrenheit, Hemoglobin A1c/Hemoglobin.total in Blood: 5%, HDL cholesterol: 73 mg/dL, glucose: 103 mg/dL, albumin/globulin ratio: 2 (calc), Oxygen saturation: 98 percent, Respiratory rate: 18 Breaths / minute, creatinine: 1 mg/dL, ALT: 21 U/L, Body weight: 112037 gram, globulin: 2 g/dL (calc), carbon dioxide: 25 mmol/L, Body mass index (BMI): 40 kilogram / (meter ^ 2), alkaline phosphatase: 77 U/L, estimated avg. glucose: 108 mg/dL (calc), chloride: 102 mmol/L, blood urea nitrogen: 19 mg/dL, bilirubin, total: 1 mg/dL, GFR non-african american: 78 , triglycerides: 111 mg/dL, BUN/creatinine ratio: 24 (calc), Cholesterol in LDL [Mass/volume] in Serum or Plasma: 155 mg/dL (calc), GFR african american: 90 , albumin: 5 g/dL, Heart rate: 72 Beats / minute, anion gap: 12 (calc), sodium: 139 mmol/L, vitamin D 25-oh, total: 29 NG/mL, Blood pressure systolic and diastolic:  , calcium: 10 mg/dL, AST: 24 U/L, cholesterol: 250 mg/dL, total protein: 7 g/dL\",\n",
      "      \"Procedure codes\": \"80053, 99214, 83036, 80061, 36415, 82306\",\n",
      "      \"note\": [\"Continue increasing physical activity as well as holistic diet with elimination of processed carbs and sugars\",\n",
      "        \"labs today - continue current prescription as the current dose is appropriate\",\n",
      "        \"recheck labs today for eval - last LDL at 190\",\n",
      "        \"stable with medication dose\",\n",
      "        \"stable currently\",\n",
      "        \"Stable on current medication\",\n",
      "        \"Continue bisoprolol HCTZ and we will increase losartan to 100 mg daily.  Continue to monitor BP at home with goal of 120/80\",\n",
      "        \"Continue diet changes and recheck levels today\"]\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-03-31\", \n",
      "      \"Lab results\": \"cologuard result:\", \n",
      "      \"note\": []\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-05-05\",\n",
      "      \"Lab results\": \"white blood cells: 8 K/uL, Unknown:  , vitamin D 25-oh, total: 43 NG/mL, Unknown:  , glucose: 119 mg/dL, albumin/globulin ratio: 2 (calc), GFR: 59 , Unknown:  , Blood pressure systolic and diastolic:  , Body mass index (BMI): 44 kilogram / (meter ^ 2), % monocytes: 5%, Unknown:  , % eosinophils: 4%, Unknown:  , neutrophil,absolute: 6 K/uL, monocyte,absolute: 0 K/uL, eosinophil,absolute: 0 K/uL, Unknown:  , Unknown: 5 , Unknown:  , Body temperature: 99 degree Fahrenheit, Unknown:  , estimated avg. glucose: 123 mg/dL (calc), creatinine: 1 mg/dL, sodium: 140 mmol/L, MPV: 9 fL, chloride: 103 mmol/L, hyaline casts:  , % lymphocytes: 16%, AST: 30 U/L, ALT: 27 U/L, TSH: 4 uIU/mL, basophil,absolute: 0 K/uL, bilirubin, total: 1 mg/dL, reflex culture:  , % neutrophils: 74%, squamous epi. cells:  , Hemoglobin A1c/Hemoglobin.total in Blood: 6%, potassium: 4 mmol/L, anion gap: 11 (calc), cholesterol: 226 mg/dL, platelet count: 245 K/uL, Respiratory rate: 18 Breaths / minute, Heart rate: 89 Beats / minute, RBC, urine:  , hematocrit: 39%, Unknown:  , Body weight: 123377 gram, WBC, urine:  , RDW: 14%, nucleated red cells: 0%, Oxygen saturation: 98 percent, total protein: 7 g/dL, MCH: 32 pg, % basophils: 1%, Unknown:  , lymphocyte,absolute: 1 K/uL, alkaline phosphatase: 78 U/L, nucleated RBCs, absolute: 0 K/uL, mucus, urine:  , Unknown: 1 , globulin: 3 g/dL (calc), bacteria:  , triglycerides: 178 mg/dL, calcium: 10 mg/dL, BUN/creatinine ratio: 17 (calc), Unknown:  , albumin: 4 g/dL, HDL cholesterol: 59 mg/dL, MCV: 96 fL, hemoglobin: 13 g/dL, MCHC: 34 g/dL, Unknown:  , Cholesterol in LDL [Mass/volume] in Serum or Plasma: 131 mg/dL (calc), red blood cells: 4 M/uL, carbon dioxide: 26 mmol/L, 12 lead Electrocardiogram performed.:  , blood urea nitrogen: 18 mg/dL\",\n",
      "      \"Procedure codes\": \"G0439, 93000, 3288F, 99397, 82044, 81003, G0444, 80061, 85025, 84443, 80053, 83036, 36415, 82306, 81015, 93000\",\n",
      "      \"note\": [\"stable with medication dose of Celexa at 40 mg daily. We will continue with lifestyle modification and and improving socialization activities use PHQ-9 at 0\",\n",
      "        \"BMI is at 43.9 today.  This is quite significant 25 pounds increased from her last appointment.  She is highly motivated for weight loss and will start exercising regularly and continue to monitor for more holistic diet with Mediterranean like diet changes.  Goal of 10 to 15 pound weight loss by her next appointment.\",\n",
      "        \"Advised patient on exercising stretching and other modalities for her to continue at home.  PT and/or hand orthopedic referral if this continues to be problematic\",\n",
      "        \"utd with immunizations/other screenings Patient is not a fall risk and PHQ-9 is at 0\",\n",
      "        \"Continue bisoprolol HCTZ and losartan to 100 mg daily. Continue to monitor BP at home with goal below 140/90. DASH diet recommended as well. Advised her to keep BP log and bring that with her to next cardiology appointment for further assessment for better BP control as well\",\n",
      "        \"labs today - last vit d at 29 - continue current prescription as the current dose is appropriate of vitamin D 50,000 units once daily. Continue NAME exposure as stated\",\n",
      "        \"Mild changes with ST and lateral leads specifically 2 and V4 and V6 -we will refer to cardiology for further assessment due to history of mild aortic valve sclerosis and mild change with BP values.\",\n",
      "        \"Last echocardiogram DATE did display mild aortic valve sclerosis and stenosis. We will continue to monitor for any progressing symptoms and control cholesterol and blood pressure levels\",\n",
      "        \"Stable on current medication of methocarbamol as needed. We will continue with low back stretching and movement exercises\",\n",
      "        \"rx for bactrim\",\n",
      "        \"stable currently physical activity and meloxicam as needed. If it advised patient avoidance of other NSAIDs and will continue to monitor GFR closely\",\n",
      "        \"Continue diet changes and recheck levels today -last A1c at 5.4%. We will continue with diet modification and Mediterranean food with increasing fiber intake\",\n",
      "        \"recheck labs today for eval - last LDL improved at 155 from 190 at the last appointment. We will continue with high-fiber diet and pravastatin at 40 mg daily\",\n",
      "        \"Continue increasing physical activity as well as holistic diet with elimination of processed carbs and sugars. Last BMI 39.9\"]\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-07-04\", \n",
      "      \"note\": [\"Patient visited doctor for red rash on hands that begins a few days after the pain. Skin is sensitive to touch, itching. There are fluid-filled blisters that break open and crust over. Doctor prescribed Acyclovir\"]},\n",
      "    {\n",
      "      \"Date\": \"2016-08-20\", \n",
      "      \"note\": [\"Doctor visit. Patient no longer complained of skin rash. Physical check up confirmed no rash or redness in the hand. Doctor asked to stop taking Acyclovir.\"]\n",
      "    }\n",
      "  ]\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "s3_client =boto3.client('s3')\n",
    "s3_clientobj = s3_client.get_object(Bucket=s3_bucket, Key=s3_input_object_key)\n",
    "s3_clientdata = s3_clientobj['Body'].read().decode('utf-8')\n",
    "\n",
    "patient_notes = s3_clientdata\n",
    "\n",
    "print(\"----------------------------\")\n",
    "print(\"------ Patient Notes: ------\")\n",
    "print(\"----------------------------\")\n",
    "print(patient_notes)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c6dfb1cc-8d27-4ab6-b4b3-0e016436de9d",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Call Comprehend Medical\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "440eb8ed-6b31-4c2e-a33c-ca165d9864ba",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--------------------------\n",
      "------ CM Response: ------\n",
      "--------------------------\n",
      "{'Entities': [{'Id': 117, 'Text': 'Stable', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.877546489238739, 'BeginOffset': 1688, 'EndOffset': 1694, 'Attributes': [], 'Traits': [{'Name': 'SIGN', 'Score': 0.7299559712409973}], 'ICD10CMConcepts': [{'Description': 'Other general symptoms and signs', 'Code': 'R68.89', 'Score': 0.0384138785302639}, {'Description': 'Finding of steroid agent in blood', 'Code': 'R78.6', 'Score': 0.029319066554307938}, {'Description': 'Other serum reactions', 'Code': 'T80.6', 'Score': 0.024561259895563126}, {'Description': 'Findings of drugs and other substances, not normally found in blood', 'Code': 'R78', 'Score': 0.023703327402472496}, {'Description': 'Encounter for therapeutic drug level monitoring', 'Code': 'Z51.81', 'Score': 0.022971119731664658}]}, {'Id': 326, 'Text': '25 pounds increased', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.6603351831436157, 'BeginOffset': 4223, 'EndOffset': 4242, 'Attributes': [{'Type': 'QUALITY', 'Score': 0.5330596566200256, 'RelationshipScore': 0.5068173408508301, 'Id': 325, 'BeginOffset': 4205, 'EndOffset': 4222, 'Text': 'quite significant', 'Traits': []}], 'Traits': [{'Name': 'SIGN', 'Score': 0.5752319693565369}], 'ICD10CMConcepts': [{'Description': 'Abnormal weight gain', 'Code': 'R63.5', 'Score': 0.3259369134902954}, {'Description': 'Other abnormal glucose', 'Code': 'R73.09', 'Score': 0.04541439190506935}, {'Description': 'Abnormal blood-gas level', 'Code': 'R79.81', 'Score': 0.02932211011648178}, {'Description': 'Abnormal glucose', 'Code': 'R73.0', 'Score': 0.024818645790219307}, {'Description': 'Other specified disorders of carbohydrate metabolism', 'Code': 'E74.89', 'Score': 0.02386150322854519}]}, {'Id': 327, 'Text': 'highly motivated for weight loss', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.5971075296401978, 'BeginOffset': 4278, 'EndOffset': 4310, 'Attributes': [], 'Traits': [{'Name': 'SIGN', 'Score': 0.47435709834098816}], 'ICD10CMConcepts': [{'Description': 'Abnormal weight loss', 'Code': 'R63.4', 'Score': 0.7660455703735352}, {'Description': 'Other obesity', 'Code': 'E66.8', 'Score': 0.27239030599594116}, {'Description': 'Lack of physical exercise', 'Code': 'Z72.3', 'Score': 0.2547645568847656}, {'Description': 'Other fatigue', 'Code': 'R53.83', 'Score': 0.23700842261314392}, {'Description': 'Other obesity due to excess calories', 'Code': 'E66.09', 'Score': 0.23307979106903076}]}, {'Id': 331, 'Text': 'weight loss', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.6603351831436157, 'BeginOffset': 4456, 'EndOffset': 4467, 'Attributes': [], 'Traits': [{'Name': 'HYPOTHETICAL', 'Score': 0.5752319693565369}, {'Name': 'SIGN', 'Score': 0.5752319693565369}], 'ICD10CMConcepts': [{'Description': 'Abnormal weight loss', 'Code': 'R63.4', 'Score': 0.9162859320640564}, {'Description': 'Anorexia', 'Code': 'R63.0', 'Score': 0.1115875244140625}, {'Description': 'Other specified eating disorder', 'Code': 'F50.89', 'Score': 0.11019854992628098}, {'Description': 'Underweight', 'Code': 'R63.6', 'Score': 0.10991422832012177}, {'Description': 'Overweight', 'Code': 'E66.3', 'Score': 0.09634019434452057}]}, {'Id': 336, 'Text': 'problematic', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.6603351831436157, 'BeginOffset': 4655, 'EndOffset': 4666, 'Attributes': [], 'Traits': [{'Name': 'HYPOTHETICAL', 'Score': 0.47435709834098816}, {'Name': 'SIGN', 'Score': 0.47435709834098816}], 'ICD10CMConcepts': [{'Description': 'Other general symptoms and signs', 'Code': 'R68.89', 'Score': 0.6734291315078735}, {'Description': 'Joint disorder, unspecified', 'Code': 'M25.9', 'Score': 0.5466351509094238}, {'Description': 'Other symptoms and signs involving the musculoskeletal system', 'Code': 'R29.898', 'Score': 0.5400105714797974}, {'Description': 'Other specified joint disorders, unspecified hand', 'Code': 'M25.849', 'Score': 0.47579842805862427}, {'Description': 'Other mechanical complication of other internal joint prosthesis, initial encounter', 'Code': 'T84.098A', 'Score': 0.45921534299850464}]}, {'Id': 339, 'Text': 'fall', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.8435389995574951, 'BeginOffset': 4735, 'EndOffset': 4739, 'Attributes': [], 'Traits': [{'Name': 'NEGATION', 'Score': 0.6768204569816589}, {'Name': 'SYMPTOM', 'Score': 0.8787732124328613}], 'ICD10CMConcepts': [{'Description': 'Unspecified fall, initial encounter', 'Code': 'W19.XXXA', 'Score': 0.9556540250778198}, {'Description': 'Repeated falls', 'Code': 'R29.6', 'Score': 0.8441276550292969}, {'Description': 'Unspecified fall', 'Code': 'W19', 'Score': 0.7992795705795288}, {'Description': 'History of falling', 'Code': 'Z91.81', 'Score': 0.7986705899238586}, {'Description': 'Unspecified fall, sequela', 'Code': 'W19.XXXS', 'Score': 0.6819535493850708}]}, {'Id': 348, 'Text': 'below 140/90', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.6603351831436157, 'BeginOffset': 4870, 'EndOffset': 4882, 'Attributes': [], 'Traits': [{'Name': 'HYPOTHETICAL', 'Score': 0.47435709834098816}, {'Name': 'SIGN', 'Score': 0.47435709834098816}], 'ICD10CMConcepts': [{'Description': 'Nonspecific low blood-pressure reading', 'Code': 'R03.1', 'Score': 0.3853638470172882}, {'Description': 'Elevated blood-pressure reading, without diagnosis of hypertension', 'Code': 'R03.0', 'Score': 0.16015568375587463}, {'Description': 'Hypotension, unspecified', 'Code': 'I95.9', 'Score': 0.14079247415065765}, {'Description': 'Abnormal blood-pressure reading, without diagnosis', 'Code': 'R03', 'Score': 0.11426270008087158}, {'Description': 'Hypothermia, not associated with low environmental temperature', 'Code': 'R68.0', 'Score': 0.09873898327350616}]}, {'Id': 358, 'Text': 'changes with ST and lateral leads', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.5971075296401978, 'BeginOffset': 5245, 'EndOffset': 5278, 'Attributes': [{'Type': 'QUALITY', 'Score': 0.5330596566200256, 'RelationshipScore': 0.5068173408508301, 'Id': 357, 'BeginOffset': 5240, 'EndOffset': 5244, 'Text': 'Mild', 'Traits': []}, {'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.5330596566200256, 'RelationshipScore': 0.5068173408508301, 'Id': 359, 'BeginOffset': 5292, 'EndOffset': 5307, 'Text': '2 and V4 and V6', 'Traits': []}], 'Traits': [{'Name': 'SIGN', 'Score': 0.5752319693565369}], 'ICD10CMConcepts': [{'Description': 'Abnormal electrocardiogram [ECG] [EKG]', 'Code': 'R94.31', 'Score': 0.7085309028625488}, {'Description': 'Abnormal findings on diagnostic imaging of heart and coronary circulation', 'Code': 'R93.1', 'Score': 0.37433943152427673}, {'Description': 'Conduction disorder, unspecified', 'Code': 'I45.9', 'Score': 0.36227092146873474}, {'Description': 'ST elevation (STEMI) myocardial infarction of unspecified site', 'Code': 'I21.3', 'Score': 0.31920674443244934}, {'Description': 'Other specified conduction disorders', 'Code': 'I45.89', 'Score': 0.31501197814941406}]}, {'Id': 362, 'Text': 'aortic valve sclerosis', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.7950295805931091, 'BeginOffset': 5383, 'EndOffset': 5405, 'Attributes': [{'Type': 'QUALITY', 'Score': 0.5330596566200256, 'RelationshipScore': 0.5068173408508301, 'Id': 360, 'BeginOffset': 5378, 'EndOffset': 5382, 'Text': 'mild', 'Traits': []}, {'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.8435389995574951, 'RelationshipScore': 0.8534350991249084, 'Id': 361, 'BeginOffset': 5383, 'EndOffset': 5395, 'Text': 'aortic valve', 'Traits': []}], 'Traits': [{'Name': 'DIAGNOSIS', 'Score': 0.6248409748077393}], 'ICD10CMConcepts': [{'Description': 'Other nonrheumatic aortic valve disorders', 'Code': 'I35.8', 'Score': 0.736549437046051}, {'Description': 'Congenital insufficiency of aortic valve', 'Code': 'Q23.1', 'Score': 0.7113588452339172}, {'Description': 'Nonrheumatic aortic (valve) stenosis', 'Code': 'I35.0', 'Score': 0.6494830846786499}, {'Description': 'Congenital stenosis of aortic valve', 'Code': 'Q23.0', 'Score': 0.642909049987793}, {'Description': 'Other rheumatic aortic valve diseases', 'Code': 'I06.8', 'Score': 0.6418565511703491}]}, {'Id': 364, 'Text': 'change with BP values', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.5330596566200256, 'BeginOffset': 5415, 'EndOffset': 5436, 'Attributes': [{'Type': 'QUALITY', 'Score': 0.6603351831436157, 'RelationshipScore': 0.6270833611488342, 'Id': 363, 'BeginOffset': 5410, 'EndOffset': 5414, 'Text': 'mild', 'Traits': []}], 'Traits': [{'Name': 'SIGN', 'Score': 0.5296252369880676}], 'ICD10CMConcepts': [{'Description': 'Elevated blood-pressure reading, without diagnosis of hypertension', 'Code': 'R03.0', 'Score': 0.3201068937778473}, {'Description': 'Essential (primary) hypertension', 'Code': 'I10', 'Score': 0.3044389486312866}, {'Description': 'Nonspecific low blood-pressure reading', 'Code': 'R03.1', 'Score': 0.17122405767440796}, {'Description': 'Abnormal blood-pressure reading, without diagnosis', 'Code': 'R03', 'Score': 0.13782459497451782}, {'Description': 'Encounter for examination of blood pressure with abnormal findings', 'Code': 'Z01.31', 'Score': 0.11927143484354019}]}, {'Id': 368, 'Text': 'sclerosis', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.5971075296401978, 'BeginOffset': 5504, 'EndOffset': 5513, 'Attributes': [{'Type': 'QUALITY', 'Score': 0.7613970637321472, 'RelationshipScore': 0.7552722692489624, 'Id': 366, 'BeginOffset': 5486, 'EndOffset': 5490, 'Text': 'mild', 'Traits': []}, {'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.821601390838623, 'RelationshipScore': 0.8219892978668213, 'Id': 367, 'BeginOffset': 5491, 'EndOffset': 5503, 'Text': 'aortic valve', 'Traits': []}], 'Traits': [{'Name': 'SIGN', 'Score': 0.5296252369880676}], 'ICD10CMConcepts': [{'Description': 'Atherosclerosis of aorta', 'Code': 'I70.0', 'Score': 0.6308323740959167}, {'Description': 'Other nonrheumatic aortic valve disorders', 'Code': 'I35.8', 'Score': 0.621761679649353}, {'Description': 'Nonrheumatic aortic (valve) stenosis', 'Code': 'I35.0', 'Score': 0.5928664207458496}, {'Description': 'Renal sclerosis, unspecified', 'Code': 'N26.9', 'Score': 0.5724194049835205}, {'Description': 'Congenital stenosis of aortic valve', 'Code': 'Q23.0', 'Score': 0.5012235641479492}]}, {'Id': 369, 'Text': 'stenosis', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.9201511740684509, 'BeginOffset': 5518, 'EndOffset': 5526, 'Attributes': [{'Type': 'QUALITY', 'Score': 0.7613970637321472, 'RelationshipScore': 0.6270833611488342, 'Id': 366, 'BeginOffset': 5486, 'EndOffset': 5490, 'Text': 'mild', 'Traits': []}, {'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.821601390838623, 'RelationshipScore': 0.6795811653137207, 'Id': 367, 'BeginOffset': 5491, 'EndOffset': 5503, 'Text': 'aortic valve', 'Traits': []}], 'Traits': [{'Name': 'SIGN', 'Score': 0.8203471899032593}], 'ICD10CMConcepts': [{'Description': 'Nonrheumatic aortic (valve) stenosis', 'Code': 'I35.0', 'Score': 0.8572348356246948}, {'Description': 'Rheumatic aortic stenosis', 'Code': 'I06.0', 'Score': 0.5796012282371521}, {'Description': 'Nonrheumatic pulmonary valve stenosis', 'Code': 'I37.0', 'Score': 0.4960099160671234}, {'Description': 'Congenital stenosis of aortic valve', 'Code': 'Q23.0', 'Score': 0.48543959856033325}, {'Description': 'Rheumatic disorders of both aortic and tricuspid valves', 'Code': 'I08.2', 'Score': 0.47998926043510437}]}, {'Id': 371, 'Text': 'symptoms', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.877546489238739, 'BeginOffset': 5576, 'EndOffset': 5584, 'Attributes': [{'Type': 'QUALITY', 'Score': 0.5971075296401978, 'RelationshipScore': 0.5692254304885864, 'Id': 370, 'BeginOffset': 5564, 'EndOffset': 5575, 'Text': 'progressing', 'Traits': []}], 'Traits': [{'Name': 'HYPOTHETICAL', 'Score': 0.6248409748077393}, {'Name': 'SYMPTOM', 'Score': 0.9013108015060425}], 'ICD10CMConcepts': [{'Description': 'Other general symptoms and signs', 'Code': 'R68.89', 'Score': 0.9532518982887268}, {'Description': 'Other specified symptoms and signs involving the circulatory and respiratory systems', 'Code': 'R09.89', 'Score': 0.47292599081993103}, {'Description': 'Unspecified symptoms and signs involving the nervous system', 'Code': 'R29.90', 'Score': 0.33317261934280396}, {'Description': 'Other symptoms and signs involving the nervous system', 'Code': 'R29.818', 'Score': 0.30948492884635925}, {'Description': 'Unspecified symptoms and signs involving the musculoskeletal system', 'Code': 'R29.91', 'Score': 0.30812355875968933}]}, {'Id': 373, 'Text': 'Stable', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.90631103515625, 'BeginOffset': 5646, 'EndOffset': 5652, 'Attributes': [], 'Traits': [{'Name': 'SIGN', 'Score': 0.6248409748077393}], 'ICD10CMConcepts': [{'Description': 'Other general symptoms and signs', 'Code': 'R68.89', 'Score': 0.2091754823923111}, {'Description': 'Finding of steroid agent in blood', 'Code': 'R78.6', 'Score': 0.08639752119779587}, {'Description': 'Weakness', 'Code': 'R53.1', 'Score': 0.08077625185251236}, {'Description': 'Abnormal finding of blood chemistry, unspecified', 'Code': 'R79.9', 'Score': 0.07073190808296204}, {'Description': 'Other hypertension', 'Code': 'I1A', 'Score': 0.07016459852457047}]}, {'Id': 412, 'Text': 'rash', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.821601390838623, 'BeginOffset': 6519, 'EndOffset': 6523, 'Attributes': [{'Type': 'QUALITY', 'Score': 0.5971075296401978, 'RelationshipScore': 0.5692254304885864, 'Id': 411, 'BeginOffset': 6515, 'EndOffset': 6518, 'Text': 'red', 'Traits': []}, {'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.821601390838623, 'RelationshipScore': 0.6270833611488342, 'Id': 413, 'BeginOffset': 6527, 'EndOffset': 6532, 'Text': 'hands', 'Traits': []}], 'Traits': [{'Name': 'SYMPTOM', 'Score': 0.8530592322349548}], 'ICD10CMConcepts': [{'Description': 'Rash and other nonspecific skin eruption', 'Code': 'R21', 'Score': 0.8398987650871277}, {'Description': 'Other specified dermatitis', 'Code': 'L30.8', 'Score': 0.201450914144516}, {'Description': 'Irritant contact dermatitis, unspecified cause', 'Code': 'L24.9', 'Score': 0.20045068860054016}, {'Description': 'Dermatitis, unspecified', 'Code': 'L30.9', 'Score': 0.18232540786266327}, {'Description': 'Other seborrheic dermatitis', 'Code': 'L21.8', 'Score': 0.18203896284103394}]}, {'Id': 414, 'Text': 'few days', 'Category': 'TIME_EXPRESSION', 'Type': 'TIME_TO_DX_NAME', 'Score': 0.5330596566200256, 'BeginOffset': 6547, 'EndOffset': 6555, 'Attributes': [{'Type': 'DX_NAME', 'Score': 0.821601390838623, 'RelationshipScore': 0.5068173408508301, 'Id': 412, 'BeginOffset': 6519, 'EndOffset': 6523, 'Text': 'rash', 'Traits': [{'Name': 'SYMPTOM', 'Score': 0.8530592322349548}]}], 'Traits': [], 'ICD10CMConcepts': []}, {'Id': 415, 'Text': 'pain', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.8435389995574951, 'BeginOffset': 6566, 'EndOffset': 6570, 'Attributes': [], 'Traits': [{'Name': 'SYMPTOM', 'Score': 0.8787732124328613}], 'ICD10CMConcepts': [{'Description': 'Pain, unspecified', 'Code': 'R52', 'Score': 0.6537946462631226}, {'Description': 'Pain in right hand', 'Code': 'M79.641', 'Score': 0.6386856436729431}, {'Description': 'Pain in left hand', 'Code': 'M79.642', 'Score': 0.579860508441925}, {'Description': 'Pain in unspecified hand', 'Code': 'M79.643', 'Score': 0.5604330897331238}, {'Description': 'Pain in joints of hand', 'Code': 'M25.54', 'Score': 0.48980093002319336}]}, {'Id': 417, 'Text': 'sensitive to touch', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.7172441482543945, 'BeginOffset': 6580, 'EndOffset': 6598, 'Attributes': [{'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.7613970637321472, 'RelationshipScore': 0.7552722692489624, 'Id': 416, 'BeginOffset': 6572, 'EndOffset': 6576, 'Text': 'Skin', 'Traits': []}], 'Traits': [{'Name': 'SYMPTOM', 'Score': 0.7299559712409973}], 'ICD10CMConcepts': [{'Description': 'Other disturbances of skin sensation', 'Code': 'R20.8', 'Score': 0.5959574580192566}, {'Description': 'Unspecified disturbances of skin sensation', 'Code': 'R20.9', 'Score': 0.5272861123085022}, {'Description': 'Pruritus, unspecified', 'Code': 'L29.9', 'Score': 0.48811274766921997}, {'Description': 'Paresthesia of skin', 'Code': 'R20.2', 'Score': 0.45607855916023254}, {'Description': 'Other prurigo', 'Code': 'L28.2', 'Score': 0.4175488352775574}]}, {'Id': 418, 'Text': 'itching', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.877546489238739, 'BeginOffset': 6600, 'EndOffset': 6607, 'Attributes': [{'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.7613970637321472, 'RelationshipScore': 0.7223333120346069, 'Id': 416, 'BeginOffset': 6572, 'EndOffset': 6576, 'Text': 'Skin', 'Traits': []}], 'Traits': [{'Name': 'SYMPTOM', 'Score': 0.9214484095573425}], 'ICD10CMConcepts': [{'Description': 'Pruritus, unspecified', 'Code': 'L29.9', 'Score': 0.8980244398117065}, {'Description': 'Other pruritus', 'Code': 'L29.8', 'Score': 0.3706026077270508}, {'Description': 'Other prurigo', 'Code': 'L28.2', 'Score': 0.3412642776966095}, {'Description': 'Pruritus ani', 'Code': 'L29.0', 'Score': 0.33927926421165466}, {'Description': 'Pruritus', 'Code': 'L29', 'Score': 0.22453995048999786}]}, {'Id': 419, 'Text': 'fluid-filled blisters', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.821601390838623, 'BeginOffset': 6619, 'EndOffset': 6640, 'Attributes': [{'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.7613970637321472, 'RelationshipScore': 0.5068173408508301, 'Id': 416, 'BeginOffset': 6572, 'EndOffset': 6576, 'Text': 'Skin', 'Traits': []}, {'Type': 'QUALITY', 'Score': 0.6603351831436157, 'RelationshipScore': 0.5692254304885864, 'Id': 420, 'BeginOffset': 6646, 'EndOffset': 6656, 'Text': 'break open', 'Traits': []}, {'Type': 'QUALITY', 'Score': 0.7172441482543945, 'RelationshipScore': 0.5692254304885864, 'Id': 421, 'BeginOffset': 6661, 'EndOffset': 6671, 'Text': 'crust over', 'Traits': []}], 'Traits': [{'Name': 'SYMPTOM', 'Score': 0.8530592322349548}], 'ICD10CMConcepts': [{'Description': 'Blister (nonthermal) of unspecified hand, initial encounter', 'Code': 'S60.529A', 'Score': 0.5283889174461365}, {'Description': 'Blister (nonthermal) of right hand, initial encounter', 'Code': 'S60.521A', 'Score': 0.39321663975715637}, {'Description': 'Blister (nonthermal) of unspecified finger, initial encounter', 'Code': 'S60.429A', 'Score': 0.36531075835227966}, {'Description': 'Blister (nonthermal) of left hand, initial encounter', 'Code': 'S60.522A', 'Score': 0.34177812933921814}, {'Description': 'Other skin changes', 'Code': 'R23.8', 'Score': 0.29212021827697754}]}, {'Id': 424, 'Text': 'skin rash', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.8921527862548828, 'BeginOffset': 6802, 'EndOffset': 6811, 'Attributes': [{'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.6603351831436157, 'RelationshipScore': 0.6795811653137207, 'Id': 423, 'BeginOffset': 6802, 'EndOffset': 6806, 'Text': 'skin', 'Traits': []}], 'Traits': [{'Name': 'SYMPTOM', 'Score': 0.9214484095573425}], 'ICD10CMConcepts': [{'Description': 'Rash and other nonspecific skin eruption', 'Code': 'R21', 'Score': 0.9416992664337158}, {'Description': 'Generalized skin eruption due to drugs and medicaments taken internally', 'Code': 'L27.0', 'Score': 0.27165454626083374}, {'Description': 'Irritant contact dermatitis due to friction or contact with body fluids, unspecified', 'Code': 'L24.A0', 'Score': 0.21047455072402954}, {'Description': 'Localized skin eruption due to drugs and medicaments taken internally', 'Code': 'L27.1', 'Score': 0.19448132812976837}, {'Description': 'Irritant contact dermatitis due to friction or contact with body fluids', 'Code': 'L24.A', 'Score': 0.1693795770406723}]}, {'Id': 426, 'Text': 'rash', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.9201511740684509, 'BeginOffset': 6844, 'EndOffset': 6848, 'Attributes': [{'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.877546489238739, 'RelationshipScore': 0.7552722692489624, 'Id': 428, 'BeginOffset': 6867, 'EndOffset': 6871, 'Text': 'hand', 'Traits': []}], 'Traits': [{'Name': 'NEGATION', 'Score': 0.8787732124328613}, {'Name': 'SYMPTOM', 'Score': 0.9405226111412048}], 'ICD10CMConcepts': [{'Description': 'Rash and other nonspecific skin eruption', 'Code': 'R21', 'Score': 0.8565017580986023}, {'Description': 'Dermatitis, unspecified', 'Code': 'L30.9', 'Score': 0.12302198261022568}, {'Description': 'Generalized skin eruption due to drugs and medicaments taken internally', 'Code': 'L27.0', 'Score': 0.12076328694820404}, {'Description': 'Dermatophytosis, unspecified', 'Code': 'B35.9', 'Score': 0.10925427824258804}, {'Description': 'Other seborrheic dermatitis', 'Code': 'L21.8', 'Score': 0.09352556616067886}]}, {'Id': 427, 'Text': 'redness', 'Category': 'MEDICAL_CONDITION', 'Type': 'DX_NAME', 'Score': 0.9350614547729492, 'BeginOffset': 6852, 'EndOffset': 6859, 'Attributes': [{'Type': 'SYSTEM_ORGAN_SITE', 'Score': 0.877546489238739, 'RelationshipScore': 0.8031880259513855, 'Id': 428, 'BeginOffset': 6867, 'EndOffset': 6871, 'Text': 'hand', 'Traits': []}], 'Traits': [{'Name': 'NEGATION', 'Score': 0.9214484095573425}, {'Name': 'SYMPTOM', 'Score': 0.9596198797225952}], 'ICD10CMConcepts': [{'Description': 'Erythematous condition, unspecified', 'Code': 'L53.9', 'Score': 0.8183447122573853}, {'Description': 'Other skin changes', 'Code': 'R23.8', 'Score': 0.6003503799438477}, {'Description': 'Other specified erythematous conditions', 'Code': 'L53.8', 'Score': 0.3974093794822693}, {'Description': 'Other rosacea', 'Code': 'L71.8', 'Score': 0.2689204216003418}, {'Description': 'Other erythematous conditions', 'Code': 'L53', 'Score': 0.2682272493839264}]}], 'ModelVersion': '3.0.0.20231001', 'ResponseMetadata': {'RequestId': '017fe7fa-e2e1-4f49-83ff-83864925911d', 'HTTPStatusCode': 200, 'HTTPHeaders': {'x-amzn-requestid': '017fe7fa-e2e1-4f49-83ff-83864925911d', 'content-type': 'application/x-amz-json-1.1', 'content-length': '20156', 'date': 'Sat, 05 Oct 2024 13:53:36 GMT'}, 'RetryAttempts': 0}}\n",
      "\n",
      "\n",
      "\n",
      "---------------------------------------------------------------------\n",
      "------ CM Output: Entities with score above than the threshold ------\n",
      "---------------------------------------------------------------------\n",
      "[{'cm_text': 'highly motivated for weight loss', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Abnormal weight loss', 'Code': 'R63.4', 'Score': 0.7660455703735352}}]}, {'cm_text': 'weight loss', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Abnormal weight loss', 'Code': 'R63.4', 'Score': 0.9162859320640564}}]}, {'cm_text': 'fall', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Unspecified fall, initial encounter', 'Code': 'W19.XXXA', 'Score': 0.9556540250778198}}, {'cm_icd10concept': {'Description': 'Repeated falls', 'Code': 'R29.6', 'Score': 0.8441276550292969}}, {'cm_icd10concept': {'Description': 'Unspecified fall', 'Code': 'W19', 'Score': 0.7992795705795288}}, {'cm_icd10concept': {'Description': 'History of falling', 'Code': 'Z91.81', 'Score': 0.7986705899238586}}]}, {'cm_text': 'changes with ST and lateral leads', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Abnormal electrocardiogram [ECG] [EKG]', 'Code': 'R94.31', 'Score': 0.7085309028625488}}]}, {'cm_text': 'aortic valve sclerosis', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Other nonrheumatic aortic valve disorders', 'Code': 'I35.8', 'Score': 0.736549437046051}}, {'cm_icd10concept': {'Description': 'Congenital insufficiency of aortic valve', 'Code': 'Q23.1', 'Score': 0.7113588452339172}}]}, {'cm_text': 'stenosis', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Nonrheumatic aortic (valve) stenosis', 'Code': 'I35.0', 'Score': 0.8572348356246948}}]}, {'cm_text': 'symptoms', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Other general symptoms and signs', 'Code': 'R68.89', 'Score': 0.9532518982887268}}]}, {'cm_text': 'rash', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Rash and other nonspecific skin eruption', 'Code': 'R21', 'Score': 0.8398987650871277}}]}, {'cm_text': 'itching', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Pruritus, unspecified', 'Code': 'L29.9', 'Score': 0.8980244398117065}}]}, {'cm_text': 'skin rash', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Rash and other nonspecific skin eruption', 'Code': 'R21', 'Score': 0.9416992664337158}}]}, {'cm_text': 'rash', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Rash and other nonspecific skin eruption', 'Code': 'R21', 'Score': 0.8565017580986023}}]}, {'cm_text': 'redness', 'cm_category': 'MEDICAL_CONDITION', 'cm_icd10concepts_above_threshold_score': [{'cm_icd10concept': {'Description': 'Erythematous condition, unspecified', 'Code': 'L53.9', 'Score': 0.8183447122573853}}]}]\n"
     ]
    }
   ],
   "source": [
    "if use_comprehend_medical == 'Y':\n",
    "    comprehend_med = boto3.client('comprehendmedical')\n",
    "\n",
    "    cm_response = comprehend_med.infer_icd10_cm(\n",
    "        Text = patient_notes\n",
    "    )\n",
    "    print(\"--------------------------\")\n",
    "    print(\"------ CM Response: ------\")\n",
    "    print(\"--------------------------\")\n",
    "    print(cm_response)\n",
    "\n",
    "    cm_output = []\n",
    "\n",
    "    response_entities = cm_response[\"Entities\"]\n",
    "    for entity in response_entities:\n",
    "        cm_text = entity[\"Text\"]\n",
    "        cm_category = entity[\"Category\"]\n",
    "        cm_icd10concepts = entity[\"ICD10CMConcepts\"]\n",
    "\n",
    "        cm_icd10concepts_above_threshold_score = []\n",
    "\n",
    "        inclusion_flag = \"N\" \n",
    "\n",
    "        for cm_icd10concept in cm_icd10concepts:\n",
    "            if cm_icd10concept[\"Score\"] >= cm_threshold:\n",
    "                inclusion_flag = \"Y\"\n",
    "                cm_icd10concepts_above_threshold_score.append({\n",
    "                    'cm_icd10concept' : cm_icd10concept\n",
    "                })\n",
    "\n",
    "        if inclusion_flag == \"Y\":\n",
    "            cm_output.append({\n",
    "                'cm_text': cm_text,\n",
    "                'cm_category': cm_category,\n",
    "                'cm_icd10concepts_above_threshold_score' : cm_icd10concepts_above_threshold_score\n",
    "            })\n",
    "            \n",
    "    print(\"\\n\\n\")\n",
    "    print(\"---------------------------------------------------------------------\")\n",
    "    print(\"------ CM Output: Entities with score above than the threshold ------\")\n",
    "    print(\"---------------------------------------------------------------------\")\n",
    "    print(cm_output)\n",
    "    cm_output_str = json.dumps(cm_output)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a9bd23a6-b97f-44f6-bd1c-475bb5603748",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Prompt Template:\n",
    "\n",
    "This is the base prompt template that has been broken down into multiple segments based on the prompt engineering [best practices](https://docs.anthropic.com/claude/docs/prompt-engineering) suggested by Anthropic.\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "053b7e42-5e1a-406f-90a4-e5491b48e0cc",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "-----------------------------------------------------------------------------------------------\n",
      "--------------------------- Full prompt with variable substitutions ---------------------------\n",
      "-----------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "-----USER TURN-----\n",
      "You are a medical reviewer. You review patient notes and provide recommendation to the doctor about the medical conditions of the patient. Your recommendation includes patients current and chronic medical conditions. Your recommendation helps the doctor to decide on the treatment plan.\n",
      "\n",
      "You should maintain a friendly customer service tone.\n",
      "\n",
      "Here are some important rules for the interaction:\n",
      "\n",
      "- Refer to the <patient_notes>. Carefully read through the history, medications, encounters. For each encounter, carefully review the lab results, note. Check line-by-line to look for any evidence of medical conditions. \n",
      "\n",
      "- Lab results contain comma separated list of lab readings, which can be lengthy. Please read through each and every value carefully. Maintain a list of common lab value thresholds that indicate potential conditions, and cross-check any out-of-range values against this list. \n",
      "\n",
      "- When reviewing notes, actively look for any mention of symptoms, diagnoses, medications prescribed, or procedures done that could indicate a condition. Only list a medical condition when you see clear evidence in the lab results or notes to support a diagnosis. \n",
      "\n",
      "- Refer to the findings from comprehend medical inside <comprehend_medical></comprehend_medical> XML tag. Use this as a helper tool to identify the medical conditions.\n",
      "\n",
      "- Please do not make any assumptions without verifying supporting evidence for the specific date.\n",
      "\n",
      "- For each date, list all the medical conditions, corresponding ICD 10 codes, relevant explanation as evidence.\n",
      "\n",
      "- Only use the information provided to generate the recommendation. If there are no medical condition to recommend to the doctor tell no medical condition to report.\n",
      "\n",
      "- Provide the final recommendation inside <recommendation></recommendation> XML tags in JSON format, with each condition formatted as:\n",
      "{\n",
      "  \"Active_Condition\":[\n",
      "  {\"Review\": {  \n",
      "  \"DX_Code\": \"ICD10 Code\",\n",
      "  \"Description\": \"Condition description\",\n",
      "  \"Memo\": {\n",
      "              \"date\":\"date\",\n",
      "              \"note\":\"Explanation from notes\"\n",
      "          }\n",
      "  }},\n",
      "  {\"Review\": {\n",
      "  \"DX_Code\": \"ICD10 Code\",\n",
      "  \"Description\": \"Condition description\",\n",
      "  \"Memo\": {\n",
      "              \"date\":\"date\",\n",
      "              \"note\":\"Explanation from notes\"\n",
      "          }\n",
      "  }}],\n",
      "  \"Inactive_Condition\": [\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"ICD10 Code\",\n",
      "      \"Description\": \"Condition description\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"date\",\n",
      "        \"note\": \"Explanation from notes\"\n",
      "      }\n",
      "  }}]\n",
      "}\n",
      "\n",
      "\n",
      "Here is an example inside <example></example> XML tag on how to perform the task: \n",
      "<example>\n",
      "user: <patient_notes>\n",
      "{\n",
      "  \"name\": \"XYZ\",\n",
      "  \"age\": \"60 years\",\n",
      "  \"sex\": \"Male\",\n",
      "  \"encounters\": [ \n",
      "    {\n",
      "      \"Date\": \"2022-01-04\", \n",
      "      \"Procedure codes\": \"99214\",\n",
      "      \"note\": [\"Blood pressure has been stable. Pt is overdue for physical and labs. Pt will come to the lab next month and will schedule an appointment for a physical.\", \"stable\"]\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2022-02-04\", \n",
      "      \"note\": [\"Dual-chamber pacemaker was placed for sinus node dysfunction.\"]\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2023-07-22\",\n",
      "      \"note\": [\"Had unprovoked PE.  Still on anticoagulation.  Oncology note dated 07/05/2023: long term anticoagulation recommended.  It can be primary hypercoagulability.\"]\n",
      "    }, \n",
      "    {\n",
      "      \"Date\": \"2023-07-31\", \n",
      "      \"note\": [\"Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\", \"Patient visited doctor for cough, chest soreness, runny nose, headache, slight fever, and sore throat. Doctor suggested to take Ibuprofen and cough suppressant\"]\n",
      "    }\n",
      "  ]\n",
      "}\n",
      "</patient_notes>\n",
      "\n",
      "assistant: <response>\n",
      "<thinking>\n",
      "Date: 2022-01-04\n",
      "No evidence of medical conditions\n",
      "\n",
      "Date: 2022-02-04\n",
      "Condition: Sinus node dysfunction \n",
      "ICD10: I49.5\n",
      "Evidence: Dual-chamber pacemaker was placed for sinus node dysfunction.\n",
      "\n",
      "Date: 2023-07-22  \n",
      "Condition: Pulmonary embolism\n",
      "ICD10: I26.99\n",
      "Evidence: Had unprovoked PE. Still on anticoagulation. Oncology note dated 07/05/2023: long term anticoagulation recommended. It can be primary hypercoagulability.\n",
      "\n",
      "Date: 2023-07-31\n",
      "Condition 1: Type 2 diabetes mellitus with diabetic polyneuropathy\n",
      "ICD10: E11.42\n",
      "Evidence: Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\n",
      "\n",
      "Condition 2: Upper respiratory infection \n",
      "ICD10: J06.9\n",
      "Evidence: Patient visited doctor for cough, chest soreness, runny nose, headache, slight fever, and sore throat. Doctor suggested to take Ibuprofen and cough suppressant.\n",
      "\n",
      "Date: 2023-09-01\n",
      "Condition 1: Vitamin D deficiency\n",
      "ICD10: E55.9\n",
      "Evidence: vitamin D 25-oh, total: 43 NG/mL\n",
      "\n",
      "Condition 2: Upper respiratory infection (inactive)\n",
      "ICD10: J06.9\n",
      "Evidence: Doctor visit. Patient no longer complained of cough. Patient is not taking Ibuprofen and cough suppressant anymore.\n",
      "\n",
      "Inactive Conditions:\n",
      "- Upper respiratory infection (J06.9)\n",
      "\n",
      "Active Conditions:  \n",
      "- Sinus node dysfunction (I49.5)\n",
      "- Pulmonary embolism (I26.99)\n",
      "- Type 2 diabetes mellitus with diabetic polyneuropathy (E11.42)\n",
      "- Prostate cancer (C61)\n",
      "- Vitamin D deficiency (E55.9)\n",
      "</thinking>\n",
      "\n",
      "<recommendation>\n",
      "{\n",
      "  \"Active_Condition\": [ \n",
      "  {\"Review\":{\n",
      "    \"DX_Code\": \"I49.5\",  \n",
      "    \"Description\": \"Sinus node dysfunction\",\n",
      "    \"Memo\": {\n",
      "      \"date\": \"2022-02-04\",\n",
      "      \"note\": \"Dual-chamber pacemaker was placed for sinus node dysfunction.\"\n",
      "    }\n",
      "  }},  \n",
      "  {\"Review\": {  \n",
      "    \"DX_Code\": \"I26.99\",\n",
      "    \"Description\": \"Pulmonary embolism\", \n",
      "    \"Memo\": {\n",
      "      \"date\": \"2023-07-22\",  \n",
      "      \"note\": \"Had unprovoked PE. Still on anticoagulation. Oncology note dated 07/05/2023: long term anticoagulation recommended. It can be primary hypercoagulability.\"\n",
      "    }\n",
      "  }},\n",
      "  {\"Review\": {\n",
      "    \"DX_Code\": \"E11.42\",  \n",
      "    \"Description\": \"Type 2 diabetes mellitus with diabetic polyneuropathy\",\n",
      "    \"Memo\": {\n",
      "      \"date\": \"2023-07-31\",\n",
      "      \"note\": \"Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\"\n",
      "    }\n",
      "  }},\n",
      "  {\"Review\": {\n",
      "    \"DX_Code\": \"E55.9\",\n",
      "    \"Description\": \"Vitamin D deficiency\",  \n",
      "    \"Memo\": {\n",
      "        \"date\": \"2023-09-01\",\n",
      "        \"note\": \"vitamin D 25-oh, total: 43 NG/mL\"\n",
      "      }\n",
      "    }}],\n",
      "  \"Inactive_Condition\": [\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"J06.9\",\n",
      "      \"Description\": \"Upper respiratory infection\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2023-09-01\",\n",
      "        \"note\": \"Doctor visit. Patient no longer complained of cough. Patient is not taking Ibuprofen and cough suppressant anymore.\"\n",
      "      }\n",
      "    }}]\n",
      "  }\n",
      "</recommendation>\n",
      "</response>\n",
      "</example>\n",
      "\n",
      "Here are the patient notes: \n",
      "<patient_notes>\n",
      "{\n",
      "  \"name\": \"Patient 1\",\n",
      "  \"age\": \"57 years\",\n",
      "  \"sex\": \"Male\",\n",
      "  \"encounters\": [\n",
      "    {\n",
      "      \"Date\": \"2016-01-21\",\n",
      "      \"ICD10 diagnoses\": \"R01.1\",\n",
      "      \"Procedure codes\": \"93306\",\n",
      "      \"note\": []\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-02-25\",\n",
      "      \"Lab results\": \"potassium: 4 mmol/L, Body temperature: 97 degree Fahrenheit, Hemoglobin A1c/Hemoglobin.total in Blood: 5%, HDL cholesterol: 73 mg/dL, glucose: 103 mg/dL, albumin/globulin ratio: 2 (calc), Oxygen saturation: 98 percent, Respiratory rate: 18 Breaths / minute, creatinine: 1 mg/dL, ALT: 21 U/L, Body weight: 112037 gram, globulin: 2 g/dL (calc), carbon dioxide: 25 mmol/L, Body mass index (BMI): 40 kilogram / (meter ^ 2), alkaline phosphatase: 77 U/L, estimated avg. glucose: 108 mg/dL (calc), chloride: 102 mmol/L, blood urea nitrogen: 19 mg/dL, bilirubin, total: 1 mg/dL, GFR non-african american: 78 , triglycerides: 111 mg/dL, BUN/creatinine ratio: 24 (calc), Cholesterol in LDL [Mass/volume] in Serum or Plasma: 155 mg/dL (calc), GFR african american: 90 , albumin: 5 g/dL, Heart rate: 72 Beats / minute, anion gap: 12 (calc), sodium: 139 mmol/L, vitamin D 25-oh, total: 29 NG/mL, Blood pressure systolic and diastolic:  , calcium: 10 mg/dL, AST: 24 U/L, cholesterol: 250 mg/dL, total protein: 7 g/dL\",\n",
      "      \"Procedure codes\": \"80053, 99214, 83036, 80061, 36415, 82306\",\n",
      "      \"note\": [\"Continue increasing physical activity as well as holistic diet with elimination of processed carbs and sugars\",\n",
      "        \"labs today - continue current prescription as the current dose is appropriate\",\n",
      "        \"recheck labs today for eval - last LDL at 190\",\n",
      "        \"stable with medication dose\",\n",
      "        \"stable currently\",\n",
      "        \"Stable on current medication\",\n",
      "        \"Continue bisoprolol HCTZ and we will increase losartan to 100 mg daily.  Continue to monitor BP at home with goal of 120/80\",\n",
      "        \"Continue diet changes and recheck levels today\"]\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-03-31\", \n",
      "      \"Lab results\": \"cologuard result:\", \n",
      "      \"note\": []\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-05-05\",\n",
      "      \"Lab results\": \"white blood cells: 8 K/uL, Unknown:  , vitamin D 25-oh, total: 43 NG/mL, Unknown:  , glucose: 119 mg/dL, albumin/globulin ratio: 2 (calc), GFR: 59 , Unknown:  , Blood pressure systolic and diastolic:  , Body mass index (BMI): 44 kilogram / (meter ^ 2), % monocytes: 5%, Unknown:  , % eosinophils: 4%, Unknown:  , neutrophil,absolute: 6 K/uL, monocyte,absolute: 0 K/uL, eosinophil,absolute: 0 K/uL, Unknown:  , Unknown: 5 , Unknown:  , Body temperature: 99 degree Fahrenheit, Unknown:  , estimated avg. glucose: 123 mg/dL (calc), creatinine: 1 mg/dL, sodium: 140 mmol/L, MPV: 9 fL, chloride: 103 mmol/L, hyaline casts:  , % lymphocytes: 16%, AST: 30 U/L, ALT: 27 U/L, TSH: 4 uIU/mL, basophil,absolute: 0 K/uL, bilirubin, total: 1 mg/dL, reflex culture:  , % neutrophils: 74%, squamous epi. cells:  , Hemoglobin A1c/Hemoglobin.total in Blood: 6%, potassium: 4 mmol/L, anion gap: 11 (calc), cholesterol: 226 mg/dL, platelet count: 245 K/uL, Respiratory rate: 18 Breaths / minute, Heart rate: 89 Beats / minute, RBC, urine:  , hematocrit: 39%, Unknown:  , Body weight: 123377 gram, WBC, urine:  , RDW: 14%, nucleated red cells: 0%, Oxygen saturation: 98 percent, total protein: 7 g/dL, MCH: 32 pg, % basophils: 1%, Unknown:  , lymphocyte,absolute: 1 K/uL, alkaline phosphatase: 78 U/L, nucleated RBCs, absolute: 0 K/uL, mucus, urine:  , Unknown: 1 , globulin: 3 g/dL (calc), bacteria:  , triglycerides: 178 mg/dL, calcium: 10 mg/dL, BUN/creatinine ratio: 17 (calc), Unknown:  , albumin: 4 g/dL, HDL cholesterol: 59 mg/dL, MCV: 96 fL, hemoglobin: 13 g/dL, MCHC: 34 g/dL, Unknown:  , Cholesterol in LDL [Mass/volume] in Serum or Plasma: 131 mg/dL (calc), red blood cells: 4 M/uL, carbon dioxide: 26 mmol/L, 12 lead Electrocardiogram performed.:  , blood urea nitrogen: 18 mg/dL\",\n",
      "      \"Procedure codes\": \"G0439, 93000, 3288F, 99397, 82044, 81003, G0444, 80061, 85025, 84443, 80053, 83036, 36415, 82306, 81015, 93000\",\n",
      "      \"note\": [\"stable with medication dose of Celexa at 40 mg daily. We will continue with lifestyle modification and and improving socialization activities use PHQ-9 at 0\",\n",
      "        \"BMI is at 43.9 today.  This is quite significant 25 pounds increased from her last appointment.  She is highly motivated for weight loss and will start exercising regularly and continue to monitor for more holistic diet with Mediterranean like diet changes.  Goal of 10 to 15 pound weight loss by her next appointment.\",\n",
      "        \"Advised patient on exercising stretching and other modalities for her to continue at home.  PT and/or hand orthopedic referral if this continues to be problematic\",\n",
      "        \"utd with immunizations/other screenings Patient is not a fall risk and PHQ-9 is at 0\",\n",
      "        \"Continue bisoprolol HCTZ and losartan to 100 mg daily. Continue to monitor BP at home with goal below 140/90. DASH diet recommended as well. Advised her to keep BP log and bring that with her to next cardiology appointment for further assessment for better BP control as well\",\n",
      "        \"labs today - last vit d at 29 - continue current prescription as the current dose is appropriate of vitamin D 50,000 units once daily. Continue NAME exposure as stated\",\n",
      "        \"Mild changes with ST and lateral leads specifically 2 and V4 and V6 -we will refer to cardiology for further assessment due to history of mild aortic valve sclerosis and mild change with BP values.\",\n",
      "        \"Last echocardiogram DATE did display mild aortic valve sclerosis and stenosis. We will continue to monitor for any progressing symptoms and control cholesterol and blood pressure levels\",\n",
      "        \"Stable on current medication of methocarbamol as needed. We will continue with low back stretching and movement exercises\",\n",
      "        \"rx for bactrim\",\n",
      "        \"stable currently physical activity and meloxicam as needed. If it advised patient avoidance of other NSAIDs and will continue to monitor GFR closely\",\n",
      "        \"Continue diet changes and recheck levels today -last A1c at 5.4%. We will continue with diet modification and Mediterranean food with increasing fiber intake\",\n",
      "        \"recheck labs today for eval - last LDL improved at 155 from 190 at the last appointment. We will continue with high-fiber diet and pravastatin at 40 mg daily\",\n",
      "        \"Continue increasing physical activity as well as holistic diet with elimination of processed carbs and sugars. Last BMI 39.9\"]\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-07-04\", \n",
      "      \"note\": [\"Patient visited doctor for red rash on hands that begins a few days after the pain. Skin is sensitive to touch, itching. There are fluid-filled blisters that break open and crust over. Doctor prescribed Acyclovir\"]},\n",
      "    {\n",
      "      \"Date\": \"2016-08-20\", \n",
      "      \"note\": [\"Doctor visit. Patient no longer complained of skin rash. Physical check up confirmed no rash or redness in the hand. Doctor asked to stop taking Acyclovir.\"]\n",
      "    }\n",
      "  ]\n",
      "}\n",
      "</patient_notes>\n",
      "\n",
      "Here are the comprehend medical findings:\n",
      "    <comprehend_medical> \n",
      "    [{\"cm_text\": \"highly motivated for weight loss\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Abnormal weight loss\", \"Code\": \"R63.4\", \"Score\": 0.7660455703735352}}]}, {\"cm_text\": \"weight loss\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Abnormal weight loss\", \"Code\": \"R63.4\", \"Score\": 0.9162859320640564}}]}, {\"cm_text\": \"fall\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Unspecified fall, initial encounter\", \"Code\": \"W19.XXXA\", \"Score\": 0.9556540250778198}}, {\"cm_icd10concept\": {\"Description\": \"Repeated falls\", \"Code\": \"R29.6\", \"Score\": 0.8441276550292969}}, {\"cm_icd10concept\": {\"Description\": \"Unspecified fall\", \"Code\": \"W19\", \"Score\": 0.7992795705795288}}, {\"cm_icd10concept\": {\"Description\": \"History of falling\", \"Code\": \"Z91.81\", \"Score\": 0.7986705899238586}}]}, {\"cm_text\": \"changes with ST and lateral leads\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Abnormal electrocardiogram [ECG] [EKG]\", \"Code\": \"R94.31\", \"Score\": 0.7085309028625488}}]}, {\"cm_text\": \"aortic valve sclerosis\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Other nonrheumatic aortic valve disorders\", \"Code\": \"I35.8\", \"Score\": 0.736549437046051}}, {\"cm_icd10concept\": {\"Description\": \"Congenital insufficiency of aortic valve\", \"Code\": \"Q23.1\", \"Score\": 0.7113588452339172}}]}, {\"cm_text\": \"stenosis\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Nonrheumatic aortic (valve) stenosis\", \"Code\": \"I35.0\", \"Score\": 0.8572348356246948}}]}, {\"cm_text\": \"symptoms\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Other general symptoms and signs\", \"Code\": \"R68.89\", \"Score\": 0.9532518982887268}}]}, {\"cm_text\": \"rash\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Rash and other nonspecific skin eruption\", \"Code\": \"R21\", \"Score\": 0.8398987650871277}}]}, {\"cm_text\": \"itching\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Pruritus, unspecified\", \"Code\": \"L29.9\", \"Score\": 0.8980244398117065}}]}, {\"cm_text\": \"skin rash\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Rash and other nonspecific skin eruption\", \"Code\": \"R21\", \"Score\": 0.9416992664337158}}]}, {\"cm_text\": \"rash\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Rash and other nonspecific skin eruption\", \"Code\": \"R21\", \"Score\": 0.8565017580986023}}]}, {\"cm_text\": \"redness\", \"cm_category\": \"MEDICAL_CONDITION\", \"cm_icd10concepts_above_threshold_score\": [{\"cm_icd10concept\": {\"Description\": \"Erythematous condition, unspecified\", \"Code\": \"L53.9\", \"Score\": 0.8183447122573853}}]}] \n",
      "    </comprehend_medical>\n",
      "\n",
      "Here is the user's question:\n",
      "<question>\n",
      "Share your recommendation about the medical conditions of the patient\n",
      "</question>\n",
      "\n",
      "How do you respond to the user's question?\n",
      "\n",
      "Think step by step about your answer first before you respond. When you reply, first find all the medical conditions, corresponding ICD10 codes, explanation and write them down inside <thinking></thinking> XML tags.  This is a space for you to write down relevant content. Once you are done extracting relevant information, double check your work. Look back over the lab results and notes again with fresh eyes to make sure nothing was missed. Now answer the question. Put your recommendation inside <recommendation></recommendation> XML tag.\n",
      "\n",
      "Put your response in <response></response> tags.\n",
      "\n",
      "\n",
      "-----ASSISTANT TURN-----\n",
      "[assistant] <response>\n"
     ]
    }
   ],
   "source": [
    "######################################## INPUT VARIABLES ########################################\n",
    "\n",
    "# First input variable - the conversation history (this can also be added as preceding `user` and `assistant` messages in the API call)\n",
    "HISTORY = \"\"\n",
    "\n",
    "# Second input variable - the user's question\n",
    "QUESTION = \"Share your recommendation about the medical conditions of the patient\"\n",
    "\n",
    "\n",
    "\n",
    "######################################## PROMPT ELEMENTS ########################################\n",
    "\n",
    "##### Prompt element 1: `user` role\n",
    "# Make sure that your Messages API call always starts with a `user` role in the messages array.\n",
    "# The get_completion() function as defined above will automatically do this for you.\n",
    "\n",
    "##### Prompt element 2: Task context\n",
    "# Give Claude context about the role it should take on or what goals and overarching tasks you want it to undertake with the prompt.\n",
    "# It's best to put context early in the body of the prompt.\n",
    "TASK_CONTEXT = \"You are a medical reviewer. You review patient notes and provide recommendation to the doctor about the medical conditions of the patient. Your recommendation includes patients current and chronic medical conditions. Your recommendation helps the doctor to decide on the treatment plan.\"\n",
    "\n",
    "##### Prompt element 3: Tone context\n",
    "# If important to the interaction, tell Claude what tone it should use.\n",
    "# This element may not be necessary depending on the task.\n",
    "TONE_CONTEXT = \"You should maintain a friendly customer service tone.\"\n",
    "\n",
    "##### Prompt element 4: Detailed task description and rules\n",
    "# Expand on the specific tasks you want Claude to do, as well as any rules that Claude might have to follow.\n",
    "# This is also where you can give Claude an \"out\" if it doesn't have an answer or doesn't know.\n",
    "# It's ideal to show this description and rules to a friend to make sure it is laid out logically and that any ambiguous words are clearly defined.\n",
    "\n",
    "TASK_DESCRIPTION = \"\"\"Here are some important rules for the interaction:\n",
    "\n",
    "- Refer to the <patient_notes>. Carefully read through the history, medications, encounters. For each encounter, carefully review the lab results, note. Check line-by-line to look for any evidence of medical conditions. \n",
    "\n",
    "- Lab results contain comma separated list of lab readings, which can be lengthy. Please read through each and every value carefully. Maintain a list of common lab value thresholds that indicate potential conditions, and cross-check any out-of-range values against this list. \n",
    "\n",
    "- When reviewing notes, actively look for any mention of symptoms, diagnoses, medications prescribed, or procedures done that could indicate a condition. Only list a medical condition when you see clear evidence in the lab results or notes to support a diagnosis. \n",
    "\n",
    "$cm_instruction$\n",
    "\n",
    "- Please do not make any assumptions without verifying supporting evidence for the specific date.\n",
    "\n",
    "- For each date, list all the medical conditions, corresponding ICD 10 codes, relevant explanation as evidence.\n",
    "\n",
    "- Only use the information provided to generate the recommendation. If there are no medical condition to recommend to the doctor tell no medical condition to report.\n",
    "\n",
    "- Provide the final recommendation inside <recommendation></recommendation> XML tags in JSON format, with each condition formatted as:\n",
    "{\n",
    "  \"Active_Condition\":[\n",
    "  {\"Review\": {  \n",
    "  \"DX_Code\": \"ICD10 Code\",\n",
    "  \"Description\": \"Condition description\",\n",
    "  \"Memo\": {\n",
    "              \"date\":\"date\",\n",
    "              \"note\":\"Explanation from notes\"\n",
    "          }\n",
    "  }},\n",
    "  {\"Review\": {\n",
    "  \"DX_Code\": \"ICD10 Code\",\n",
    "  \"Description\": \"Condition description\",\n",
    "  \"Memo\": {\n",
    "              \"date\":\"date\",\n",
    "              \"note\":\"Explanation from notes\"\n",
    "          }\n",
    "  }}],\n",
    "  \"Inactive_Condition\": [\n",
    "    {\"Review\": {\n",
    "      \"DX_Code\": \"ICD10 Code\",\n",
    "      \"Description\": \"Condition description\",\n",
    "      \"Memo\": {\n",
    "        \"date\": \"date\",\n",
    "        \"note\": \"Explanation from notes\"\n",
    "      }\n",
    "  }}]\n",
    "}\n",
    "\"\"\"\n",
    "\n",
    "cm_instruction = \"\"\n",
    "if use_comprehend_medical == 'Y':\n",
    "    cm_instruction = \"- Refer to the findings from comprehend medical inside <comprehend_medical></comprehend_medical> XML tag. Use this as a helper tool to identify the medical conditions.\"\n",
    "TASK_DESCRIPTION = TASK_DESCRIPTION.replace(\"$cm_instruction$\",cm_instruction)\n",
    "\n",
    "##### Prompt element 5: Examples\n",
    "# Provide Claude with at least one example of an ideal response that it can emulate. Encase this in <example></example> XML tags. Feel free to provide multiple examples.\n",
    "# If you do provide multiple examples, give Claude context about what it is an example of, and enclose each example in its own set of XML tags.\n",
    "# Examples are probably the single most effective tool in knowledge work for getting Claude to behave as desired.\n",
    "# Make sure to give Claude examples of common edge cases. If your prompt uses a scratchpad, it's effective to give examples of how the scratchpad should look.\n",
    "# Generally more examples = better.\n",
    "EXAMPLES = \"\"\"Here is an example inside <example></example> XML tag on how to perform the task: \n",
    "<example>\n",
    "user: <patient_notes>\n",
    "{\n",
    "  \"name\": \"XYZ\",\n",
    "  \"age\": \"60 years\",\n",
    "  \"sex\": \"Male\",\n",
    "  \"encounters\": [ \n",
    "    {\n",
    "      \"Date\": \"2022-01-04\", \n",
    "      \"Procedure codes\": \"99214\",\n",
    "      \"note\": [\"Blood pressure has been stable. Pt is overdue for physical and labs. Pt will come to the lab next month and will schedule an appointment for a physical.\", \"stable\"]\n",
    "    },\n",
    "    {\n",
    "      \"Date\": \"2022-02-04\", \n",
    "      \"note\": [\"Dual-chamber pacemaker was placed for sinus node dysfunction.\"]\n",
    "    },\n",
    "    {\n",
    "      \"Date\": \"2023-07-22\",\n",
    "      \"note\": [\"Had unprovoked PE.  Still on anticoagulation.  Oncology note dated 07/05/2023: long term anticoagulation recommended.  It can be primary hypercoagulability.\"]\n",
    "    }, \n",
    "    {\n",
    "      \"Date\": \"2023-07-31\", \n",
    "      \"note\": [\"Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\", \"Patient visited doctor for cough, chest soreness, runny nose, headache, slight fever, and sore throat. Doctor suggested to take Ibuprofen and cough suppressant\"]\n",
    "    }\n",
    "  ]\n",
    "}\n",
    "</patient_notes>\n",
    "\n",
    "assistant: <response>\n",
    "<thinking>\n",
    "Date: 2022-01-04\n",
    "No evidence of medical conditions\n",
    "\n",
    "Date: 2022-02-04\n",
    "Condition: Sinus node dysfunction \n",
    "ICD10: I49.5\n",
    "Evidence: Dual-chamber pacemaker was placed for sinus node dysfunction.\n",
    "\n",
    "Date: 2023-07-22  \n",
    "Condition: Pulmonary embolism\n",
    "ICD10: I26.99\n",
    "Evidence: Had unprovoked PE. Still on anticoagulation. Oncology note dated 07/05/2023: long term anticoagulation recommended. It can be primary hypercoagulability.\n",
    "\n",
    "Date: 2023-07-31\n",
    "Condition 1: Type 2 diabetes mellitus with diabetic polyneuropathy\n",
    "ICD10: E11.42\n",
    "Evidence: Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\n",
    "\n",
    "Condition 2: Upper respiratory infection \n",
    "ICD10: J06.9\n",
    "Evidence: Patient visited doctor for cough, chest soreness, runny nose, headache, slight fever, and sore throat. Doctor suggested to take Ibuprofen and cough suppressant.\n",
    "\n",
    "Date: 2023-09-01\n",
    "Condition 1: Vitamin D deficiency\n",
    "ICD10: E55.9\n",
    "Evidence: vitamin D 25-oh, total: 43 NG/mL\n",
    "\n",
    "Condition 2: Upper respiratory infection (inactive)\n",
    "ICD10: J06.9\n",
    "Evidence: Doctor visit. Patient no longer complained of cough. Patient is not taking Ibuprofen and cough suppressant anymore.\n",
    "\n",
    "Inactive Conditions:\n",
    "- Upper respiratory infection (J06.9)\n",
    "\n",
    "Active Conditions:  \n",
    "- Sinus node dysfunction (I49.5)\n",
    "- Pulmonary embolism (I26.99)\n",
    "- Type 2 diabetes mellitus with diabetic polyneuropathy (E11.42)\n",
    "- Prostate cancer (C61)\n",
    "- Vitamin D deficiency (E55.9)\n",
    "</thinking>\n",
    "\n",
    "<recommendation>\n",
    "{\n",
    "  \"Active_Condition\": [ \n",
    "  {\"Review\":{\n",
    "    \"DX_Code\": \"I49.5\",  \n",
    "    \"Description\": \"Sinus node dysfunction\",\n",
    "    \"Memo\": {\n",
    "      \"date\": \"2022-02-04\",\n",
    "      \"note\": \"Dual-chamber pacemaker was placed for sinus node dysfunction.\"\n",
    "    }\n",
    "  }},  \n",
    "  {\"Review\": {  \n",
    "    \"DX_Code\": \"I26.99\",\n",
    "    \"Description\": \"Pulmonary embolism\", \n",
    "    \"Memo\": {\n",
    "      \"date\": \"2023-07-22\",  \n",
    "      \"note\": \"Had unprovoked PE. Still on anticoagulation. Oncology note dated 07/05/2023: long term anticoagulation recommended. It can be primary hypercoagulability.\"\n",
    "    }\n",
    "  }},\n",
    "  {\"Review\": {\n",
    "    \"DX_Code\": \"E11.42\",  \n",
    "    \"Description\": \"Type 2 diabetes mellitus with diabetic polyneuropathy\",\n",
    "    \"Memo\": {\n",
    "      \"date\": \"2023-07-31\",\n",
    "      \"note\": \"Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\"\n",
    "    }\n",
    "  }},\n",
    "  {\"Review\": {\n",
    "    \"DX_Code\": \"E55.9\",\n",
    "    \"Description\": \"Vitamin D deficiency\",  \n",
    "    \"Memo\": {\n",
    "        \"date\": \"2023-09-01\",\n",
    "        \"note\": \"vitamin D 25-oh, total: 43 NG/mL\"\n",
    "      }\n",
    "    }}],\n",
    "  \"Inactive_Condition\": [\n",
    "    {\"Review\": {\n",
    "      \"DX_Code\": \"J06.9\",\n",
    "      \"Description\": \"Upper respiratory infection\",\n",
    "      \"Memo\": {\n",
    "        \"date\": \"2023-09-01\",\n",
    "        \"note\": \"Doctor visit. Patient no longer complained of cough. Patient is not taking Ibuprofen and cough suppressant anymore.\"\n",
    "      }\n",
    "    }}]\n",
    "  }\n",
    "</recommendation>\n",
    "</response>\n",
    "</example>\"\"\"\n",
    "\n",
    "##### Prompt element 6: Input data to process\n",
    "# If there is data that Claude needs to process within the prompt, include it here within relevant XML tags.\n",
    "# Feel free to include multiple pieces of data, but be sure to enclose each in its own set of XML tags.\n",
    "# This element may not be necessary depending on task. Ordering is also flexible.\n",
    "\n",
    "INPUT_DATA = f\"\"\"Here are the patient notes: \n",
    "<patient_notes>\n",
    "{patient_notes}\n",
    "</patient_notes>\n",
    "\n",
    "$cm_context$\n",
    "\n",
    "Here is the user's question:\n",
    "<question>\n",
    "{QUESTION}\n",
    "</question>\"\"\"\n",
    "\n",
    "cm_context = \"\"\n",
    "if use_comprehend_medical == 'Y':\n",
    "    cm_context = f\"\"\"Here are the comprehend medical findings:\n",
    "    <comprehend_medical> \n",
    "    {cm_output_str} \n",
    "    </comprehend_medical>\"\"\"\n",
    "INPUT_DATA = INPUT_DATA.replace(\"$cm_context$\",cm_context)\n",
    "\n",
    "##### Prompt element 7: Immediate task description or request #####\n",
    "# \"Remind\" Claude or tell Claude exactly what it's expected to immediately do to fulfill the prompt's task.\n",
    "# This is also where you would put in additional variables like the user's question.\n",
    "# It generally doesn't hurt to reiterate to Claude its immediate task. It's best to do this toward the end of a long prompt.\n",
    "# This will yield better results than putting this at the beginning.\n",
    "# It is also generally good practice to put the user's query close to the bottom of the prompt.\n",
    "IMMEDIATE_TASK = \"How do you respond to the user's question?\"\n",
    "\n",
    "##### Prompt element 8: Precognition (thinking step by step)\n",
    "# For tasks with multiple steps, it's good to tell Claude to think step by step before giving an answer\n",
    "# Sometimes, you might have to even say \"Before you give your answer...\" just to make sure Claude does this first.\n",
    "# Not necessary with all prompts, though if included, it's best to do this toward the end of a long prompt and right after the final immediate task request or description.\n",
    "PRECOGNITION = \"Think step by step about your answer first before you respond. When you reply, first find all the medical conditions, corresponding ICD10 codes, explanation and write them down inside <thinking></thinking> XML tags.  This is a space for you to write down relevant content. Once you are done extracting relevant information, double check your work. Look back over the lab results and notes again with fresh eyes to make sure nothing was missed. Now answer the question. Put your recommendation inside <recommendation></recommendation> XML tag.\"\n",
    "\n",
    "\n",
    "##### Prompt element 9: Output formatting\n",
    "# If there is a specific way you want Claude's response formatted, clearly tell Claude what that format is.\n",
    "# This element may not be necessary depending on the task.\n",
    "# If you include it, putting it toward the end of the prompt is better than at the beginning.\n",
    "OUTPUT_FORMATTING = \"Put your response in <response></response> tags.\"\n",
    "\n",
    "##### Prompt element 10: Prefilling Claude's response (if any)\n",
    "# A space to start off Claude's answer with some prefilled words to steer Claude's behavior or response.\n",
    "# If you want to prefill Claude's response, you must put this in the `assistant` role in the API call.\n",
    "# This element may not be necessary depending on the task.\n",
    "PREFILL = \"[assistant] <response>\"\n",
    "\n",
    "\n",
    "\n",
    "######################################## COMBINE ELEMENTS ########################################\n",
    "\n",
    "PROMPT = \"\"\n",
    "\n",
    "if TASK_CONTEXT:\n",
    "    PROMPT += f\"\"\"{TASK_CONTEXT}\"\"\"\n",
    "\n",
    "if TONE_CONTEXT:\n",
    "    PROMPT += f\"\"\"\\n\\n{TONE_CONTEXT}\"\"\"\n",
    "\n",
    "if TASK_DESCRIPTION:\n",
    "    PROMPT += f\"\"\"\\n\\n{TASK_DESCRIPTION}\"\"\"\n",
    "\n",
    "if EXAMPLES:\n",
    "    PROMPT += f\"\"\"\\n\\n{EXAMPLES}\"\"\"\n",
    "\n",
    "if INPUT_DATA:\n",
    "    PROMPT += f\"\"\"\\n\\n{INPUT_DATA}\"\"\"\n",
    "\n",
    "if IMMEDIATE_TASK:\n",
    "    PROMPT += f\"\"\"\\n\\n{IMMEDIATE_TASK}\"\"\"\n",
    "\n",
    "if PRECOGNITION:\n",
    "    PROMPT += f\"\"\"\\n\\n{PRECOGNITION}\"\"\"\n",
    "\n",
    "if OUTPUT_FORMATTING:\n",
    "    PROMPT += f\"\"\"\\n\\n{OUTPUT_FORMATTING}\"\"\"\n",
    "\n",
    "# Print full prompt\n",
    "print(\"-----------------------------------------------------------------------------------------------\")\n",
    "print(\"--------------------------- Full prompt with variable substitutions ---------------------------\")\n",
    "print(\"-----------------------------------------------------------------------------------------------\")\n",
    "\n",
    "print(\"\\n\")\n",
    "print(\"-----USER TURN-----\")\n",
    "print(PROMPT)\n",
    "\n",
    "print(\"\\n\")\n",
    "print(\"-----ASSISTANT TURN-----\")\n",
    "print(PREFILL)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2b879e2d-1917-4adf-9883-964890320735",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Call LLM\n",
    "Now let's run the prompt! Run the cell below to see LLM's output.\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "d768fd67-057c-42cb-b821-09c6b7ea4256",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--------------------------------------------------------------------------------------------\n",
      "--------------------------------------- LLM's response -------------------------------------\n",
      "--------------------------------------------------------------------------------------------\n",
      "Input tokens: %s 5777\n",
      "Output tokens: %s 2262\n",
      "Total tokens: %s 8039\n",
      "Stop reason: %s end_turn\n",
      "\n",
      "<thinking>\n",
      "Date: 2016-01-21\n",
      "Condition: Cardiac murmur\n",
      "ICD10: R01.1\n",
      "Evidence: ICD10 diagnosis code R01.1\n",
      "\n",
      "Date: 2016-02-25\n",
      "Condition 1: Obesity\n",
      "ICD10: E66.9\n",
      "Evidence: Body mass index (BMI): 40 kilogram / (meter ^ 2)\n",
      "\n",
      "Condition 2: Hyperlipidemia\n",
      "ICD10: E78.5\n",
      "Evidence: cholesterol: 250 mg/dL, triglycerides: 111 mg/dL, HDL cholesterol: 73 mg/dL, Cholesterol in LDL [Mass/volume] in Serum or Plasma: 155 mg/dL (calc)\n",
      "\n",
      "Condition 3: Vitamin D deficiency\n",
      "ICD10: E55.9\n",
      "Evidence: vitamin D 25-oh, total: 29 NG/mL\n",
      "\n",
      "Condition 4: Hypertension\n",
      "ICD10: I10\n",
      "Evidence: \"Continue bisoprolol HCTZ and we will increase losartan to 100 mg daily. Continue to monitor BP at home with goal of 120/80\"\n",
      "\n",
      "Condition 5: Prediabetes\n",
      "ICD10: R73.03\n",
      "Evidence: Hemoglobin A1c/Hemoglobin.total in Blood: 5%, glucose: 103 mg/dL, estimated avg. glucose: 108 mg/dL (calc)\n",
      "\n",
      "Date: 2016-03-31\n",
      "No medical conditions found\n",
      "\n",
      "Date: 2016-05-05\n",
      "Condition 1: Obesity (continued)\n",
      "ICD10: E66.9\n",
      "Evidence: Body mass index (BMI): 44 kilogram / (meter ^ 2)\n",
      "\n",
      "Condition 2: Hyperlipidemia (continued)\n",
      "ICD10: E78.5  \n",
      "Evidence: cholesterol: 226 mg/dL, triglycerides: 178 mg/dL, HDL cholesterol: 59 mg/dL, Cholesterol in LDL [Mass/volume] in Serum or Plasma: 131 mg/dL (calc)\n",
      "\n",
      "Condition 3: Vitamin D deficiency (continued)\n",
      "ICD10: E55.9\n",
      "Evidence: vitamin D 25-oh, total: 43 NG/mL  \n",
      "\n",
      "Condition 4: Hypertension (continued)\n",
      "ICD10: I10\n",
      "Evidence: \"Continue bisoprolol HCTZ and losartan to 100 mg daily. Continue to monitor BP at home with goal below 140/90.\"\n",
      "\n",
      "Condition 5: Prediabetes (continued)\n",
      "ICD10: R73.03\n",
      "Evidence: Hemoglobin A1c/Hemoglobin.total in Blood: 6%, glucose: 119 mg/dL, estimated avg. glucose: 123 mg/dL (calc)  \n",
      "\n",
      "Condition 6: Chronic kidney disease, stage 3\n",
      "ICD10: N18.3\n",
      "Evidence: GFR: 59\n",
      "\n",
      "Condition 7: Hypothyroidism\n",
      "ICD10: E03.9\n",
      "Evidence: TSH: 4 uIU/mL\n",
      "\n",
      "Condition 8: Abnormal electrocardiogram\n",
      "ICD10: R94.31\n",
      "Evidence: \"Mild changes with ST and lateral leads specifically 2 and V4 and V6 -we will refer to cardiology for further assessment due to history of mild aortic valve sclerosis and mild change with BP values.\"\n",
      "\n",
      "Condition 9: Aortic valve disorder\n",
      "ICD10: I35.8\n",
      "Evidence: \"Last echocardiogram DATE did display mild aortic valve sclerosis and stenosis.\"\n",
      "\n",
      "Date: 2016-07-04\n",
      "Condition: Herpes simplex\n",
      "ICD10: B00.9\n",
      "Evidence: \"Patient visited doctor for red rash on hands that begins a few days after the pain. Skin is sensitive to touch, itching. There are fluid-filled blisters that break open and crust over. Doctor prescribed Acyclovir\"\n",
      "\n",
      "Date: 2016-08-20\n",
      "No active medical conditions found\n",
      "Evidence: \"Doctor visit. Patient no longer complained of skin rash. Physical check up confirmed no rash or redness in the hand. Doctor asked to stop taking Acyclovir.\"\n",
      "\n",
      "Inactive Conditions:\n",
      "- Herpes simplex (B00.9)\n",
      "\n",
      "Active Conditions:\n",
      "- Cardiac murmur (R01.1)\n",
      "- Obesity (E66.9)\n",
      "- Hyperlipidemia (E78.5)\n",
      "- Vitamin D deficiency (E55.9)  \n",
      "- Hypertension (I10)\n",
      "- Prediabetes (R73.03)\n",
      "- Chronic kidney disease, stage 3 (N18.3)\n",
      "- Hypothyroidism (E03.9)\n",
      "- Abnormal electrocardiogram (R94.31)\n",
      "- Aortic valve disorder (I35.8)\n",
      "</thinking>\n",
      "\n",
      "<recommendation>\n",
      "{\n",
      "  \"Active_Condition\": [\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R01.1\",\n",
      "      \"Description\": \"Cardiac murmur\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-01-21\",\n",
      "        \"note\": \"ICD10 diagnosis code R01.1\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E66.9\",\n",
      "      \"Description\": \"Obesity\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Body mass index (BMI): 44 kilogram / (meter ^ 2)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E78.5\",\n",
      "      \"Description\": \"Hyperlipidemia\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"cholesterol: 226 mg/dL, triglycerides: 178 mg/dL, HDL cholesterol: 59 mg/dL, Cholesterol in LDL [Mass/volume] in Serum or Plasma: 131 mg/dL (calc)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E55.9\",\n",
      "      \"Description\": \"Vitamin D deficiency\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"vitamin D 25-oh, total: 43 NG/mL\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"I10\",\n",
      "      \"Description\": \"Hypertension\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Continue bisoprolol HCTZ and losartan to 100 mg daily. Continue to monitor BP at home with goal below 140/90.\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R73.03\",\n",
      "      \"Description\": \"Prediabetes\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Hemoglobin A1c/Hemoglobin.total in Blood: 6%, glucose: 119 mg/dL, estimated avg. glucose: 123 mg/dL (calc)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"N18.3\",\n",
      "      \"Description\": \"Chronic kidney disease, stage 3\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"GFR: 59\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E03.9\",\n",
      "      \"Description\": \"Hypothyroidism\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"TSH: 4 uIU/mL\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R94.31\",\n",
      "      \"Description\": \"Abnormal electrocardiogram\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Mild changes with ST and lateral leads specifically 2 and V4 and V6 -we will refer to cardiology for further assessment due to history of mild aortic valve sclerosis and mild change with BP values.\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"I35.8\",\n",
      "      \"Description\": \"Aortic valve disorder\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Last echocardiogram DATE did display mild aortic valve sclerosis and stenosis.\"\n",
      "      }\n",
      "    }}\n",
      "  ],\n",
      "  \"Inactive_Condition\": [\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"B00.9\",\n",
      "      \"Description\": \"Herpes simplex\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-08-20\",\n",
      "        \"note\": \"Doctor visit. Patient no longer complained of skin rash. Physical check up confirmed no rash or redness in the hand. Doctor asked to stop taking Acyclovir.\"\n",
      "      }\n",
      "    }}\n",
      "  ]\n",
      "}\n",
      "</recommendation>\n",
      "</response>\n"
     ]
    }
   ],
   "source": [
    "print(\"--------------------------------------------------------------------------------------------\")\n",
    "print(\"--------------------------------------- LLM's response -------------------------------------\")\n",
    "print(\"--------------------------------------------------------------------------------------------\")\n",
    "llm_output_text = (get_completion(PROMPT, prefill=PREFILL))\n",
    "print(llm_output_text)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a21db472-067b-4377-9a68-e76a029a6cc0",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Parse initial recommendation\n",
    "List all the medical condistions identified based on the initial recommendation\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "4c55677b-f11f-4a4b-ab76-a795878959e7",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "-------------------------------\n",
      "------Medical Conditions:------\n",
      "-------------------------------\n",
      "['Cardiac murmur', 'Obesity', 'Hyperlipidemia', 'Vitamin D deficiency', 'Hypertension', 'Prediabetes', 'Chronic kidney disease, stage 3', 'Hypothyroidism', 'Abnormal electrocardiogram', 'Aortic valve disorder', 'Herpes simplex']\n"
     ]
    }
   ],
   "source": [
    "if use_knowledge_base == 'Y':\n",
    "    \n",
    "    # Find text between <recommendation> tags using regex\n",
    "    pattern = r'<recommendation>(.*?)</recommendation>'\n",
    "    match = re.search(pattern, llm_output_text, re.DOTALL)\n",
    "\n",
    "    medical_conditions = []\n",
    "\n",
    "    if match:\n",
    "        extracted_recommendation = match.group(1)\n",
    "        #print(extracted_recommendation)\n",
    "        extracted_recommendation_json = json.loads(extracted_recommendation)\n",
    "\n",
    "\n",
    "        for item in extracted_recommendation_json[\"Active_Condition\"]:\n",
    "            if (item[\"Review\"][\"Description\"]) not in medical_conditions:\n",
    "                medical_conditions.append(item[\"Review\"][\"Description\"])\n",
    "\n",
    "        for item in extracted_recommendation_json[\"Inactive_Condition\"]:\n",
    "            if (item[\"Review\"][\"Description\"]) not in medical_conditions:\n",
    "                medical_conditions.append(item[\"Review\"][\"Description\"])\n",
    "\n",
    "    else:\n",
    "        print(\"No match found.\")\n",
    "\n",
    "    print(\"-------------------------------\")\n",
    "    print(\"------Medical Conditions:------\")\n",
    "    print(\"-------------------------------\")\n",
    "    print(medical_conditions)\n",
    "\n",
    "    initial_recommendation = extracted_recommendation"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c686469-e682-444e-b387-12eea1aea038",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Fetch context from Knowledge Base\n",
    "\n",
    "Get the organization guidelines from KB based on the medical conditions found\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "7b366724-1a2c-401b-b210-c84c31778891",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--------------------------\n",
      "--------KB Output:--------\n",
      "--------------------------\n",
      "[{'medical_condition': 'Cardiac murmur', 'kb_context': [{'content': {'text': \"I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.  I50.21 - Acute systolic (congestive) heart failure: This code is used to diagnose acute systolic heart failure, which is a sudden onset of the condition where the heart's left ventricle cannot pump blood effectively due to decreased contractility.  I20.9 - Angina pectoris, unspecified: This code is used to diagnose angina pectoris or chest pain/discomfort due to reduced blood flow to the heart, but it does not specify the underlying cause (e.g., atherosclerosis, coronary artery disease, etc.).  I11.9 - Hypertensive heart disease without heart failure: This code is used to diagnose hypertensive heart disease, which is a condition where high blood pressure has caused damage or changes to the heart muscle. However, the patient does not have heart failure.  I24.9 - Acute ischemic heart disease, unspecified I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site I35.1 - Nonrheumatic aortic (valve) insufficiency I48.92 - Unspecified atrial flutter I34.0 - Nonrheumatic mitral (valve) insufficiency I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A4FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.4564133}, {'content': {'text': \"In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to I25.10, this code indicates atherosclerosis in the native coronary arteries. However, in this case, the patient experiences angina pectoris (chest pain or discomfort) due to reduced blood flow to the heart.  I50.22 - Chronic systolic (congestive) heart failure: This code is used to diagnose chronic systolic heart failure, a condition where the heart's left ventricle (the main pumping chamber) cannot pump blood effectively due to decreased contractility. It is a chronic (long-term) condition.  I48.0 - Paroxysmal atrial fibrillation: This code indicates that the patient has paroxysmal atrial fibrillation, which means the irregular heart rhythm comes and goes in episodes.  I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A3lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.4562157}, {'content': {'text': 'I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.  I21.9 - Acute myocardial infarction, unspecified: This code is used to diagnose a heart attack or myocardial infarction, but it does not specify the type (ST-elevation or non-ST-elevation) or location of the heart attack.  I48.20 - Chronic atrial fibrillation, unspecified: This code indicates the presence of chronic (persistent) atrial fibrillation, but it does not specify whether it is paroxysmal or permanent.  I49.9 - Cardiac arrhythmia, unspecified: This code is used to diagnose an irregular heart rhythm or cardiac arrhythmia, but it does not specify the type of arrhythmia (e.g., atrial fibrillation, ventricular tachycardia, etc.).  I50.9 - Heart failure, unspecified: This code is used to diagnose heart failure, but it does not specify the type (systolic or diastolic) or the underlying cause of the heart failure.  I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A31OBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.44361448}, {'content': {'text': 'ICD-10 codes in cardiology:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which supply blood to the heart muscle. However, the patient does not experience angina pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart.  I10 - Essential (primary) hypertension: This code refers to high blood pressure (hypertension) that has no identifiable cause. It is often called \"essential\" or \"primary\" hypertension.  I48.91 - Unspecified atrial fibrillation: This code indicates the presence of atrial fibrillation, an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. However, it does not specify whether the atrial fibrillation is paroxysmal (comes and goes) or chronic (persistent).  I21.4 - Non-ST elevation (NSTEMI) myocardial infarction: This code is used to diagnose a type of heart attack, specifically a non-ST-elevation myocardial infarction (NSTEMI). In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A3VOBQZIBzQkILuD-asVr', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.43512434}, {'content': {'text': 'the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A6FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.43510583}]}, {'medical_condition': 'Obesity', 'kb_context': [{'content': {'text': \"E66.9 - Obesity, unspecified This code indicates obesity without any additional details specified.  E66.01 - Morbid (severe) obesity due to excess calories This code is for severe obesity resulting from consuming excess calories.  E66.3 - Overweight This code applies when someone is overweight, but not yet classified as obese.  E66.8 - Other obesity This is a code for types of obesity that don't fit the other specific categories listed.  E66.2 - Obesity due to caloric excess This indicates obesity caused by consuming too many calories.  E66.09 - Other obesity due to excess calories This is for obesity from excess calories that doesn't fit the severe/morbid category.  E66.1 - Drug-induced obesity This code is for obesity that developed as a side effect of taking certain medications.  E66.0 - Obesity due to excess calories A general code for obesity resulting from caloric excess without additional details.  The Z68.* codes indicate the specific body mass index (BMI) range: Z68.54 - Body mass index (BMI) greater than or equal to 35, adult Z68.53 - Body mass index (BMI) 33.0-33.9, adult Z68.52 - Body mass index (BMI) 32.0-32.9, adult Z68.51 - Body mass index (BMI) 31.0-31.9, adult\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A-lOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.48345536}, {'content': {'text': \", resolved following treatment E11.37X2 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X3 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X9 - Type 2 diabetes mellitus with diabetic macular edema, unspecified E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.49 - Type 2 diabetes mellitus with other diabetic neurological complication E11.630 - Type 2 diabetes mellitus with diabetic cystopathy   ICD-10 codes related to obesity:  E66.9 - Obesity, unspecified This code indicates obesity without any additional details specified.  E66.01 - Morbid (severe) obesity due to excess calories This code is for severe obesity resulting from consuming excess calories.  E66.3 - Overweight This code applies when someone is overweight, but not yet classified as obese.  E66.8 - Other obesity This is a code for types of obesity that don't fit the other specific categories listed.  E66.2 - Obesity due to caloric excess This indicates obesity caused by consuming too many calories.  E66.09 - Other obesity due to excess calories This is for obesity from excess calories that doesn't fit the severe/morbid category.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A-VOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.45419607}, {'content': {'text': '(BMI) 32.0-32.9, adult Z68.51 - Body mass index (BMI) 31.0-31.9, adult Z68.39 - Body mass index (BMI) 39.0-39.9, adult Z68.38 - Body mass index (BMI) 38.0-38.9, adult Z68.37 - Body mass index (BMI) 37.0-37.9, adult Z68.36 - Body mass index (BMI) 36.0-36.9, adult Z68.35 - Body mass index (BMI) 35.0-35.9, adult Z68.34 - Body mass index (BMI) 34.0-34.9, adult Z68.33 - Body mass index (BMI) 33.0-33.9, adult Z68.32 - Body mass index (BMI) 32.0-32.9, adult Z68.31 - Body mass index (BMI) 31.0-31.9, adult Z68.30 - Body mass index (BMI) 30.0-30.9, adult Z68.41 - Body mass index (BMI) 40.0-44.9, adult Z68.42 - Body mass index (BMI) 45.0-49.9, adult Z68.43 - Body mass index (BMI)'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A-1OBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.44292173}, {'content': {'text': 'adult Z68.41 - Body mass index (BMI) 40.0-44.9, adult Z68.42 - Body mass index (BMI) 45.0-49.9, adult Z68.43 - Body mass index (BMI) 50-59.9, adult Z68.44 - Body mass index (BMI) 60.0-69.9, adult Z68.45 - Body mass index (BMI) 70 or greater, adult E66.8 - Other obesity, not elsewhere classified E66.1 - Drug-induced obesity, not elsewhere classified   ICD-10 codes commonly used in Rheumatology:  MM05.9 - Rheumatoid arthritis, unspecified: This code is used when rheumatoid arthritis (a chronic autoimmune disorder primarily affecting the joints) is present, but the specific site or severity is not documented.  M06.9 - Rheumatoid arthritis, unspecified: This is the same as the previous code, indicating an unspecified case of rheumatoid arthritis.  M15.9 - Polyosteoarthritis, unspecified: This code refers to osteoarthritis (a degenerative joint disease) affecting multiple joints, but the specific sites are not documented.  M17.9 - Osteoarthritis of knee, unspecified: This code is used for osteoarthritis affecting the knee joint, without specifying which knee (right or left) or the severity.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A_FOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.42061195}, {'content': {'text': 'E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.  E11.3219 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed mild nonproliferative diabetic retinopathy (an early stage of diabetic retinopathy) without macular edema.  E11.3213 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy with macular edema.  E11.3212 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy without macular edema.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A9VOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.37617218}]}, {'medical_condition': 'Hyperlipidemia', 'kb_context': [{'content': {'text': 'The specific sequelae (consequences) are not specified in this code.  I70.239 - Atherosclerosis of the extremities with ulceration of unspecified extremity: This code indicates the presence of atherosclerosis in the arteries of the extremities, which has led to the development of an ulcer (open wound) in one of the extremities. However, the specific extremity affected is not specified.  I70.223 - Atherosclerosis of the extremities with ulceration of bilateral legs: Similar to the previous code, this code indicates atherosclerosis in the arteries of the extremities, but in this case, it has led to the development of ulcers in both legs.  I70.213 - Atherosclerosis of the extremities with intermittent claudication of bilateral legs: This code indicates the presence of atherosclerosis in the arteries of the extremities, leading to intermittent claudication (pain or discomfort in the legs during walking due to reduced blood flow) in both legs.  I70.212 - Atherosclerosis of the extremities with intermittent claudication of left leg: Similar to the previous code, this code indicates atherosclerosis in the arteries of the extremities, but in this case, it is causing intermittent claudication specifically in the left leg.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A6lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.40380135}, {'content': {'text': \"In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to I25.10, this code indicates atherosclerosis in the native coronary arteries. However, in this case, the patient experiences angina pectoris (chest pain or discomfort) due to reduced blood flow to the heart.  I50.22 - Chronic systolic (congestive) heart failure: This code is used to diagnose chronic systolic heart failure, a condition where the heart's left ventricle (the main pumping chamber) cannot pump blood effectively due to decreased contractility. It is a chronic (long-term) condition.  I48.0 - Paroxysmal atrial fibrillation: This code indicates that the patient has paroxysmal atrial fibrillation, which means the irregular heart rhythm comes and goes in episodes.  I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A3lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.40202343}, {'content': {'text': 'I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris I42.9 - Cardiomyopathy, unspecified I25.5 - Ischemic cardiomyopathy I25.111 - Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm I25.110 - Atherosclerotic heart disease of native coronary artery with unstable angina pectoris I27.0 - Primary pulmonary hypertension I25.700 - Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris I50.43 - Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure I25.84 - Coronary atherosclerosis due to calcified coronary lesion I44.2 - Atrioventricular block, complete I48.1 - Persistent atrial fibrillation I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris I25.83 - Coronary atherosclerosis due to lipid rich plaque I25.6 - Silent myocardial ischemia I25.2 - Old myocardial infarction I20.0 - Unstable angina I42.0 - Dilated cardiomyopathy I50.42 - Chronic combined systolic (congestive) and diastolic (congestive) heart failure I70.92'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A4VOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.400836}, {'content': {'text': 'I70.201 - Unspecified atherosclerosis of the extremities, right leg: This code is the same as the previous one, but it specifies that the atherosclerosis in the arteries of the extremities is affecting the right leg.  I48.21 - Paroxysmal atrial fibrillation: This code refers to a type of atrial fibrillation that occurs in sudden episodes or paroxysms, which means it comes and goes intermittently.  I70.1 - Atherosclerosis of renal artery: This code indicates the presence of atherosclerosis (buildup of plaque) in the renal arteries, which are the arteries that supply blood to the kidneys.  I70.8 - Atherosclerosis of other arteries: This code is used when atherosclerosis is present in arteries other than those specifically mentioned in the other codes, such as the arteries supplying the arms, abdomen, or other regions.  I70.92 - Chronic total occlusion of artery of the extremities, left leg: This code indicates a complete blockage (occlusion) of an artery in the left leg, which has been present for a long time (chronic).  I70.91 - Chronic total occlusion of artery of the extremities, right leg: Similar to the previous code, this code indicates a chronic total occlusion of an artery, but in this case, it is affecting the right leg.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A7FOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.39936954}, {'content': {'text': 'the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A6FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.398354}]}, {'medical_condition': 'Vitamin D deficiency', 'kb_context': [{'content': {'text': 'kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which are the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A51OBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.36901987}, {'content': {'text': 'kidney disease or end-stage renal disease E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease N25.0 - Renal osteodystrophy N26.9 - Renal failure, unspecified N25.9 - Disorder resulting from impaired renal tubular function, unspecified N28.9 - Disorder of kidney and ureter, unspecified E11.21 - Type 2 diabetes mellitus with diabetic nephropathy  E08.21 - Diabetes mellitus due to underlying condition with diabetic nephropathy E10.21 - Type 1 diabetes mellitus with diabetic nephropathy I13.0 - Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.2 - Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end-stage renal disease N25.1 - Renal osteodystrophy, unspecified N25.81 - Secondary hyperparathyroidism of renal origin N25.89 - Other disorders resulting from impaired renal tubular function N28.84 - Hypertrophy of kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A5lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.3666274}, {'content': {'text': 'M25.60 - Stiffness of unspecified joint, not elsewhere classified M25.61 - Stiffness of shoulder joint, not elsewhere classified M25.62 - Stiffness of elbow joint, not elsewhere classified M25.63 - Stiffness of wrist joint, not elsewhere classified M25.64 - Stiffness of hand joint, not elsewhere classified M25.65 - Stiffness of hip joint, not elsewhere classified M25.66 - Stiffness of knee joint, not elsewhere classified M25.67 - Stiffness of ankle and foot joints, not elsewhere classified M25.68 - Stiffness of other joint, not elsewhere classified This list covers common rheumatic conditions such as rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, ankylosing spondylitis, and various types of joint pain, stiffness, and contractures.   ICD-10 codes commonly used in psychiatry:  F33 - Major Depressive Disorder, recurrent: This code is used for patients experiencing multiple episodes of major depressive disorder, with periods of remission in between.  F41.1 - Generalized Anxiety Disorder: A chronic condition characterized by excessive and uncontrollable worry and anxiety about many different aspects of life.  F32.9 - Major Depressive Disorder, single episode, unspecified: This code is used for a single episode of major depression, with the severity level not specified.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3AAFOBQZIBzQkILuD-asZ1', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.36576614}, {'content': {'text': \", resolved following treatment E11.37X2 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X3 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X9 - Type 2 diabetes mellitus with diabetic macular edema, unspecified E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.49 - Type 2 diabetes mellitus with other diabetic neurological complication E11.630 - Type 2 diabetes mellitus with diabetic cystopathy   ICD-10 codes related to obesity:  E66.9 - Obesity, unspecified This code indicates obesity without any additional details specified.  E66.01 - Morbid (severe) obesity due to excess calories This code is for severe obesity resulting from consuming excess calories.  E66.3 - Overweight This code applies when someone is overweight, but not yet classified as obese.  E66.8 - Other obesity This is a code for types of obesity that don't fit the other specific categories listed.  E66.2 - Obesity due to caloric excess This indicates obesity caused by consuming too many calories.  E66.09 - Other obesity due to excess calories This is for obesity from excess calories that doesn't fit the severe/morbid category.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A-VOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.3652193}, {'content': {'text': 'adult Z68.41 - Body mass index (BMI) 40.0-44.9, adult Z68.42 - Body mass index (BMI) 45.0-49.9, adult Z68.43 - Body mass index (BMI) 50-59.9, adult Z68.44 - Body mass index (BMI) 60.0-69.9, adult Z68.45 - Body mass index (BMI) 70 or greater, adult E66.8 - Other obesity, not elsewhere classified E66.1 - Drug-induced obesity, not elsewhere classified   ICD-10 codes commonly used in Rheumatology:  MM05.9 - Rheumatoid arthritis, unspecified: This code is used when rheumatoid arthritis (a chronic autoimmune disorder primarily affecting the joints) is present, but the specific site or severity is not documented.  M06.9 - Rheumatoid arthritis, unspecified: This is the same as the previous code, indicating an unspecified case of rheumatoid arthritis.  M15.9 - Polyosteoarthritis, unspecified: This code refers to osteoarthritis (a degenerative joint disease) affecting multiple joints, but the specific sites are not documented.  M17.9 - Osteoarthritis of knee, unspecified: This code is used for osteoarthritis affecting the knee joint, without specifying which knee (right or left) or the severity.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A_FOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.36265594}]}, {'medical_condition': 'Hypertension', 'kb_context': [{'content': {'text': 'ICD-10 codes in cardiology:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which supply blood to the heart muscle. However, the patient does not experience angina pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart.  I10 - Essential (primary) hypertension: This code refers to high blood pressure (hypertension) that has no identifiable cause. It is often called \"essential\" or \"primary\" hypertension.  I48.91 - Unspecified atrial fibrillation: This code indicates the presence of atrial fibrillation, an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. However, it does not specify whether the atrial fibrillation is paroxysmal (comes and goes) or chronic (persistent).  I21.4 - Non-ST elevation (NSTEMI) myocardial infarction: This code is used to diagnose a type of heart attack, specifically a non-ST-elevation myocardial infarction (NSTEMI). In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A3VOBQZIBzQkILuD-asVr', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.40000802}, {'content': {'text': 'the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A6FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.3979492}, {'content': {'text': 'kidney disease or end-stage renal disease E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease N25.0 - Renal osteodystrophy N26.9 - Renal failure, unspecified N25.9 - Disorder resulting from impaired renal tubular function, unspecified N28.9 - Disorder of kidney and ureter, unspecified E11.21 - Type 2 diabetes mellitus with diabetic nephropathy  E08.21 - Diabetes mellitus due to underlying condition with diabetic nephropathy E10.21 - Type 1 diabetes mellitus with diabetic nephropathy I13.0 - Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.2 - Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end-stage renal disease N25.1 - Renal osteodystrophy, unspecified N25.81 - Secondary hyperparathyroidism of renal origin N25.89 - Other disorders resulting from impaired renal tubular function N28.84 - Hypertrophy of kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A5lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.39754903}, {'content': {'text': 'kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which are the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A51OBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.39645708}, {'content': {'text': \"I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.  I50.21 - Acute systolic (congestive) heart failure: This code is used to diagnose acute systolic heart failure, which is a sudden onset of the condition where the heart's left ventricle cannot pump blood effectively due to decreased contractility.  I20.9 - Angina pectoris, unspecified: This code is used to diagnose angina pectoris or chest pain/discomfort due to reduced blood flow to the heart, but it does not specify the underlying cause (e.g., atherosclerosis, coronary artery disease, etc.).  I11.9 - Hypertensive heart disease without heart failure: This code is used to diagnose hypertensive heart disease, which is a condition where high blood pressure has caused damage or changes to the heart muscle. However, the patient does not have heart failure.  I24.9 - Acute ischemic heart disease, unspecified I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site I35.1 - Nonrheumatic aortic (valve) insufficiency I48.92 - Unspecified atrial flutter I34.0 - Nonrheumatic mitral (valve) insufficiency I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A4FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.39583558}]}, {'medical_condition': 'Prediabetes', 'kb_context': [{'content': {'text': 'E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.  E11.3219 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed mild nonproliferative diabetic retinopathy (an early stage of diabetic retinopathy) without macular edema.  E11.3213 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy with macular edema.  E11.3212 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy without macular edema.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A9VOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.4268761}, {'content': {'text': 'E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic polyneuropathy (damage to multiple peripheral nerves due to diabetes).  E11.621 - Type 2 diabetes mellitus with foot ulcer: This code indicates that the patient has Type 2 diabetes mellitus and has developed a foot ulcer as a complication of their diabetes.  E11.610 - Type 2 diabetes mellitus with diabetic neuropathic arthropathy: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic neuropathic arthropathy (a degenerative joint condition caused by nerve damage due to diabetes).  E11.8 - Type 2 diabetes mellitus with unspecified complications: This code indicates that the patient has Type 2 diabetes mellitus and has developed complications, but the specific complications are not specified.  E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication: This code is used when a patient has Type 2 diabetes mellitus and has developed other kidney complications related to their diabetes, not specified as chronic kidney disease or nephropathy.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A81OBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.42315212}, {'content': {'text': \"E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication: This code is used when a patient has Type 2 diabetes mellitus and has developed other kidney complications related to their diabetes, not specified as chronic kidney disease or nephropathy.  E11.36 - Type 2 diabetes mellitus with diabetic cataract: This code indicates that the patient has Type 2 diabetes mellitus and has developed a cataract (clouding of the eye's lens) as a complication of their diabetes.  E11.622 - Type 2 diabetes mellitus with other skin ulcer: This code is used when a patient has Type 2 diabetes mellitus and has developed skin ulcers other than foot ulcers as a complication of their diabetes.  E11.618 - Type 2 diabetes mellitus with other diabetic arthropathy: This code indicates that the patient has Type 2 diabetes mellitus and has developed other types of arthropathy (joint disease) related to their diabetes, not specified as neuropathic arthropathy.  E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A9FOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.4229759}, {'content': {'text': 'E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease: This code is used when a patient has Type 2 diabetes mellitus and has developed chronic kidney disease due to their diabetes.  E11.311 - Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed diabetic retinopathy (an eye disease affecting the retina) with macular edema (swelling in the macula, the central part of the retina).  E11.319 - Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic retinopathy, but without macular edema.  E11.59 - Type 2 diabetes mellitus with other circulatory complications: This code indicates that the patient has Type 2 diabetes mellitus and has developed other circulatory complications related to their diabetes, such as peripheral vascular disease or cardiovascular disease.  E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic polyneuropathy (damage to multiple peripheral nerves due to diabetes).'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A8lOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.4167115}, {'content': {'text': 'no documented complications related to the diabetes.  E11.65 - Type 2 diabetes mellitus with hyperglycemia: This code indicates that the patient has Type 2 diabetes mellitus and is experiencing hyperglycemia (high blood sugar levels).  E11.51 - Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic peripheral angiopathy (a condition affecting the blood vessels in the extremities, particularly the legs and feet) without gangrene.  E11.21 - Type 2 diabetes mellitus with diabetic nephropathy: This code indicates that the patient has Type 2 diabetes mellitus and has developed diabetic nephropathy (kidney disease or damage caused by diabetes).  E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease: This code is used when a patient has Type 2 diabetes mellitus and has developed chronic kidney disease due to their diabetes.  E11.311 - Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed diabetic retinopathy (an eye disease affecting the retina) with macular edema (swelling in the macula, the central part of the retina).'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A8VOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.41662464}]}, {'medical_condition': 'Chronic kidney disease, stage 3', 'kb_context': [{'content': {'text': '. Stage 1 CKD is usually diagnosed based on the presence of proteinuria or other markers of kidney damage, despite normal kidney function.  N18.2 - Chronic kidney disease, stage 2 (mild): This code represents mild kidney damage with a slightly decreased GFR (60-89 mL/min/1.73m). Patients in this stage typically have mild kidney dysfunction but may not experience any symptoms.  N18.3 - Chronic kidney disease, stage 3 (moderate): Stage 3 CKD is categorized as moderate kidney damage with a GFR ranging from 30-59 mL/min/1.73m. This stage is further divided into two subcategories:  N18.30 - Chronic kidney disease, stage 3 unspecified N18.31 - Chronic kidney disease, stage 3a (GFR 45-59 mL/min/1.73m) N18.32 - Chronic kidney disease, stage 3b (GFR 30-44 mL/min/1.73m) N18.4 - Chronic kidney disease, stage 4 (severe): This code indicates severe kidney damage with a GFR ranging from 15-29 mL/min/1.73m. Patients in this stage may experience symptoms such as fatigue, nausea, and fluid retention.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A5FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.63555676}, {'content': {'text': 'Patients in this stage may experience symptoms such as fatigue, nausea, and fluid retention.  N18.5 - Chronic kidney disease, stage 5: Stage 5 CKD is also known as end-stage renal disease (ESRD) or kidney failure, with a GFR <15 mL/min/1.73m. At this stage, dialysis or a kidney transplant is typically required to sustain life.  N18.6 - End-stage renal disease: This code specifically refers to ESRD or kidney failure requiring dialysis or a kidney transplant.  N18.9 - Chronic kidney disease, unspecified: This code is used when chronic kidney disease is present, but the specific stage is not documented or specified.  I12.9 - Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.11 - Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end-stage renal disease E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease E08.22 - Diabetes mellitus due to underlying condition with diabetic chronic kidney disease N19 - Unspecified kidney failure I12.0 - Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end-stage renal disease E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease N25.0 - Renal osteodystrophy'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A5VOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.60636896}, {'content': {'text': 'kidney disease, stage 1: This code indicates the presence of kidney damage with normal or increased glomerular filtration rate (GFR 90 mL/min/1.73m). Stage 1 CKD is usually diagnosed based on the presence of proteinuria or other markers of kidney damage, despite normal kidney function.  N18.2 - Chronic kidney disease, stage 2 (mild): This code represents mild kidney damage with a slightly decreased GFR (60-89 mL/min/1.73m). Patients in this stage typically have mild kidney dysfunction but may not experience any symptoms.  N18.3 - Chronic kidney disease, stage 3 (moderate): Stage 3 CKD is categorized as moderate kidney damage with a GFR ranging from 30-59 mL/min/1.73m. This stage is further divided into two subcategories:  N18.30 - Chronic kidney disease, stage 3 unspecified N18.31 - Chronic kidney disease, stage 3a (GFR 45-59 mL/min/1.73m) N18.32 - Chronic kidney disease, stage 3b (GFR 30-44 mL/min/1.73m) N18.4 - Chronic kidney disease, stage 4 (severe): This code indicates severe kidney damage with a GFR ranging from 15-29 mL/min/1.73m.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A41OBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.5937614}, {'content': {'text': '- Silent myocardial ischemia I25.2 - Old myocardial infarction I20.0 - Unstable angina I42.0 - Dilated cardiomyopathy I50.42 - Chronic combined systolic (congestive) and diastolic (congestive) heart failure I70.92 - Chronic total occlusion of artery of the extremities I34.1 - Nonrheumatic mitral (valve) prolapse I50.33 - Acute on chronic diastolic (congestive) heart failure I24.8 - Other forms of acute ischemic heart disease I25.9 - Chronic ischemic heart disease, unspecified I44.1 - Atrioventricular block, second degree I42.5 - Other restrictive cardiomyopathy I35.8 - Other nonrheumatic aortic valve disorders I47.1 - Supraventricular tachycardia   ICD-10 codes for chronic kidney disease (CKD):  N18.1 - Chronic kidney disease, stage 1: This code indicates the presence of kidney damage with normal or increased glomerular filtration rate (GFR 90 mL/min/1.73m). Stage 1 CKD is usually diagnosed based on the presence of proteinuria or other markers of kidney damage, despite normal kidney function.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A4lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.4990366}, {'content': {'text': 'kidney disease or end-stage renal disease E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease N25.0 - Renal osteodystrophy N26.9 - Renal failure, unspecified N25.9 - Disorder resulting from impaired renal tubular function, unspecified N28.9 - Disorder of kidney and ureter, unspecified E11.21 - Type 2 diabetes mellitus with diabetic nephropathy  E08.21 - Diabetes mellitus due to underlying condition with diabetic nephropathy E10.21 - Type 1 diabetes mellitus with diabetic nephropathy I13.0 - Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.2 - Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end-stage renal disease N25.1 - Renal osteodystrophy, unspecified N25.81 - Secondary hyperparathyroidism of renal origin N25.89 - Other disorders resulting from impaired renal tubular function N28.84 - Hypertrophy of kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A5lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.46019468}]}, {'medical_condition': 'Hypothyroidism', 'kb_context': [{'content': {'text': 'E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.  E11.3219 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed mild nonproliferative diabetic retinopathy (an early stage of diabetic retinopathy) without macular edema.  E11.3213 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy with macular edema.  E11.3212 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy without macular edema.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A9VOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.37411034}, {'content': {'text': \"E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication: This code is used when a patient has Type 2 diabetes mellitus and has developed other kidney complications related to their diabetes, not specified as chronic kidney disease or nephropathy.  E11.36 - Type 2 diabetes mellitus with diabetic cataract: This code indicates that the patient has Type 2 diabetes mellitus and has developed a cataract (clouding of the eye's lens) as a complication of their diabetes.  E11.622 - Type 2 diabetes mellitus with other skin ulcer: This code is used when a patient has Type 2 diabetes mellitus and has developed skin ulcers other than foot ulcers as a complication of their diabetes.  E11.618 - Type 2 diabetes mellitus with other diabetic arthropathy: This code indicates that the patient has Type 2 diabetes mellitus and has developed other types of arthropathy (joint disease) related to their diabetes, not specified as neuropathic arthropathy.  E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A9FOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.37381303}, {'content': {'text': \", resolved following treatment E11.37X2 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X3 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X9 - Type 2 diabetes mellitus with diabetic macular edema, unspecified E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.49 - Type 2 diabetes mellitus with other diabetic neurological complication E11.630 - Type 2 diabetes mellitus with diabetic cystopathy   ICD-10 codes related to obesity:  E66.9 - Obesity, unspecified This code indicates obesity without any additional details specified.  E66.01 - Morbid (severe) obesity due to excess calories This code is for severe obesity resulting from consuming excess calories.  E66.3 - Overweight This code applies when someone is overweight, but not yet classified as obese.  E66.8 - Other obesity This is a code for types of obesity that don't fit the other specific categories listed.  E66.2 - Obesity due to caloric excess This indicates obesity caused by consuming too many calories.  E66.09 - Other obesity due to excess calories This is for obesity from excess calories that doesn't fit the severe/morbid category.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A-VOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.3716726}, {'content': {'text': 'E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease: This code is used when a patient has Type 2 diabetes mellitus and has developed chronic kidney disease due to their diabetes.  E11.311 - Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed diabetic retinopathy (an eye disease affecting the retina) with macular edema (swelling in the macula, the central part of the retina).  E11.319 - Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic retinopathy, but without macular edema.  E11.59 - Type 2 diabetes mellitus with other circulatory complications: This code indicates that the patient has Type 2 diabetes mellitus and has developed other circulatory complications related to their diabetes, such as peripheral vascular disease or cardiovascular disease.  E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic polyneuropathy (damage to multiple peripheral nerves due to diabetes).'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A8lOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.36957046}, {'content': {'text': \"F51.01 - Insomnia Disorder due to another medical condition: Insomnia caused by an underlying medical condition. F44.9 - Dissociative Disorder, unspecified F31.0 - Bipolar Disorder, current episode hypomanic F60.2 - Antisocial Personality Disorder F33.41 - Major Depressive Disorder, recurrent, in partial remission F44.4 - Conversion Disorder with motor symptom or deficit F51.03 - Insomnia Disorder due to drug or substance F31.62 - Bipolar Disorder, current episode with mixed features F06.31 - Mood Disorder due to another medical condition with depressive features F48.9 - Nonpsychotic Mental Disorder, unspecified F31.76 - Bipolar Disorder, in partial remission, most recent episode mixed F41.8 - Other Specified Anxiety Disorders F95.2 - Tourette's Disorder F63.3 - Gambling Disorder\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3ABVOBQZIBzQkILuD-asZ1', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.36905342}]}, {'medical_condition': 'Abnormal electrocardiogram', 'kb_context': [{'content': {'text': 'I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.  I21.9 - Acute myocardial infarction, unspecified: This code is used to diagnose a heart attack or myocardial infarction, but it does not specify the type (ST-elevation or non-ST-elevation) or location of the heart attack.  I48.20 - Chronic atrial fibrillation, unspecified: This code indicates the presence of chronic (persistent) atrial fibrillation, but it does not specify whether it is paroxysmal or permanent.  I49.9 - Cardiac arrhythmia, unspecified: This code is used to diagnose an irregular heart rhythm or cardiac arrhythmia, but it does not specify the type of arrhythmia (e.g., atrial fibrillation, ventricular tachycardia, etc.).  I50.9 - Heart failure, unspecified: This code is used to diagnose heart failure, but it does not specify the type (systolic or diastolic) or the underlying cause of the heart failure.  I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A31OBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.4801703}, {'content': {'text': \"In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to I25.10, this code indicates atherosclerosis in the native coronary arteries. However, in this case, the patient experiences angina pectoris (chest pain or discomfort) due to reduced blood flow to the heart.  I50.22 - Chronic systolic (congestive) heart failure: This code is used to diagnose chronic systolic heart failure, a condition where the heart's left ventricle (the main pumping chamber) cannot pump blood effectively due to decreased contractility. It is a chronic (long-term) condition.  I48.0 - Paroxysmal atrial fibrillation: This code indicates that the patient has paroxysmal atrial fibrillation, which means the irregular heart rhythm comes and goes in episodes.  I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A3lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.47731468}, {'content': {'text': \"I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.  I50.21 - Acute systolic (congestive) heart failure: This code is used to diagnose acute systolic heart failure, which is a sudden onset of the condition where the heart's left ventricle cannot pump blood effectively due to decreased contractility.  I20.9 - Angina pectoris, unspecified: This code is used to diagnose angina pectoris or chest pain/discomfort due to reduced blood flow to the heart, but it does not specify the underlying cause (e.g., atherosclerosis, coronary artery disease, etc.).  I11.9 - Hypertensive heart disease without heart failure: This code is used to diagnose hypertensive heart disease, which is a condition where high blood pressure has caused damage or changes to the heart muscle. However, the patient does not have heart failure.  I24.9 - Acute ischemic heart disease, unspecified I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site I35.1 - Nonrheumatic aortic (valve) insufficiency I48.92 - Unspecified atrial flutter I34.0 - Nonrheumatic mitral (valve) insufficiency I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A4FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.47351635}, {'content': {'text': 'the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A6FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.45496997}, {'content': {'text': 'ICD-10 codes in cardiology:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which supply blood to the heart muscle. However, the patient does not experience angina pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart.  I10 - Essential (primary) hypertension: This code refers to high blood pressure (hypertension) that has no identifiable cause. It is often called \"essential\" or \"primary\" hypertension.  I48.91 - Unspecified atrial fibrillation: This code indicates the presence of atrial fibrillation, an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. However, it does not specify whether the atrial fibrillation is paroxysmal (comes and goes) or chronic (persistent).  I21.4 - Non-ST elevation (NSTEMI) myocardial infarction: This code is used to diagnose a type of heart attack, specifically a non-ST-elevation myocardial infarction (NSTEMI). In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A3VOBQZIBzQkILuD-asVr', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.44684735}]}, {'medical_condition': 'Aortic valve disorder', 'kb_context': [{'content': {'text': \"I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.  I50.21 - Acute systolic (congestive) heart failure: This code is used to diagnose acute systolic heart failure, which is a sudden onset of the condition where the heart's left ventricle cannot pump blood effectively due to decreased contractility.  I20.9 - Angina pectoris, unspecified: This code is used to diagnose angina pectoris or chest pain/discomfort due to reduced blood flow to the heart, but it does not specify the underlying cause (e.g., atherosclerosis, coronary artery disease, etc.).  I11.9 - Hypertensive heart disease without heart failure: This code is used to diagnose hypertensive heart disease, which is a condition where high blood pressure has caused damage or changes to the heart muscle. However, the patient does not have heart failure.  I24.9 - Acute ischemic heart disease, unspecified I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site I35.1 - Nonrheumatic aortic (valve) insufficiency I48.92 - Unspecified atrial flutter I34.0 - Nonrheumatic mitral (valve) insufficiency I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A4FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.42573658}, {'content': {'text': '- Silent myocardial ischemia I25.2 - Old myocardial infarction I20.0 - Unstable angina I42.0 - Dilated cardiomyopathy I50.42 - Chronic combined systolic (congestive) and diastolic (congestive) heart failure I70.92 - Chronic total occlusion of artery of the extremities I34.1 - Nonrheumatic mitral (valve) prolapse I50.33 - Acute on chronic diastolic (congestive) heart failure I24.8 - Other forms of acute ischemic heart disease I25.9 - Chronic ischemic heart disease, unspecified I44.1 - Atrioventricular block, second degree I42.5 - Other restrictive cardiomyopathy I35.8 - Other nonrheumatic aortic valve disorders I47.1 - Supraventricular tachycardia   ICD-10 codes for chronic kidney disease (CKD):  N18.1 - Chronic kidney disease, stage 1: This code indicates the presence of kidney damage with normal or increased glomerular filtration rate (GFR 90 mL/min/1.73m). Stage 1 CKD is usually diagnosed based on the presence of proteinuria or other markers of kidney damage, despite normal kidney function.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A4lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.41587397}, {'content': {'text': 'kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which are the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A51OBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.40606195}, {'content': {'text': 'the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A6FOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.40526533}, {'content': {'text': 'ICD-10 codes in cardiology:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which supply blood to the heart muscle. However, the patient does not experience angina pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart.  I10 - Essential (primary) hypertension: This code refers to high blood pressure (hypertension) that has no identifiable cause. It is often called \"essential\" or \"primary\" hypertension.  I48.91 - Unspecified atrial fibrillation: This code indicates the presence of atrial fibrillation, an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. However, it does not specify whether the atrial fibrillation is paroxysmal (comes and goes) or chronic (persistent).  I21.4 - Non-ST elevation (NSTEMI) myocardial infarction: This code is used to diagnose a type of heart attack, specifically a non-ST-elevation myocardial infarction (NSTEMI). In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A3VOBQZIBzQkILuD-asVr', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.40256235}]}, {'medical_condition': 'Herpes simplex', 'kb_context': [{'content': {'text': \"E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication: This code is used when a patient has Type 2 diabetes mellitus and has developed other kidney complications related to their diabetes, not specified as chronic kidney disease or nephropathy.  E11.36 - Type 2 diabetes mellitus with diabetic cataract: This code indicates that the patient has Type 2 diabetes mellitus and has developed a cataract (clouding of the eye's lens) as a complication of their diabetes.  E11.622 - Type 2 diabetes mellitus with other skin ulcer: This code is used when a patient has Type 2 diabetes mellitus and has developed skin ulcers other than foot ulcers as a complication of their diabetes.  E11.618 - Type 2 diabetes mellitus with other diabetic arthropathy: This code indicates that the patient has Type 2 diabetes mellitus and has developed other types of arthropathy (joint disease) related to their diabetes, not specified as neuropathic arthropathy.  E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.\"}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A9FOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.35405943}, {'content': {'text': '- Cerebral infarction due to unspecified occlusion or stenosis of left vertebral arteries I63.329 - Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral arteries I63.331 - Cerebral infarction due to thrombosis of right carotid artery I63.339 - Cerebral infarction due to thrombosis of unspecified carotid artery I63.341 - Cerebral infarction due to embolism of right carotid artery I63.342 - Cerebral infarction due to embolism of left carotid artery I63.349 - Cerebral infarction due to embolism of unspecified carotid artery I63.39 - Cerebral infarction due to thrombosis of unspecified cerebral artery I63.40 - Cerebral infarction due to embolism of unspecified cerebral artery I63.411 - Cerebral infarction due to embolism of right vertebral artery I63.419 - Cerebral infarction due to embolism of unspecified vertebral artery I63.421 - Cerebral infarction due to embolism of right carotid artery I63.429 - Cerebral infarction due to embolism of unspecified carotid artery I63.49 - Cerebral infarction due to embolism of'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A7lOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.35057873}, {'content': {'text': 'E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.  E11.3219 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed mild nonproliferative diabetic retinopathy (an early stage of diabetic retinopathy) without macular edema.  E11.3213 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy with macular edema.  E11.3212 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy without macular edema.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A9VOBQZIBzQkILuD-asV0', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.34972504}, {'content': {'text': 'The specific sequelae (consequences) are not specified in this code.  I70.239 - Atherosclerosis of the extremities with ulceration of unspecified extremity: This code indicates the presence of atherosclerosis in the arteries of the extremities, which has led to the development of an ulcer (open wound) in one of the extremities. However, the specific extremity affected is not specified.  I70.223 - Atherosclerosis of the extremities with ulceration of bilateral legs: Similar to the previous code, this code indicates atherosclerosis in the arteries of the extremities, but in this case, it has led to the development of ulcers in both legs.  I70.213 - Atherosclerosis of the extremities with intermittent claudication of bilateral legs: This code indicates the presence of atherosclerosis in the arteries of the extremities, leading to intermittent claudication (pain or discomfort in the legs during walking due to reduced blood flow) in both legs.  I70.212 - Atherosclerosis of the extremities with intermittent claudication of left leg: Similar to the previous code, this code indicates atherosclerosis in the arteries of the extremities, but in this case, it is causing intermittent claudication specifically in the left leg.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3A6lOBQZIBzQkILuD-asVz', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.34850034}, {'content': {'text': 'M25.60 - Stiffness of unspecified joint, not elsewhere classified M25.61 - Stiffness of shoulder joint, not elsewhere classified M25.62 - Stiffness of elbow joint, not elsewhere classified M25.63 - Stiffness of wrist joint, not elsewhere classified M25.64 - Stiffness of hand joint, not elsewhere classified M25.65 - Stiffness of hip joint, not elsewhere classified M25.66 - Stiffness of knee joint, not elsewhere classified M25.67 - Stiffness of ankle and foot joints, not elsewhere classified M25.68 - Stiffness of other joint, not elsewhere classified This list covers common rheumatic conditions such as rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, ankylosing spondylitis, and various types of joint pain, stiffness, and contractures.   ICD-10 codes commonly used in psychiatry:  F33 - Major Depressive Disorder, recurrent: This code is used for patients experiencing multiple episodes of major depressive disorder, with periods of remission in between.  F41.1 - Generalized Anxiety Disorder: A chronic condition characterized by excessive and uncontrollable worry and anxiety about many different aspects of life.  F32.9 - Major Depressive Disorder, single episode, unspecified: This code is used for a single episode of major depression, with the severity level not specified.'}, 'location': {'s3Location': {'uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt'}, 'type': 'S3'}, 'metadata': {'x-amz-bedrock-kb-source-uri': 's3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt', 'x-amz-bedrock-kb-chunk-id': '1%3A0%3AAFOBQZIBzQkILuD-asZ1', 'x-amz-bedrock-kb-data-source-id': 'SMXZNVKHKR'}, 'score': 0.3474978}]}]\n"
     ]
    }
   ],
   "source": [
    "if use_knowledge_base == 'Y':\n",
    "    \n",
    "    # Fetch the context from the Knowledge base\n",
    "    kb_output = []\n",
    "\n",
    "    for medical_condition in medical_conditions:\n",
    "        query = \"Find all the information about \" + medical_condition\n",
    "\n",
    "        kb_response = bedrock_agent_client.retrieve(\n",
    "            retrievalQuery= {\n",
    "                'text': query\n",
    "            },\n",
    "            knowledgeBaseId=kb_id,\n",
    "            retrievalConfiguration= {\n",
    "                'vectorSearchConfiguration': {\n",
    "                    'numberOfResults': kb_number_of_results\n",
    "                }\n",
    "            }\n",
    "        )\n",
    "\n",
    "        kb_output.append({\n",
    "                'medical_condition': medical_condition,\n",
    "                'kb_context': kb_response['retrievalResults'] \n",
    "                })\n",
    "\n",
    "    guidelines = json.dumps(kb_output)\n",
    "\n",
    "    print(\"--------------------------\")\n",
    "    print(\"--------KB Output:--------\")\n",
    "    print(\"--------------------------\")\n",
    "    print(kb_output)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "09d0b4aa-d2a8-4035-94bf-69f51c3dd238",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Prompt Template:\n",
    "\n",
    "This is the base prompt template that has been broken down into multiple segments based on the prompt engineering [best practices](https://docs.anthropic.com/claude/docs/prompt-engineering) suggested by Anthropic.\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "977c263e-cb68-4818-b413-1f431d9c507a",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "-----------------------------------------------------------------------------------------------\n",
      "--------------------------- Full prompt with variable substitutions ---------------------------\n",
      "-----------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "------USER TURN------\n",
      "You are a medical reviewer. You review patient notes and provide recommendation to the doctor about the medical conditions of the patient. Your recommendation includes patients current and chronic medical conditions. Your recommendation helps the doctor to decide on the treatment plan.\n",
      "\n",
      "You should maintain a friendly customer service tone.\n",
      "\n",
      "The patient notes are provided inside <patient_notes></patient_notes> XML tag. It contains date, medication, history, procedure codes, lab results and note.\n",
      "\n",
      "    Your initial recommendations based on the patient notes analysis are provided inside <initial_recommendation></initial_recommendation> XML tag. \n",
      "\n",
      "    Guidelines about the medical conditions and corresponding ICD 10 codes are provided inside <guidelines></guidelines> XML tag. \n",
      "\n",
      "    When you reply, you follow these steps:\n",
      "\n",
      "    - Refer to the <patient_notes>. Carefully read through the history, medications, encounters. For each encounter, carefully review the lab results, note. Check line-by-line to look for any evidence of medical conditions. \n",
      "\n",
      "    - Lab results contain comma separated list of lab readings, which can be lengthy. Please read through each and every value carefully. Maintain a list of common lab value thresholds that indicate potential conditions, and cross-check any out-of-range values against this list. \n",
      "\n",
      "    - When reviewing notes, actively look for any mention of symptoms, diagnoses, medications prescribed, or procedures done that could indicate a condition. Only list a medical condition when you see clear evidence in the lab results or notes to support a diagnosis. \n",
      "\n",
      "    - Refer to the guidelines from the knowledge base inside <guidelines></guidelines> XML tag. Use it as a helper tool to identify the medical conditions and ICD 10 codes.\n",
      "\n",
      "    - Refer to your initial recommendations inside <initial_recommendation></initial_recommendation> XML tag. Please adjust any recommendations as appropriate.\n",
      "\n",
      "    - Please do not make any assumptions without verifying supporting evidence for the specific date.\n",
      "\n",
      "    - For each date, list all the medical conditions, corresponding ICD 10 codes, relevant explanation as evidence.\n",
      "\n",
      "    - Only use the information provided to generate the recommendation. If there are no medical condition to recommend to the doctor tell no medical condition to report.\n",
      "\n",
      "    - Provide the final recommendation inside <recommendation></recommendation> XML tags in JSON format, with each condition formatted as:\n",
      "    {\n",
      "      \"Active_Condition\":[\n",
      "      {\"Review\": {  \n",
      "      \"DX_Code\": \"ICD10 Code\",\n",
      "      \"Description\": \"Condition description\",\n",
      "      \"Memo\": {\n",
      "                  \"date\":\"date\",\n",
      "                  \"note\":\"Explanation from notes\"\n",
      "              }\n",
      "      }},\n",
      "      {\"Review\": {\n",
      "      \"DX_Code\": \"ICD10 Code\",\n",
      "      \"Description\": \"Condition description\",\n",
      "      \"Memo\": {\n",
      "                  \"date\":\"date\",\n",
      "                  \"note\":\"Explanation from notes\"\n",
      "              }\n",
      "      }}],\n",
      "      \"Inactive_Condition\": [\n",
      "        {\"Review\": {\n",
      "          \"DX_Code\": \"ICD10 Code\",\n",
      "          \"Description\": \"Condition description\",\n",
      "          \"Memo\": {\n",
      "            \"date\": \"date\",\n",
      "            \"note\": \"Explanation from notes\"\n",
      "          }\n",
      "      }}]\n",
      "    }\n",
      "    \n",
      "\n",
      "Here is an example inside <example></example> XML tag on how to perform the task: \n",
      "    <example>\n",
      "    user: <patient_notes>\n",
      "    {\n",
      "      \"name\": \"XYZ\",\n",
      "      \"age\": \"60 years\",\n",
      "      \"sex\": \"Male\",\n",
      "      \"encounters\": [ \n",
      "        {\n",
      "          \"Date\": \"2022-01-04\", \n",
      "          \"Procedure codes\": \"99214\",\n",
      "          \"note\": [\"Blood pressure has been stable. Pt is overdue for physical and labs. Pt will come to the lab next month and will schedule an appointment for a physical.\", \"stable\"]\n",
      "        },\n",
      "        {\n",
      "          \"Date\": \"2022-02-04\", \n",
      "          \"note\": [\"Dual-chamber pacemaker was placed for sinus node dysfunction.\"]\n",
      "        },\n",
      "        {\n",
      "          \"Date\": \"2023-07-22\",\n",
      "          \"note\": [\"Had unprovoked PE.  Still on anticoagulation.  Oncology note dated 07/05/2023: long term anticoagulation recommended.  It can be primary hypercoagulability.\"]\n",
      "        }, \n",
      "        {\n",
      "          \"Date\": \"2023-07-31\", \n",
      "          \"note\": [\"Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\", \"Patient visited doctor for cough, chest soreness, runny nose, headache, slight fever, and sore throat. Doctor suggested to take Ibuprofen and cough suppressant\"]\n",
      "        }\n",
      "      ]\n",
      "    }\n",
      "    </patient_notes>\n",
      "\n",
      "    assistant: <response>\n",
      "    <thinking>\n",
      "    Date: 2022-01-04\n",
      "    No evidence of medical conditions\n",
      "\n",
      "    Date: 2022-02-04\n",
      "    Condition: Sinus node dysfunction \n",
      "    ICD10: I49.5\n",
      "    Evidence: Dual-chamber pacemaker was placed for sinus node dysfunction.\n",
      "\n",
      "    Date: 2023-07-22  \n",
      "    Condition: Pulmonary embolism\n",
      "    ICD10: I26.99\n",
      "    Evidence: Had unprovoked PE. Still on anticoagulation. Oncology note dated 07/05/2023: long term anticoagulation recommended. It can be primary hypercoagulability.\n",
      "\n",
      "    Date: 2023-07-31\n",
      "    Condition 1: Type 2 diabetes mellitus with diabetic polyneuropathy\n",
      "    ICD10: E11.42\n",
      "    Evidence: Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\n",
      "\n",
      "    Condition 2: Upper respiratory infection \n",
      "    ICD10: J06.9\n",
      "    Evidence: Patient visited doctor for cough, chest soreness, runny nose, headache, slight fever, and sore throat. Doctor suggested to take Ibuprofen and cough suppressant.\n",
      "\n",
      "    Date: 2023-09-01\n",
      "    Condition 1: Vitamin D deficiency\n",
      "    ICD10: E55.9\n",
      "    Evidence: vitamin D 25-oh, total: 43 NG/mL\n",
      "\n",
      "    Condition 2: Upper respiratory infection (inactive)\n",
      "    ICD10: J06.9\n",
      "    Evidence: Doctor visit. Patient no longer complained of cough. Patient is not taking Ibuprofen and cough suppressant anymore.\n",
      "\n",
      "    Inactive Conditions:\n",
      "    - Upper respiratory infection (J06.9)\n",
      "\n",
      "    Active Conditions:  \n",
      "    - Sinus node dysfunction (I49.5)\n",
      "    - Pulmonary embolism (I26.99)\n",
      "    - Type 2 diabetes mellitus with diabetic polyneuropathy (E11.42)\n",
      "    - Prostate cancer (C61)\n",
      "    - Vitamin D deficiency (E55.9)\n",
      "    </thinking>\n",
      "\n",
      "    <recommendation>\n",
      "    {\n",
      "      \"Active_Condition\": [ \n",
      "      {\"Review\":{\n",
      "        \"DX_Code\": \"I49.5\",  \n",
      "        \"Description\": \"Sinus node dysfunction\",\n",
      "        \"Memo\": {\n",
      "          \"date\": \"2022-02-04\",\n",
      "          \"note\": \"Dual-chamber pacemaker was placed for sinus node dysfunction.\"\n",
      "        }\n",
      "      }},  \n",
      "      {\"Review\": {  \n",
      "        \"DX_Code\": \"I26.99\",\n",
      "        \"Description\": \"Pulmonary embolism\", \n",
      "        \"Memo\": {\n",
      "          \"date\": \"2023-07-22\",  \n",
      "          \"note\": \"Had unprovoked PE. Still on anticoagulation. Oncology note dated 07/05/2023: long term anticoagulation recommended. It can be primary hypercoagulability.\"\n",
      "        }\n",
      "      }},\n",
      "      {\"Review\": {\n",
      "        \"DX_Code\": \"E11.42\",  \n",
      "        \"Description\": \"Type 2 diabetes mellitus with diabetic polyneuropathy\",\n",
      "        \"Memo\": {\n",
      "          \"date\": \"2023-07-31\",\n",
      "          \"note\": \"Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\"\n",
      "        }\n",
      "      }},\n",
      "      {\"Review\": {\n",
      "        \"DX_Code\": \"E55.9\",\n",
      "        \"Description\": \"Vitamin D deficiency\",  \n",
      "        \"Memo\": {\n",
      "            \"date\": \"2023-09-01\",\n",
      "            \"note\": \"vitamin D 25-oh, total: 43 NG/mL\"\n",
      "          }\n",
      "        }}],\n",
      "      \"Inactive_Condition\": [\n",
      "        {\"Review\": {\n",
      "          \"DX_Code\": \"J06.9\",\n",
      "          \"Description\": \"Upper respiratory infection\",\n",
      "          \"Memo\": {\n",
      "            \"date\": \"2023-09-01\",\n",
      "            \"note\": \"Doctor visit. Patient no longer complained of cough. Patient is not taking Ibuprofen and cough suppressant anymore.\"\n",
      "          }\n",
      "        }}]\n",
      "      }\n",
      "    </recommendation>\n",
      "    </response>\n",
      "    </example>\n",
      "\n",
      "Here are the patient notes: \n",
      "    <patient_notes>\n",
      "    {\n",
      "  \"name\": \"Patient 1\",\n",
      "  \"age\": \"57 years\",\n",
      "  \"sex\": \"Male\",\n",
      "  \"encounters\": [\n",
      "    {\n",
      "      \"Date\": \"2016-01-21\",\n",
      "      \"ICD10 diagnoses\": \"R01.1\",\n",
      "      \"Procedure codes\": \"93306\",\n",
      "      \"note\": []\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-02-25\",\n",
      "      \"Lab results\": \"potassium: 4 mmol/L, Body temperature: 97 degree Fahrenheit, Hemoglobin A1c/Hemoglobin.total in Blood: 5%, HDL cholesterol: 73 mg/dL, glucose: 103 mg/dL, albumin/globulin ratio: 2 (calc), Oxygen saturation: 98 percent, Respiratory rate: 18 Breaths / minute, creatinine: 1 mg/dL, ALT: 21 U/L, Body weight: 112037 gram, globulin: 2 g/dL (calc), carbon dioxide: 25 mmol/L, Body mass index (BMI): 40 kilogram / (meter ^ 2), alkaline phosphatase: 77 U/L, estimated avg. glucose: 108 mg/dL (calc), chloride: 102 mmol/L, blood urea nitrogen: 19 mg/dL, bilirubin, total: 1 mg/dL, GFR non-african american: 78 , triglycerides: 111 mg/dL, BUN/creatinine ratio: 24 (calc), Cholesterol in LDL [Mass/volume] in Serum or Plasma: 155 mg/dL (calc), GFR african american: 90 , albumin: 5 g/dL, Heart rate: 72 Beats / minute, anion gap: 12 (calc), sodium: 139 mmol/L, vitamin D 25-oh, total: 29 NG/mL, Blood pressure systolic and diastolic:  , calcium: 10 mg/dL, AST: 24 U/L, cholesterol: 250 mg/dL, total protein: 7 g/dL\",\n",
      "      \"Procedure codes\": \"80053, 99214, 83036, 80061, 36415, 82306\",\n",
      "      \"note\": [\"Continue increasing physical activity as well as holistic diet with elimination of processed carbs and sugars\",\n",
      "        \"labs today - continue current prescription as the current dose is appropriate\",\n",
      "        \"recheck labs today for eval - last LDL at 190\",\n",
      "        \"stable with medication dose\",\n",
      "        \"stable currently\",\n",
      "        \"Stable on current medication\",\n",
      "        \"Continue bisoprolol HCTZ and we will increase losartan to 100 mg daily.  Continue to monitor BP at home with goal of 120/80\",\n",
      "        \"Continue diet changes and recheck levels today\"]\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-03-31\", \n",
      "      \"Lab results\": \"cologuard result:\", \n",
      "      \"note\": []\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-05-05\",\n",
      "      \"Lab results\": \"white blood cells: 8 K/uL, Unknown:  , vitamin D 25-oh, total: 43 NG/mL, Unknown:  , glucose: 119 mg/dL, albumin/globulin ratio: 2 (calc), GFR: 59 , Unknown:  , Blood pressure systolic and diastolic:  , Body mass index (BMI): 44 kilogram / (meter ^ 2), % monocytes: 5%, Unknown:  , % eosinophils: 4%, Unknown:  , neutrophil,absolute: 6 K/uL, monocyte,absolute: 0 K/uL, eosinophil,absolute: 0 K/uL, Unknown:  , Unknown: 5 , Unknown:  , Body temperature: 99 degree Fahrenheit, Unknown:  , estimated avg. glucose: 123 mg/dL (calc), creatinine: 1 mg/dL, sodium: 140 mmol/L, MPV: 9 fL, chloride: 103 mmol/L, hyaline casts:  , % lymphocytes: 16%, AST: 30 U/L, ALT: 27 U/L, TSH: 4 uIU/mL, basophil,absolute: 0 K/uL, bilirubin, total: 1 mg/dL, reflex culture:  , % neutrophils: 74%, squamous epi. cells:  , Hemoglobin A1c/Hemoglobin.total in Blood: 6%, potassium: 4 mmol/L, anion gap: 11 (calc), cholesterol: 226 mg/dL, platelet count: 245 K/uL, Respiratory rate: 18 Breaths / minute, Heart rate: 89 Beats / minute, RBC, urine:  , hematocrit: 39%, Unknown:  , Body weight: 123377 gram, WBC, urine:  , RDW: 14%, nucleated red cells: 0%, Oxygen saturation: 98 percent, total protein: 7 g/dL, MCH: 32 pg, % basophils: 1%, Unknown:  , lymphocyte,absolute: 1 K/uL, alkaline phosphatase: 78 U/L, nucleated RBCs, absolute: 0 K/uL, mucus, urine:  , Unknown: 1 , globulin: 3 g/dL (calc), bacteria:  , triglycerides: 178 mg/dL, calcium: 10 mg/dL, BUN/creatinine ratio: 17 (calc), Unknown:  , albumin: 4 g/dL, HDL cholesterol: 59 mg/dL, MCV: 96 fL, hemoglobin: 13 g/dL, MCHC: 34 g/dL, Unknown:  , Cholesterol in LDL [Mass/volume] in Serum or Plasma: 131 mg/dL (calc), red blood cells: 4 M/uL, carbon dioxide: 26 mmol/L, 12 lead Electrocardiogram performed.:  , blood urea nitrogen: 18 mg/dL\",\n",
      "      \"Procedure codes\": \"G0439, 93000, 3288F, 99397, 82044, 81003, G0444, 80061, 85025, 84443, 80053, 83036, 36415, 82306, 81015, 93000\",\n",
      "      \"note\": [\"stable with medication dose of Celexa at 40 mg daily. We will continue with lifestyle modification and and improving socialization activities use PHQ-9 at 0\",\n",
      "        \"BMI is at 43.9 today.  This is quite significant 25 pounds increased from her last appointment.  She is highly motivated for weight loss and will start exercising regularly and continue to monitor for more holistic diet with Mediterranean like diet changes.  Goal of 10 to 15 pound weight loss by her next appointment.\",\n",
      "        \"Advised patient on exercising stretching and other modalities for her to continue at home.  PT and/or hand orthopedic referral if this continues to be problematic\",\n",
      "        \"utd with immunizations/other screenings Patient is not a fall risk and PHQ-9 is at 0\",\n",
      "        \"Continue bisoprolol HCTZ and losartan to 100 mg daily. Continue to monitor BP at home with goal below 140/90. DASH diet recommended as well. Advised her to keep BP log and bring that with her to next cardiology appointment for further assessment for better BP control as well\",\n",
      "        \"labs today - last vit d at 29 - continue current prescription as the current dose is appropriate of vitamin D 50,000 units once daily. Continue NAME exposure as stated\",\n",
      "        \"Mild changes with ST and lateral leads specifically 2 and V4 and V6 -we will refer to cardiology for further assessment due to history of mild aortic valve sclerosis and mild change with BP values.\",\n",
      "        \"Last echocardiogram DATE did display mild aortic valve sclerosis and stenosis. We will continue to monitor for any progressing symptoms and control cholesterol and blood pressure levels\",\n",
      "        \"Stable on current medication of methocarbamol as needed. We will continue with low back stretching and movement exercises\",\n",
      "        \"rx for bactrim\",\n",
      "        \"stable currently physical activity and meloxicam as needed. If it advised patient avoidance of other NSAIDs and will continue to monitor GFR closely\",\n",
      "        \"Continue diet changes and recheck levels today -last A1c at 5.4%. We will continue with diet modification and Mediterranean food with increasing fiber intake\",\n",
      "        \"recheck labs today for eval - last LDL improved at 155 from 190 at the last appointment. We will continue with high-fiber diet and pravastatin at 40 mg daily\",\n",
      "        \"Continue increasing physical activity as well as holistic diet with elimination of processed carbs and sugars. Last BMI 39.9\"]\n",
      "    },\n",
      "    {\n",
      "      \"Date\": \"2016-07-04\", \n",
      "      \"note\": [\"Patient visited doctor for red rash on hands that begins a few days after the pain. Skin is sensitive to touch, itching. There are fluid-filled blisters that break open and crust over. Doctor prescribed Acyclovir\"]},\n",
      "    {\n",
      "      \"Date\": \"2016-08-20\", \n",
      "      \"note\": [\"Doctor visit. Patient no longer complained of skin rash. Physical check up confirmed no rash or redness in the hand. Doctor asked to stop taking Acyclovir.\"]\n",
      "    }\n",
      "  ]\n",
      "}\n",
      "    </patient_notes>\n",
      "\n",
      "    Here are the initial recommendations: \n",
      "    <initial_recommendation>\n",
      "    \n",
      "{\n",
      "  \"Active_Condition\": [\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R01.1\",\n",
      "      \"Description\": \"Cardiac murmur\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-01-21\",\n",
      "        \"note\": \"ICD10 diagnosis code R01.1\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E66.9\",\n",
      "      \"Description\": \"Obesity\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Body mass index (BMI): 44 kilogram / (meter ^ 2)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E78.5\",\n",
      "      \"Description\": \"Hyperlipidemia\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"cholesterol: 226 mg/dL, triglycerides: 178 mg/dL, HDL cholesterol: 59 mg/dL, Cholesterol in LDL [Mass/volume] in Serum or Plasma: 131 mg/dL (calc)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E55.9\",\n",
      "      \"Description\": \"Vitamin D deficiency\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"vitamin D 25-oh, total: 43 NG/mL\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"I10\",\n",
      "      \"Description\": \"Hypertension\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Continue bisoprolol HCTZ and losartan to 100 mg daily. Continue to monitor BP at home with goal below 140/90.\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R73.03\",\n",
      "      \"Description\": \"Prediabetes\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Hemoglobin A1c/Hemoglobin.total in Blood: 6%, glucose: 119 mg/dL, estimated avg. glucose: 123 mg/dL (calc)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"N18.3\",\n",
      "      \"Description\": \"Chronic kidney disease, stage 3\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"GFR: 59\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E03.9\",\n",
      "      \"Description\": \"Hypothyroidism\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"TSH: 4 uIU/mL\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R94.31\",\n",
      "      \"Description\": \"Abnormal electrocardiogram\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Mild changes with ST and lateral leads specifically 2 and V4 and V6 -we will refer to cardiology for further assessment due to history of mild aortic valve sclerosis and mild change with BP values.\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"I35.8\",\n",
      "      \"Description\": \"Aortic valve disorder\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Last echocardiogram DATE did display mild aortic valve sclerosis and stenosis.\"\n",
      "      }\n",
      "    }}\n",
      "  ],\n",
      "  \"Inactive_Condition\": [\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"B00.9\",\n",
      "      \"Description\": \"Herpes simplex\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-08-20\",\n",
      "        \"note\": \"Doctor visit. Patient no longer complained of skin rash. Physical check up confirmed no rash or redness in the hand. Doctor asked to stop taking Acyclovir.\"\n",
      "      }\n",
      "    }}\n",
      "  ]\n",
      "}\n",
      "\n",
      "    </initial_recommendation>\n",
      "\n",
      "    Here are the guidelines: \n",
      "    <guidelines>\n",
      "    [{\"medical_condition\": \"Cardiac murmur\", \"kb_context\": [{\"content\": {\"text\": \"I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.  I50.21 - Acute systolic (congestive) heart failure: This code is used to diagnose acute systolic heart failure, which is a sudden onset of the condition where the heart's left ventricle cannot pump blood effectively due to decreased contractility.  I20.9 - Angina pectoris, unspecified: This code is used to diagnose angina pectoris or chest pain/discomfort due to reduced blood flow to the heart, but it does not specify the underlying cause (e.g., atherosclerosis, coronary artery disease, etc.).  I11.9 - Hypertensive heart disease without heart failure: This code is used to diagnose hypertensive heart disease, which is a condition where high blood pressure has caused damage or changes to the heart muscle. However, the patient does not have heart failure.  I24.9 - Acute ischemic heart disease, unspecified I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site I35.1 - Nonrheumatic aortic (valve) insufficiency I48.92 - Unspecified atrial flutter I34.0 - Nonrheumatic mitral (valve) insufficiency I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A4FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.4564133}, {\"content\": {\"text\": \"In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to I25.10, this code indicates atherosclerosis in the native coronary arteries. However, in this case, the patient experiences angina pectoris (chest pain or discomfort) due to reduced blood flow to the heart.  I50.22 - Chronic systolic (congestive) heart failure: This code is used to diagnose chronic systolic heart failure, a condition where the heart's left ventricle (the main pumping chamber) cannot pump blood effectively due to decreased contractility. It is a chronic (long-term) condition.  I48.0 - Paroxysmal atrial fibrillation: This code indicates that the patient has paroxysmal atrial fibrillation, which means the irregular heart rhythm comes and goes in episodes.  I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A3lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.4562157}, {\"content\": {\"text\": \"I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.  I21.9 - Acute myocardial infarction, unspecified: This code is used to diagnose a heart attack or myocardial infarction, but it does not specify the type (ST-elevation or non-ST-elevation) or location of the heart attack.  I48.20 - Chronic atrial fibrillation, unspecified: This code indicates the presence of chronic (persistent) atrial fibrillation, but it does not specify whether it is paroxysmal or permanent.  I49.9 - Cardiac arrhythmia, unspecified: This code is used to diagnose an irregular heart rhythm or cardiac arrhythmia, but it does not specify the type of arrhythmia (e.g., atrial fibrillation, ventricular tachycardia, etc.).  I50.9 - Heart failure, unspecified: This code is used to diagnose heart failure, but it does not specify the type (systolic or diastolic) or the underlying cause of the heart failure.  I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A31OBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.44361448}, {\"content\": {\"text\": \"ICD-10 codes in cardiology:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which supply blood to the heart muscle. However, the patient does not experience angina pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart.  I10 - Essential (primary) hypertension: This code refers to high blood pressure (hypertension) that has no identifiable cause. It is often called \\\"essential\\\" or \\\"primary\\\" hypertension.  I48.91 - Unspecified atrial fibrillation: This code indicates the presence of atrial fibrillation, an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. However, it does not specify whether the atrial fibrillation is paroxysmal (comes and goes) or chronic (persistent).  I21.4 - Non-ST elevation (NSTEMI) myocardial infarction: This code is used to diagnose a type of heart attack, specifically a non-ST-elevation myocardial infarction (NSTEMI). In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A3VOBQZIBzQkILuD-asVr\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.43512434}, {\"content\": {\"text\": \"the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A6FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.43510583}]}, {\"medical_condition\": \"Obesity\", \"kb_context\": [{\"content\": {\"text\": \"E66.9 - Obesity, unspecified This code indicates obesity without any additional details specified.  E66.01 - Morbid (severe) obesity due to excess calories This code is for severe obesity resulting from consuming excess calories.  E66.3 - Overweight This code applies when someone is overweight, but not yet classified as obese.  E66.8 - Other obesity This is a code for types of obesity that don't fit the other specific categories listed.  E66.2 - Obesity due to caloric excess This indicates obesity caused by consuming too many calories.  E66.09 - Other obesity due to excess calories This is for obesity from excess calories that doesn't fit the severe/morbid category.  E66.1 - Drug-induced obesity This code is for obesity that developed as a side effect of taking certain medications.  E66.0 - Obesity due to excess calories A general code for obesity resulting from caloric excess without additional details.  The Z68.* codes indicate the specific body mass index (BMI) range: Z68.54 - Body mass index (BMI) greater than or equal to 35, adult Z68.53 - Body mass index (BMI) 33.0-33.9, adult Z68.52 - Body mass index (BMI) 32.0-32.9, adult Z68.51 - Body mass index (BMI) 31.0-31.9, adult\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A-lOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.48345536}, {\"content\": {\"text\": \", resolved following treatment E11.37X2 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X3 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X9 - Type 2 diabetes mellitus with diabetic macular edema, unspecified E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.49 - Type 2 diabetes mellitus with other diabetic neurological complication E11.630 - Type 2 diabetes mellitus with diabetic cystopathy   ICD-10 codes related to obesity:  E66.9 - Obesity, unspecified This code indicates obesity without any additional details specified.  E66.01 - Morbid (severe) obesity due to excess calories This code is for severe obesity resulting from consuming excess calories.  E66.3 - Overweight This code applies when someone is overweight, but not yet classified as obese.  E66.8 - Other obesity This is a code for types of obesity that don't fit the other specific categories listed.  E66.2 - Obesity due to caloric excess This indicates obesity caused by consuming too many calories.  E66.09 - Other obesity due to excess calories This is for obesity from excess calories that doesn't fit the severe/morbid category.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A-VOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.45419607}, {\"content\": {\"text\": \"(BMI) 32.0-32.9, adult Z68.51 - Body mass index (BMI) 31.0-31.9, adult Z68.39 - Body mass index (BMI) 39.0-39.9, adult Z68.38 - Body mass index (BMI) 38.0-38.9, adult Z68.37 - Body mass index (BMI) 37.0-37.9, adult Z68.36 - Body mass index (BMI) 36.0-36.9, adult Z68.35 - Body mass index (BMI) 35.0-35.9, adult Z68.34 - Body mass index (BMI) 34.0-34.9, adult Z68.33 - Body mass index (BMI) 33.0-33.9, adult Z68.32 - Body mass index (BMI) 32.0-32.9, adult Z68.31 - Body mass index (BMI) 31.0-31.9, adult Z68.30 - Body mass index (BMI) 30.0-30.9, adult Z68.41 - Body mass index (BMI) 40.0-44.9, adult Z68.42 - Body mass index (BMI) 45.0-49.9, adult Z68.43 - Body mass index (BMI)\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A-1OBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.44292173}, {\"content\": {\"text\": \"adult Z68.41 - Body mass index (BMI) 40.0-44.9, adult Z68.42 - Body mass index (BMI) 45.0-49.9, adult Z68.43 - Body mass index (BMI) 50-59.9, adult Z68.44 - Body mass index (BMI) 60.0-69.9, adult Z68.45 - Body mass index (BMI) 70 or greater, adult E66.8 - Other obesity, not elsewhere classified E66.1 - Drug-induced obesity, not elsewhere classified   ICD-10 codes commonly used in Rheumatology:  MM05.9 - Rheumatoid arthritis, unspecified: This code is used when rheumatoid arthritis (a chronic autoimmune disorder primarily affecting the joints) is present, but the specific site or severity is not documented.  M06.9 - Rheumatoid arthritis, unspecified: This is the same as the previous code, indicating an unspecified case of rheumatoid arthritis.  M15.9 - Polyosteoarthritis, unspecified: This code refers to osteoarthritis (a degenerative joint disease) affecting multiple joints, but the specific sites are not documented.  M17.9 - Osteoarthritis of knee, unspecified: This code is used for osteoarthritis affecting the knee joint, without specifying which knee (right or left) or the severity.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A_FOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.42061195}, {\"content\": {\"text\": \"E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.  E11.3219 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed mild nonproliferative diabetic retinopathy (an early stage of diabetic retinopathy) without macular edema.  E11.3213 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy with macular edema.  E11.3212 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy without macular edema.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A9VOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.37617218}]}, {\"medical_condition\": \"Hyperlipidemia\", \"kb_context\": [{\"content\": {\"text\": \"The specific sequelae (consequences) are not specified in this code.  I70.239 - Atherosclerosis of the extremities with ulceration of unspecified extremity: This code indicates the presence of atherosclerosis in the arteries of the extremities, which has led to the development of an ulcer (open wound) in one of the extremities. However, the specific extremity affected is not specified.  I70.223 - Atherosclerosis of the extremities with ulceration of bilateral legs: Similar to the previous code, this code indicates atherosclerosis in the arteries of the extremities, but in this case, it has led to the development of ulcers in both legs.  I70.213 - Atherosclerosis of the extremities with intermittent claudication of bilateral legs: This code indicates the presence of atherosclerosis in the arteries of the extremities, leading to intermittent claudication (pain or discomfort in the legs during walking due to reduced blood flow) in both legs.  I70.212 - Atherosclerosis of the extremities with intermittent claudication of left leg: Similar to the previous code, this code indicates atherosclerosis in the arteries of the extremities, but in this case, it is causing intermittent claudication specifically in the left leg.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A6lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.40380135}, {\"content\": {\"text\": \"In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to I25.10, this code indicates atherosclerosis in the native coronary arteries. However, in this case, the patient experiences angina pectoris (chest pain or discomfort) due to reduced blood flow to the heart.  I50.22 - Chronic systolic (congestive) heart failure: This code is used to diagnose chronic systolic heart failure, a condition where the heart's left ventricle (the main pumping chamber) cannot pump blood effectively due to decreased contractility. It is a chronic (long-term) condition.  I48.0 - Paroxysmal atrial fibrillation: This code indicates that the patient has paroxysmal atrial fibrillation, which means the irregular heart rhythm comes and goes in episodes.  I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A3lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.40202343}, {\"content\": {\"text\": \"I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris I42.9 - Cardiomyopathy, unspecified I25.5 - Ischemic cardiomyopathy I25.111 - Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm I25.110 - Atherosclerotic heart disease of native coronary artery with unstable angina pectoris I27.0 - Primary pulmonary hypertension I25.700 - Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris I50.43 - Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure I25.84 - Coronary atherosclerosis due to calcified coronary lesion I44.2 - Atrioventricular block, complete I48.1 - Persistent atrial fibrillation I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris I25.83 - Coronary atherosclerosis due to lipid rich plaque I25.6 - Silent myocardial ischemia I25.2 - Old myocardial infarction I20.0 - Unstable angina I42.0 - Dilated cardiomyopathy I50.42 - Chronic combined systolic (congestive) and diastolic (congestive) heart failure I70.92\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A4VOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.400836}, {\"content\": {\"text\": \"I70.201 - Unspecified atherosclerosis of the extremities, right leg: This code is the same as the previous one, but it specifies that the atherosclerosis in the arteries of the extremities is affecting the right leg.  I48.21 - Paroxysmal atrial fibrillation: This code refers to a type of atrial fibrillation that occurs in sudden episodes or paroxysms, which means it comes and goes intermittently.  I70.1 - Atherosclerosis of renal artery: This code indicates the presence of atherosclerosis (buildup of plaque) in the renal arteries, which are the arteries that supply blood to the kidneys.  I70.8 - Atherosclerosis of other arteries: This code is used when atherosclerosis is present in arteries other than those specifically mentioned in the other codes, such as the arteries supplying the arms, abdomen, or other regions.  I70.92 - Chronic total occlusion of artery of the extremities, left leg: This code indicates a complete blockage (occlusion) of an artery in the left leg, which has been present for a long time (chronic).  I70.91 - Chronic total occlusion of artery of the extremities, right leg: Similar to the previous code, this code indicates a chronic total occlusion of an artery, but in this case, it is affecting the right leg.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A7FOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.39936954}, {\"content\": {\"text\": \"the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A6FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.398354}]}, {\"medical_condition\": \"Vitamin D deficiency\", \"kb_context\": [{\"content\": {\"text\": \"kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which are the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A51OBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.36901987}, {\"content\": {\"text\": \"kidney disease or end-stage renal disease E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease N25.0 - Renal osteodystrophy N26.9 - Renal failure, unspecified N25.9 - Disorder resulting from impaired renal tubular function, unspecified N28.9 - Disorder of kidney and ureter, unspecified E11.21 - Type 2 diabetes mellitus with diabetic nephropathy  E08.21 - Diabetes mellitus due to underlying condition with diabetic nephropathy E10.21 - Type 1 diabetes mellitus with diabetic nephropathy I13.0 - Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.2 - Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end-stage renal disease N25.1 - Renal osteodystrophy, unspecified N25.81 - Secondary hyperparathyroidism of renal origin N25.89 - Other disorders resulting from impaired renal tubular function N28.84 - Hypertrophy of kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A5lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.3666274}, {\"content\": {\"text\": \"M25.60 - Stiffness of unspecified joint, not elsewhere classified M25.61 - Stiffness of shoulder joint, not elsewhere classified M25.62 - Stiffness of elbow joint, not elsewhere classified M25.63 - Stiffness of wrist joint, not elsewhere classified M25.64 - Stiffness of hand joint, not elsewhere classified M25.65 - Stiffness of hip joint, not elsewhere classified M25.66 - Stiffness of knee joint, not elsewhere classified M25.67 - Stiffness of ankle and foot joints, not elsewhere classified M25.68 - Stiffness of other joint, not elsewhere classified This list covers common rheumatic conditions such as rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, ankylosing spondylitis, and various types of joint pain, stiffness, and contractures.   ICD-10 codes commonly used in psychiatry:  F33 - Major Depressive Disorder, recurrent: This code is used for patients experiencing multiple episodes of major depressive disorder, with periods of remission in between.  F41.1 - Generalized Anxiety Disorder: A chronic condition characterized by excessive and uncontrollable worry and anxiety about many different aspects of life.  F32.9 - Major Depressive Disorder, single episode, unspecified: This code is used for a single episode of major depression, with the severity level not specified.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3AAFOBQZIBzQkILuD-asZ1\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.36576614}, {\"content\": {\"text\": \", resolved following treatment E11.37X2 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X3 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X9 - Type 2 diabetes mellitus with diabetic macular edema, unspecified E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.49 - Type 2 diabetes mellitus with other diabetic neurological complication E11.630 - Type 2 diabetes mellitus with diabetic cystopathy   ICD-10 codes related to obesity:  E66.9 - Obesity, unspecified This code indicates obesity without any additional details specified.  E66.01 - Morbid (severe) obesity due to excess calories This code is for severe obesity resulting from consuming excess calories.  E66.3 - Overweight This code applies when someone is overweight, but not yet classified as obese.  E66.8 - Other obesity This is a code for types of obesity that don't fit the other specific categories listed.  E66.2 - Obesity due to caloric excess This indicates obesity caused by consuming too many calories.  E66.09 - Other obesity due to excess calories This is for obesity from excess calories that doesn't fit the severe/morbid category.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A-VOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.3652193}, {\"content\": {\"text\": \"adult Z68.41 - Body mass index (BMI) 40.0-44.9, adult Z68.42 - Body mass index (BMI) 45.0-49.9, adult Z68.43 - Body mass index (BMI) 50-59.9, adult Z68.44 - Body mass index (BMI) 60.0-69.9, adult Z68.45 - Body mass index (BMI) 70 or greater, adult E66.8 - Other obesity, not elsewhere classified E66.1 - Drug-induced obesity, not elsewhere classified   ICD-10 codes commonly used in Rheumatology:  MM05.9 - Rheumatoid arthritis, unspecified: This code is used when rheumatoid arthritis (a chronic autoimmune disorder primarily affecting the joints) is present, but the specific site or severity is not documented.  M06.9 - Rheumatoid arthritis, unspecified: This is the same as the previous code, indicating an unspecified case of rheumatoid arthritis.  M15.9 - Polyosteoarthritis, unspecified: This code refers to osteoarthritis (a degenerative joint disease) affecting multiple joints, but the specific sites are not documented.  M17.9 - Osteoarthritis of knee, unspecified: This code is used for osteoarthritis affecting the knee joint, without specifying which knee (right or left) or the severity.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A_FOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.36265594}]}, {\"medical_condition\": \"Hypertension\", \"kb_context\": [{\"content\": {\"text\": \"ICD-10 codes in cardiology:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which supply blood to the heart muscle. However, the patient does not experience angina pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart.  I10 - Essential (primary) hypertension: This code refers to high blood pressure (hypertension) that has no identifiable cause. It is often called \\\"essential\\\" or \\\"primary\\\" hypertension.  I48.91 - Unspecified atrial fibrillation: This code indicates the presence of atrial fibrillation, an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. However, it does not specify whether the atrial fibrillation is paroxysmal (comes and goes) or chronic (persistent).  I21.4 - Non-ST elevation (NSTEMI) myocardial infarction: This code is used to diagnose a type of heart attack, specifically a non-ST-elevation myocardial infarction (NSTEMI). In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A3VOBQZIBzQkILuD-asVr\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.40000802}, {\"content\": {\"text\": \"the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A6FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.3979492}, {\"content\": {\"text\": \"kidney disease or end-stage renal disease E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease N25.0 - Renal osteodystrophy N26.9 - Renal failure, unspecified N25.9 - Disorder resulting from impaired renal tubular function, unspecified N28.9 - Disorder of kidney and ureter, unspecified E11.21 - Type 2 diabetes mellitus with diabetic nephropathy  E08.21 - Diabetes mellitus due to underlying condition with diabetic nephropathy E10.21 - Type 1 diabetes mellitus with diabetic nephropathy I13.0 - Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.2 - Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end-stage renal disease N25.1 - Renal osteodystrophy, unspecified N25.81 - Secondary hyperparathyroidism of renal origin N25.89 - Other disorders resulting from impaired renal tubular function N28.84 - Hypertrophy of kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A5lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.39754903}, {\"content\": {\"text\": \"kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which are the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A51OBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.39645708}, {\"content\": {\"text\": \"I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.  I50.21 - Acute systolic (congestive) heart failure: This code is used to diagnose acute systolic heart failure, which is a sudden onset of the condition where the heart's left ventricle cannot pump blood effectively due to decreased contractility.  I20.9 - Angina pectoris, unspecified: This code is used to diagnose angina pectoris or chest pain/discomfort due to reduced blood flow to the heart, but it does not specify the underlying cause (e.g., atherosclerosis, coronary artery disease, etc.).  I11.9 - Hypertensive heart disease without heart failure: This code is used to diagnose hypertensive heart disease, which is a condition where high blood pressure has caused damage or changes to the heart muscle. However, the patient does not have heart failure.  I24.9 - Acute ischemic heart disease, unspecified I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site I35.1 - Nonrheumatic aortic (valve) insufficiency I48.92 - Unspecified atrial flutter I34.0 - Nonrheumatic mitral (valve) insufficiency I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A4FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.39583558}]}, {\"medical_condition\": \"Prediabetes\", \"kb_context\": [{\"content\": {\"text\": \"E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.  E11.3219 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed mild nonproliferative diabetic retinopathy (an early stage of diabetic retinopathy) without macular edema.  E11.3213 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy with macular edema.  E11.3212 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy without macular edema.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A9VOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.4268761}, {\"content\": {\"text\": \"E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic polyneuropathy (damage to multiple peripheral nerves due to diabetes).  E11.621 - Type 2 diabetes mellitus with foot ulcer: This code indicates that the patient has Type 2 diabetes mellitus and has developed a foot ulcer as a complication of their diabetes.  E11.610 - Type 2 diabetes mellitus with diabetic neuropathic arthropathy: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic neuropathic arthropathy (a degenerative joint condition caused by nerve damage due to diabetes).  E11.8 - Type 2 diabetes mellitus with unspecified complications: This code indicates that the patient has Type 2 diabetes mellitus and has developed complications, but the specific complications are not specified.  E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication: This code is used when a patient has Type 2 diabetes mellitus and has developed other kidney complications related to their diabetes, not specified as chronic kidney disease or nephropathy.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A81OBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.42315212}, {\"content\": {\"text\": \"E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication: This code is used when a patient has Type 2 diabetes mellitus and has developed other kidney complications related to their diabetes, not specified as chronic kidney disease or nephropathy.  E11.36 - Type 2 diabetes mellitus with diabetic cataract: This code indicates that the patient has Type 2 diabetes mellitus and has developed a cataract (clouding of the eye's lens) as a complication of their diabetes.  E11.622 - Type 2 diabetes mellitus with other skin ulcer: This code is used when a patient has Type 2 diabetes mellitus and has developed skin ulcers other than foot ulcers as a complication of their diabetes.  E11.618 - Type 2 diabetes mellitus with other diabetic arthropathy: This code indicates that the patient has Type 2 diabetes mellitus and has developed other types of arthropathy (joint disease) related to their diabetes, not specified as neuropathic arthropathy.  E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A9FOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.4229759}, {\"content\": {\"text\": \"E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease: This code is used when a patient has Type 2 diabetes mellitus and has developed chronic kidney disease due to their diabetes.  E11.311 - Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed diabetic retinopathy (an eye disease affecting the retina) with macular edema (swelling in the macula, the central part of the retina).  E11.319 - Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic retinopathy, but without macular edema.  E11.59 - Type 2 diabetes mellitus with other circulatory complications: This code indicates that the patient has Type 2 diabetes mellitus and has developed other circulatory complications related to their diabetes, such as peripheral vascular disease or cardiovascular disease.  E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic polyneuropathy (damage to multiple peripheral nerves due to diabetes).\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A8lOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.4167115}, {\"content\": {\"text\": \"no documented complications related to the diabetes.  E11.65 - Type 2 diabetes mellitus with hyperglycemia: This code indicates that the patient has Type 2 diabetes mellitus and is experiencing hyperglycemia (high blood sugar levels).  E11.51 - Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic peripheral angiopathy (a condition affecting the blood vessels in the extremities, particularly the legs and feet) without gangrene.  E11.21 - Type 2 diabetes mellitus with diabetic nephropathy: This code indicates that the patient has Type 2 diabetes mellitus and has developed diabetic nephropathy (kidney disease or damage caused by diabetes).  E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease: This code is used when a patient has Type 2 diabetes mellitus and has developed chronic kidney disease due to their diabetes.  E11.311 - Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed diabetic retinopathy (an eye disease affecting the retina) with macular edema (swelling in the macula, the central part of the retina).\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A8VOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.41662464}]}, {\"medical_condition\": \"Chronic kidney disease, stage 3\", \"kb_context\": [{\"content\": {\"text\": \". Stage 1 CKD is usually diagnosed based on the presence of proteinuria or other markers of kidney damage, despite normal kidney function.  N18.2 - Chronic kidney disease, stage 2 (mild): This code represents mild kidney damage with a slightly decreased GFR (60-89 mL/min/1.73m\\u00b2). Patients in this stage typically have mild kidney dysfunction but may not experience any symptoms.  N18.3 - Chronic kidney disease, stage 3 (moderate): Stage 3 CKD is categorized as moderate kidney damage with a GFR ranging from 30-59 mL/min/1.73m\\u00b2. This stage is further divided into two subcategories:  N18.30 - Chronic kidney disease, stage 3 unspecified N18.31 - Chronic kidney disease, stage 3a (GFR 45-59 mL/min/1.73m\\u00b2) N18.32 - Chronic kidney disease, stage 3b (GFR 30-44 mL/min/1.73m\\u00b2) N18.4 - Chronic kidney disease, stage 4 (severe): This code indicates severe kidney damage with a GFR ranging from 15-29 mL/min/1.73m\\u00b2. Patients in this stage may experience symptoms such as fatigue, nausea, and fluid retention.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A5FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.63555676}, {\"content\": {\"text\": \"Patients in this stage may experience symptoms such as fatigue, nausea, and fluid retention.  N18.5 - Chronic kidney disease, stage 5: Stage 5 CKD is also known as end-stage renal disease (ESRD) or kidney failure, with a GFR <15 mL/min/1.73m\\u00b2. At this stage, dialysis or a kidney transplant is typically required to sustain life.  N18.6 - End-stage renal disease: This code specifically refers to ESRD or kidney failure requiring dialysis or a kidney transplant.  N18.9 - Chronic kidney disease, unspecified: This code is used when chronic kidney disease is present, but the specific stage is not documented or specified.  I12.9 - Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.11 - Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end-stage renal disease E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease E08.22 - Diabetes mellitus due to underlying condition with diabetic chronic kidney disease N19 - Unspecified kidney failure I12.0 - Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end-stage renal disease E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease N25.0 - Renal osteodystrophy\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A5VOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.60636896}, {\"content\": {\"text\": \"kidney disease, stage 1: This code indicates the presence of kidney damage with normal or increased glomerular filtration rate (GFR \\u226590 mL/min/1.73m\\u00b2). Stage 1 CKD is usually diagnosed based on the presence of proteinuria or other markers of kidney damage, despite normal kidney function.  N18.2 - Chronic kidney disease, stage 2 (mild): This code represents mild kidney damage with a slightly decreased GFR (60-89 mL/min/1.73m\\u00b2). Patients in this stage typically have mild kidney dysfunction but may not experience any symptoms.  N18.3 - Chronic kidney disease, stage 3 (moderate): Stage 3 CKD is categorized as moderate kidney damage with a GFR ranging from 30-59 mL/min/1.73m\\u00b2. This stage is further divided into two subcategories:  N18.30 - Chronic kidney disease, stage 3 unspecified N18.31 - Chronic kidney disease, stage 3a (GFR 45-59 mL/min/1.73m\\u00b2) N18.32 - Chronic kidney disease, stage 3b (GFR 30-44 mL/min/1.73m\\u00b2) N18.4 - Chronic kidney disease, stage 4 (severe): This code indicates severe kidney damage with a GFR ranging from 15-29 mL/min/1.73m\\u00b2.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A41OBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.5937614}, {\"content\": {\"text\": \"- Silent myocardial ischemia I25.2 - Old myocardial infarction I20.0 - Unstable angina I42.0 - Dilated cardiomyopathy I50.42 - Chronic combined systolic (congestive) and diastolic (congestive) heart failure I70.92 - Chronic total occlusion of artery of the extremities I34.1 - Nonrheumatic mitral (valve) prolapse I50.33 - Acute on chronic diastolic (congestive) heart failure I24.8 - Other forms of acute ischemic heart disease I25.9 - Chronic ischemic heart disease, unspecified I44.1 - Atrioventricular block, second degree I42.5 - Other restrictive cardiomyopathy I35.8 - Other nonrheumatic aortic valve disorders I47.1 - Supraventricular tachycardia   ICD-10 codes for chronic kidney disease (CKD):  N18.1 - Chronic kidney disease, stage 1: This code indicates the presence of kidney damage with normal or increased glomerular filtration rate (GFR \\u226590 mL/min/1.73m\\u00b2). Stage 1 CKD is usually diagnosed based on the presence of proteinuria or other markers of kidney damage, despite normal kidney function.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A4lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.4990366}, {\"content\": {\"text\": \"kidney disease or end-stage renal disease E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease N25.0 - Renal osteodystrophy N26.9 - Renal failure, unspecified N25.9 - Disorder resulting from impaired renal tubular function, unspecified N28.9 - Disorder of kidney and ureter, unspecified E11.21 - Type 2 diabetes mellitus with diabetic nephropathy  E08.21 - Diabetes mellitus due to underlying condition with diabetic nephropathy E10.21 - Type 1 diabetes mellitus with diabetic nephropathy I13.0 - Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.2 - Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end-stage renal disease N25.1 - Renal osteodystrophy, unspecified N25.81 - Secondary hyperparathyroidism of renal origin N25.89 - Other disorders resulting from impaired renal tubular function N28.84 - Hypertrophy of kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A5lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.46019468}]}, {\"medical_condition\": \"Hypothyroidism\", \"kb_context\": [{\"content\": {\"text\": \"E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.  E11.3219 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed mild nonproliferative diabetic retinopathy (an early stage of diabetic retinopathy) without macular edema.  E11.3213 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy with macular edema.  E11.3212 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy without macular edema.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A9VOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.37411034}, {\"content\": {\"text\": \"E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication: This code is used when a patient has Type 2 diabetes mellitus and has developed other kidney complications related to their diabetes, not specified as chronic kidney disease or nephropathy.  E11.36 - Type 2 diabetes mellitus with diabetic cataract: This code indicates that the patient has Type 2 diabetes mellitus and has developed a cataract (clouding of the eye's lens) as a complication of their diabetes.  E11.622 - Type 2 diabetes mellitus with other skin ulcer: This code is used when a patient has Type 2 diabetes mellitus and has developed skin ulcers other than foot ulcers as a complication of their diabetes.  E11.618 - Type 2 diabetes mellitus with other diabetic arthropathy: This code indicates that the patient has Type 2 diabetes mellitus and has developed other types of arthropathy (joint disease) related to their diabetes, not specified as neuropathic arthropathy.  E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A9FOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.37381303}, {\"content\": {\"text\": \", resolved following treatment E11.37X2 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X3 - Type 2 diabetes mellitus with diabetic macular edema, improved with current treatment E11.37X9 - Type 2 diabetes mellitus with diabetic macular edema, unspecified E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.49 - Type 2 diabetes mellitus with other diabetic neurological complication E11.630 - Type 2 diabetes mellitus with diabetic cystopathy   ICD-10 codes related to obesity:  E66.9 - Obesity, unspecified This code indicates obesity without any additional details specified.  E66.01 - Morbid (severe) obesity due to excess calories This code is for severe obesity resulting from consuming excess calories.  E66.3 - Overweight This code applies when someone is overweight, but not yet classified as obese.  E66.8 - Other obesity This is a code for types of obesity that don't fit the other specific categories listed.  E66.2 - Obesity due to caloric excess This indicates obesity caused by consuming too many calories.  E66.09 - Other obesity due to excess calories This is for obesity from excess calories that doesn't fit the severe/morbid category.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A-VOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.3716726}, {\"content\": {\"text\": \"E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease: This code is used when a patient has Type 2 diabetes mellitus and has developed chronic kidney disease due to their diabetes.  E11.311 - Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed diabetic retinopathy (an eye disease affecting the retina) with macular edema (swelling in the macula, the central part of the retina).  E11.319 - Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic retinopathy, but without macular edema.  E11.59 - Type 2 diabetes mellitus with other circulatory complications: This code indicates that the patient has Type 2 diabetes mellitus and has developed other circulatory complications related to their diabetes, such as peripheral vascular disease or cardiovascular disease.  E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy: This code is used when a patient has Type 2 diabetes mellitus and has developed diabetic polyneuropathy (damage to multiple peripheral nerves due to diabetes).\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A8lOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.36957046}, {\"content\": {\"text\": \"F51.01 - Insomnia Disorder due to another medical condition: Insomnia caused by an underlying medical condition. F44.9 - Dissociative Disorder, unspecified F31.0 - Bipolar Disorder, current episode hypomanic F60.2 - Antisocial Personality Disorder F33.41 - Major Depressive Disorder, recurrent, in partial remission F44.4 - Conversion Disorder with motor symptom or deficit F51.03 - Insomnia Disorder due to drug or substance F31.62 - Bipolar Disorder, current episode with mixed features F06.31 - Mood Disorder due to another medical condition with depressive features F48.9 - Nonpsychotic Mental Disorder, unspecified F31.76 - Bipolar Disorder, in partial remission, most recent episode mixed F41.8 - Other Specified Anxiety Disorders F95.2 - Tourette's Disorder F63.3 - Gambling Disorder\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3ABVOBQZIBzQkILuD-asZ1\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.36905342}]}, {\"medical_condition\": \"Abnormal electrocardiogram\", \"kb_context\": [{\"content\": {\"text\": \"I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.  I21.9 - Acute myocardial infarction, unspecified: This code is used to diagnose a heart attack or myocardial infarction, but it does not specify the type (ST-elevation or non-ST-elevation) or location of the heart attack.  I48.20 - Chronic atrial fibrillation, unspecified: This code indicates the presence of chronic (persistent) atrial fibrillation, but it does not specify whether it is paroxysmal or permanent.  I49.9 - Cardiac arrhythmia, unspecified: This code is used to diagnose an irregular heart rhythm or cardiac arrhythmia, but it does not specify the type of arrhythmia (e.g., atrial fibrillation, ventricular tachycardia, etc.).  I50.9 - Heart failure, unspecified: This code is used to diagnose heart failure, but it does not specify the type (systolic or diastolic) or the underlying cause of the heart failure.  I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A31OBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.4801703}, {\"content\": {\"text\": \"In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to I25.10, this code indicates atherosclerosis in the native coronary arteries. However, in this case, the patient experiences angina pectoris (chest pain or discomfort) due to reduced blood flow to the heart.  I50.22 - Chronic systolic (congestive) heart failure: This code is used to diagnose chronic systolic heart failure, a condition where the heart's left ventricle (the main pumping chamber) cannot pump blood effectively due to decreased contractility. It is a chronic (long-term) condition.  I48.0 - Paroxysmal atrial fibrillation: This code indicates that the patient has paroxysmal atrial fibrillation, which means the irregular heart rhythm comes and goes in episodes.  I63.9 - Cerebral infarction, unspecified: This code is used to diagnose a stroke or cerebral infarction (a blockage of blood flow to the brain), but it does not specify the location or type of stroke.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A3lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.47731468}, {\"content\": {\"text\": \"I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.  I50.21 - Acute systolic (congestive) heart failure: This code is used to diagnose acute systolic heart failure, which is a sudden onset of the condition where the heart's left ventricle cannot pump blood effectively due to decreased contractility.  I20.9 - Angina pectoris, unspecified: This code is used to diagnose angina pectoris or chest pain/discomfort due to reduced blood flow to the heart, but it does not specify the underlying cause (e.g., atherosclerosis, coronary artery disease, etc.).  I11.9 - Hypertensive heart disease without heart failure: This code is used to diagnose hypertensive heart disease, which is a condition where high blood pressure has caused damage or changes to the heart muscle. However, the patient does not have heart failure.  I24.9 - Acute ischemic heart disease, unspecified I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site I35.1 - Nonrheumatic aortic (valve) insufficiency I48.92 - Unspecified atrial flutter I34.0 - Nonrheumatic mitral (valve) insufficiency I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A4FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.47351635}, {\"content\": {\"text\": \"the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A6FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.45496997}, {\"content\": {\"text\": \"ICD-10 codes in cardiology:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which supply blood to the heart muscle. However, the patient does not experience angina pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart.  I10 - Essential (primary) hypertension: This code refers to high blood pressure (hypertension) that has no identifiable cause. It is often called \\\"essential\\\" or \\\"primary\\\" hypertension.  I48.91 - Unspecified atrial fibrillation: This code indicates the presence of atrial fibrillation, an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. However, it does not specify whether the atrial fibrillation is paroxysmal (comes and goes) or chronic (persistent).  I21.4 - Non-ST elevation (NSTEMI) myocardial infarction: This code is used to diagnose a type of heart attack, specifically a non-ST-elevation myocardial infarction (NSTEMI). In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A3VOBQZIBzQkILuD-asVr\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.44684735}]}, {\"medical_condition\": \"Aortic valve disorder\", \"kb_context\": [{\"content\": {\"text\": \"I51.6 - Cardiovascular disease, unspecified: This code is a general code used to diagnose an unspecified cardiovascular disease or disorder affecting the heart and blood vessels.  I50.21 - Acute systolic (congestive) heart failure: This code is used to diagnose acute systolic heart failure, which is a sudden onset of the condition where the heart's left ventricle cannot pump blood effectively due to decreased contractility.  I20.9 - Angina pectoris, unspecified: This code is used to diagnose angina pectoris or chest pain/discomfort due to reduced blood flow to the heart, but it does not specify the underlying cause (e.g., atherosclerosis, coronary artery disease, etc.).  I11.9 - Hypertensive heart disease without heart failure: This code is used to diagnose hypertensive heart disease, which is a condition where high blood pressure has caused damage or changes to the heart muscle. However, the patient does not have heart failure.  I24.9 - Acute ischemic heart disease, unspecified I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site I35.1 - Nonrheumatic aortic (valve) insufficiency I48.92 - Unspecified atrial flutter I34.0 - Nonrheumatic mitral (valve) insufficiency I25.701 - Atherosclerosis of coronary artery bypass graft(s), unspecified\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A4FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.42573658}, {\"content\": {\"text\": \"- Silent myocardial ischemia I25.2 - Old myocardial infarction I20.0 - Unstable angina I42.0 - Dilated cardiomyopathy I50.42 - Chronic combined systolic (congestive) and diastolic (congestive) heart failure I70.92 - Chronic total occlusion of artery of the extremities I34.1 - Nonrheumatic mitral (valve) prolapse I50.33 - Acute on chronic diastolic (congestive) heart failure I24.8 - Other forms of acute ischemic heart disease I25.9 - Chronic ischemic heart disease, unspecified I44.1 - Atrioventricular block, second degree I42.5 - Other restrictive cardiomyopathy I35.8 - Other nonrheumatic aortic valve disorders I47.1 - Supraventricular tachycardia   ICD-10 codes for chronic kidney disease (CKD):  N18.1 - Chronic kidney disease, stage 1: This code indicates the presence of kidney damage with normal or increased glomerular filtration rate (GFR \\u226590 mL/min/1.73m\\u00b2). Stage 1 CKD is usually diagnosed based on the presence of proteinuria or other markers of kidney damage, despite normal kidney function.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A4lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.41587397}, {\"content\": {\"text\": \"kidney N28.89 - Other specified disorders of kidney and ureter N32.1 - Calculus of kidney N32.2 - Calculus of ureter    ICD-10 codes for vascular diseases:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which are the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A51OBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.40606195}, {\"content\": {\"text\": \"the arteries that supply blood to the heart muscle. However, this condition does not cause angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris: Similar to the previous code, this code indicates atherosclerosis in the native coronary arteries, but in this case, it is accompanied by angina pectoris (chest pain or discomfort due to reduced blood flow to the heart).  I70.92 - Chronic total occlusion of artery of the extremities, unspecified extremity: This code refers to a complete blockage (occlusion) of an artery in the extremities (arms or legs), which has been present for a long time (chronic). However, the specific extremity (right or left arm/leg) is not specified.  I63.9 - Cerebral infarction, unspecified: This code indicates a stroke or cerebral infarction, which is a sudden interruption of blood supply to the brain, causing tissue damage. The code does not specify the cause or location of the infarction.  I48.91 - Unspecified atrial fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke and other heart-related complications. This code simply indicates the presence of atrial fibrillation without specifying any further details.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A6FOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.40526533}, {\"content\": {\"text\": \"ICD-10 codes in cardiology:  I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris: This code indicates the presence of atherosclerosis (buildup of plaque) in the native coronary arteries, which supply blood to the heart muscle. However, the patient does not experience angina pectoris, which is chest pain or discomfort caused by reduced blood flow to the heart.  I10 - Essential (primary) hypertension: This code refers to high blood pressure (hypertension) that has no identifiable cause. It is often called \\\"essential\\\" or \\\"primary\\\" hypertension.  I48.91 - Unspecified atrial fibrillation: This code indicates the presence of atrial fibrillation, an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. However, it does not specify whether the atrial fibrillation is paroxysmal (comes and goes) or chronic (persistent).  I21.4 - Non-ST elevation (NSTEMI) myocardial infarction: This code is used to diagnose a type of heart attack, specifically a non-ST-elevation myocardial infarction (NSTEMI). In an NSTEMI, there is partial blockage of a coronary artery, leading to reduced blood flow and damage to the heart muscle.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A3VOBQZIBzQkILuD-asVr\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.40256235}]}, {\"medical_condition\": \"Herpes simplex\", \"kb_context\": [{\"content\": {\"text\": \"E11.29 - Type 2 diabetes mellitus with other diabetic kidney complication: This code is used when a patient has Type 2 diabetes mellitus and has developed other kidney complications related to their diabetes, not specified as chronic kidney disease or nephropathy.  E11.36 - Type 2 diabetes mellitus with diabetic cataract: This code indicates that the patient has Type 2 diabetes mellitus and has developed a cataract (clouding of the eye's lens) as a complication of their diabetes.  E11.622 - Type 2 diabetes mellitus with other skin ulcer: This code is used when a patient has Type 2 diabetes mellitus and has developed skin ulcers other than foot ulcers as a complication of their diabetes.  E11.618 - Type 2 diabetes mellitus with other diabetic arthropathy: This code indicates that the patient has Type 2 diabetes mellitus and has developed other types of arthropathy (joint disease) related to their diabetes, not specified as neuropathic arthropathy.  E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A9FOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.35405943}, {\"content\": {\"text\": \"- Cerebral infarction due to unspecified occlusion or stenosis of left vertebral arteries I63.329 - Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral arteries I63.331 - Cerebral infarction due to thrombosis of right carotid artery I63.339 - Cerebral infarction due to thrombosis of unspecified carotid artery I63.341 - Cerebral infarction due to embolism of right carotid artery I63.342 - Cerebral infarction due to embolism of left carotid artery I63.349 - Cerebral infarction due to embolism of unspecified carotid artery I63.39 - Cerebral infarction due to thrombosis of unspecified cerebral artery I63.40 - Cerebral infarction due to embolism of unspecified cerebral artery I63.411 - Cerebral infarction due to embolism of right vertebral artery I63.419 - Cerebral infarction due to embolism of unspecified vertebral artery I63.421 - Cerebral infarction due to embolism of right carotid artery I63.429 - Cerebral infarction due to embolism of unspecified carotid artery I63.49 - Cerebral infarction due to embolism of\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A7lOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.35057873}, {\"content\": {\"text\": \"E11.638 - Type 2 diabetes mellitus with other oral complications: This code is used when a patient has Type 2 diabetes mellitus and has developed other oral complications related to their diabetes, such as periodontal disease or dry mouth.  E11.3219 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed mild nonproliferative diabetic retinopathy (an early stage of diabetic retinopathy) without macular edema.  E11.3213 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema: This code is used when a patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy with macular edema.  E11.3212 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema: This code indicates that the patient has Type 2 diabetes mellitus and has developed moderate nonproliferative diabetic retinopathy without macular edema.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A9VOBQZIBzQkILuD-asV0\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.34972504}, {\"content\": {\"text\": \"The specific sequelae (consequences) are not specified in this code.  I70.239 - Atherosclerosis of the extremities with ulceration of unspecified extremity: This code indicates the presence of atherosclerosis in the arteries of the extremities, which has led to the development of an ulcer (open wound) in one of the extremities. However, the specific extremity affected is not specified.  I70.223 - Atherosclerosis of the extremities with ulceration of bilateral legs: Similar to the previous code, this code indicates atherosclerosis in the arteries of the extremities, but in this case, it has led to the development of ulcers in both legs.  I70.213 - Atherosclerosis of the extremities with intermittent claudication of bilateral legs: This code indicates the presence of atherosclerosis in the arteries of the extremities, leading to intermittent claudication (pain or discomfort in the legs during walking due to reduced blood flow) in both legs.  I70.212 - Atherosclerosis of the extremities with intermittent claudication of left leg: Similar to the previous code, this code indicates atherosclerosis in the arteries of the extremities, but in this case, it is causing intermittent claudication specifically in the left leg.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3A6lOBQZIBzQkILuD-asVz\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.34850034}, {\"content\": {\"text\": \"M25.60 - Stiffness of unspecified joint, not elsewhere classified M25.61 - Stiffness of shoulder joint, not elsewhere classified M25.62 - Stiffness of elbow joint, not elsewhere classified M25.63 - Stiffness of wrist joint, not elsewhere classified M25.64 - Stiffness of hand joint, not elsewhere classified M25.65 - Stiffness of hip joint, not elsewhere classified M25.66 - Stiffness of knee joint, not elsewhere classified M25.67 - Stiffness of ankle and foot joints, not elsewhere classified M25.68 - Stiffness of other joint, not elsewhere classified This list covers common rheumatic conditions such as rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, ankylosing spondylitis, and various types of joint pain, stiffness, and contractures.   ICD-10 codes commonly used in psychiatry:  F33 - Major Depressive Disorder, recurrent: This code is used for patients experiencing multiple episodes of major depressive disorder, with periods of remission in between.  F41.1 - Generalized Anxiety Disorder: A chronic condition characterized by excessive and uncontrollable worry and anxiety about many different aspects of life.  F32.9 - Major Depressive Disorder, single episode, unspecified: This code is used for a single episode of major depression, with the severity level not specified.\"}, \"location\": {\"s3Location\": {\"uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\"}, \"type\": \"S3\"}, \"metadata\": {\"x-amz-bedrock-kb-source-uri\": \"s3://patientdiagnosissummarystack-knowledgebase6979138a-wkhqto8napa4/icd0-kb.txt\", \"x-amz-bedrock-kb-chunk-id\": \"1%3A0%3AAFOBQZIBzQkILuD-asZ1\", \"x-amz-bedrock-kb-data-source-id\": \"SMXZNVKHKR\"}, \"score\": 0.3474978}]}]\n",
      "    </guidelines>\n",
      "\n",
      "    Here is the user's question:\n",
      "    <question>\n",
      "    Share your recommendation about the medical conditions of the patient\n",
      "    </question>\n",
      "\n",
      "How do you respond to the user's question?\n",
      "\n",
      "Think step by step about your answer first before you respond. When you reply, first find all the medical conditions, corresponding ICD10 codes, explanation and write them down inside <thinking></thinking> XML tags.  This is a space for you to write down relevant content. Once you are done extracting relevant information, double check your work. Look back over the lab results and notes again with fresh eyes to make sure nothing was missed. Now answer the question. Put your recommendation inside <recommendation></recommendation> XML tag.\n",
      "\n",
      "Put your response in <response></response> tags.\n",
      "\n",
      "\n",
      "------ASSISTANT TURN------\n",
      "[assistant] <response>\n"
     ]
    }
   ],
   "source": [
    "if use_knowledge_base == 'Y':\n",
    "\n",
    "    ######################################## INPUT VARIABLES ########################################\n",
    "\n",
    "    # First input variable - the conversation history (this can also be added as preceding `user` and `assistant` messages in the API call)\n",
    "    HISTORY = \"\"\n",
    "\n",
    "    # Second input variable - the user's question\n",
    "    QUESTION = \"Share your recommendation about the medical conditions of the patient\"\n",
    "\n",
    "\n",
    "\n",
    "    ######################################## PROMPT ELEMENTS ########################################\n",
    "\n",
    "    ##### Prompt element 1: `user` role\n",
    "    # Make sure that your Messages API call always starts with a `user` role in the messages array.\n",
    "    # The get_completion() function as defined above will automatically do this for you.\n",
    "\n",
    "    ##### Prompt element 2: Task context\n",
    "    # Give Claude context about the role it should take on or what goals and overarching tasks you want it to undertake with the prompt.\n",
    "    # It's best to put context early in the body of the prompt.\n",
    "    TASK_CONTEXT = \"You are a medical reviewer. You review patient notes and provide recommendation to the doctor about the medical conditions of the patient. Your recommendation includes patients current and chronic medical conditions. Your recommendation helps the doctor to decide on the treatment plan.\"\n",
    "\n",
    "    ##### Prompt element 3: Tone context\n",
    "    # If important to the interaction, tell Claude what tone it should use.\n",
    "    # This element may not be necessary depending on the task.\n",
    "    TONE_CONTEXT = \"You should maintain a friendly customer service tone.\"\n",
    "\n",
    "    ##### Prompt element 4: Detailed task description and rules\n",
    "    # Expand on the specific tasks you want Claude to do, as well as any rules that Claude might have to follow.\n",
    "    # This is also where you can give Claude an \"out\" if it doesn't have an answer or doesn't know.\n",
    "    # It's ideal to show this description and rules to a friend to make sure it is laid out logically and that any ambiguous words are clearly defined.\n",
    "    TASK_DESCRIPTION = \"\"\"The patient notes are provided inside <patient_notes></patient_notes> XML tag. It contains date, medication, history, procedure codes, lab results and note.\n",
    "\n",
    "    Your initial recommendations based on the patient notes analysis are provided inside <initial_recommendation></initial_recommendation> XML tag. \n",
    "\n",
    "    Guidelines about the medical conditions and corresponding ICD 10 codes are provided inside <guidelines></guidelines> XML tag. \n",
    "\n",
    "    When you reply, you follow these steps:\n",
    "\n",
    "    - Refer to the <patient_notes>. Carefully read through the history, medications, encounters. For each encounter, carefully review the lab results, note. Check line-by-line to look for any evidence of medical conditions. \n",
    "\n",
    "    - Lab results contain comma separated list of lab readings, which can be lengthy. Please read through each and every value carefully. Maintain a list of common lab value thresholds that indicate potential conditions, and cross-check any out-of-range values against this list. \n",
    "\n",
    "    - When reviewing notes, actively look for any mention of symptoms, diagnoses, medications prescribed, or procedures done that could indicate a condition. Only list a medical condition when you see clear evidence in the lab results or notes to support a diagnosis. \n",
    "\n",
    "    - Refer to the guidelines from the knowledge base inside <guidelines></guidelines> XML tag. Use it as a helper tool to identify the medical conditions and ICD 10 codes.\n",
    "\n",
    "    - Refer to your initial recommendations inside <initial_recommendation></initial_recommendation> XML tag. Please adjust any recommendations as appropriate.\n",
    "\n",
    "    - Please do not make any assumptions without verifying supporting evidence for the specific date.\n",
    "\n",
    "    - For each date, list all the medical conditions, corresponding ICD 10 codes, relevant explanation as evidence.\n",
    "\n",
    "    - Only use the information provided to generate the recommendation. If there are no medical condition to recommend to the doctor tell no medical condition to report.\n",
    "\n",
    "    - Provide the final recommendation inside <recommendation></recommendation> XML tags in JSON format, with each condition formatted as:\n",
    "    {\n",
    "      \"Active_Condition\":[\n",
    "      {\"Review\": {  \n",
    "      \"DX_Code\": \"ICD10 Code\",\n",
    "      \"Description\": \"Condition description\",\n",
    "      \"Memo\": {\n",
    "                  \"date\":\"date\",\n",
    "                  \"note\":\"Explanation from notes\"\n",
    "              }\n",
    "      }},\n",
    "      {\"Review\": {\n",
    "      \"DX_Code\": \"ICD10 Code\",\n",
    "      \"Description\": \"Condition description\",\n",
    "      \"Memo\": {\n",
    "                  \"date\":\"date\",\n",
    "                  \"note\":\"Explanation from notes\"\n",
    "              }\n",
    "      }}],\n",
    "      \"Inactive_Condition\": [\n",
    "        {\"Review\": {\n",
    "          \"DX_Code\": \"ICD10 Code\",\n",
    "          \"Description\": \"Condition description\",\n",
    "          \"Memo\": {\n",
    "            \"date\": \"date\",\n",
    "            \"note\": \"Explanation from notes\"\n",
    "          }\n",
    "      }}]\n",
    "    }\n",
    "    \"\"\"\n",
    "\n",
    "    ##### Prompt element 5: Examples\n",
    "    # Provide Claude with at least one example of an ideal response that it can emulate. Encase this in <example></example> XML tags. Feel free to provide multiple examples.\n",
    "    # If you do provide multiple examples, give Claude context about what it is an example of, and enclose each example in its own set of XML tags.\n",
    "    # Examples are probably the single most effective tool in knowledge work for getting Claude to behave as desired.\n",
    "    # Make sure to give Claude examples of common edge cases. If your prompt uses a scratchpad, it's effective to give examples of how the scratchpad should look.\n",
    "    # Generally more examples = better.\n",
    "    EXAMPLES = \"\"\"Here is an example inside <example></example> XML tag on how to perform the task: \n",
    "    <example>\n",
    "    user: <patient_notes>\n",
    "    {\n",
    "      \"name\": \"XYZ\",\n",
    "      \"age\": \"60 years\",\n",
    "      \"sex\": \"Male\",\n",
    "      \"encounters\": [ \n",
    "        {\n",
    "          \"Date\": \"2022-01-04\", \n",
    "          \"Procedure codes\": \"99214\",\n",
    "          \"note\": [\"Blood pressure has been stable. Pt is overdue for physical and labs. Pt will come to the lab next month and will schedule an appointment for a physical.\", \"stable\"]\n",
    "        },\n",
    "        {\n",
    "          \"Date\": \"2022-02-04\", \n",
    "          \"note\": [\"Dual-chamber pacemaker was placed for sinus node dysfunction.\"]\n",
    "        },\n",
    "        {\n",
    "          \"Date\": \"2023-07-22\",\n",
    "          \"note\": [\"Had unprovoked PE.  Still on anticoagulation.  Oncology note dated 07/05/2023: long term anticoagulation recommended.  It can be primary hypercoagulability.\"]\n",
    "        }, \n",
    "        {\n",
    "          \"Date\": \"2023-07-31\", \n",
    "          \"note\": [\"Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\", \"Patient visited doctor for cough, chest soreness, runny nose, headache, slight fever, and sore throat. Doctor suggested to take Ibuprofen and cough suppressant\"]\n",
    "        }\n",
    "      ]\n",
    "    }\n",
    "    </patient_notes>\n",
    "\n",
    "    assistant: <response>\n",
    "    <thinking>\n",
    "    Date: 2022-01-04\n",
    "    No evidence of medical conditions\n",
    "\n",
    "    Date: 2022-02-04\n",
    "    Condition: Sinus node dysfunction \n",
    "    ICD10: I49.5\n",
    "    Evidence: Dual-chamber pacemaker was placed for sinus node dysfunction.\n",
    "\n",
    "    Date: 2023-07-22  \n",
    "    Condition: Pulmonary embolism\n",
    "    ICD10: I26.99\n",
    "    Evidence: Had unprovoked PE. Still on anticoagulation. Oncology note dated 07/05/2023: long term anticoagulation recommended. It can be primary hypercoagulability.\n",
    "\n",
    "    Date: 2023-07-31\n",
    "    Condition 1: Type 2 diabetes mellitus with diabetic polyneuropathy\n",
    "    ICD10: E11.42\n",
    "    Evidence: Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\n",
    "\n",
    "    Condition 2: Upper respiratory infection \n",
    "    ICD10: J06.9\n",
    "    Evidence: Patient visited doctor for cough, chest soreness, runny nose, headache, slight fever, and sore throat. Doctor suggested to take Ibuprofen and cough suppressant.\n",
    "\n",
    "    Date: 2023-09-01\n",
    "    Condition 1: Vitamin D deficiency\n",
    "    ICD10: E55.9\n",
    "    Evidence: vitamin D 25-oh, total: 43 NG/mL\n",
    "\n",
    "    Condition 2: Upper respiratory infection (inactive)\n",
    "    ICD10: J06.9\n",
    "    Evidence: Doctor visit. Patient no longer complained of cough. Patient is not taking Ibuprofen and cough suppressant anymore.\n",
    "\n",
    "    Inactive Conditions:\n",
    "    - Upper respiratory infection (J06.9)\n",
    "\n",
    "    Active Conditions:  \n",
    "    - Sinus node dysfunction (I49.5)\n",
    "    - Pulmonary embolism (I26.99)\n",
    "    - Type 2 diabetes mellitus with diabetic polyneuropathy (E11.42)\n",
    "    - Prostate cancer (C61)\n",
    "    - Vitamin D deficiency (E55.9)\n",
    "    </thinking>\n",
    "\n",
    "    <recommendation>\n",
    "    {\n",
    "      \"Active_Condition\": [ \n",
    "      {\"Review\":{\n",
    "        \"DX_Code\": \"I49.5\",  \n",
    "        \"Description\": \"Sinus node dysfunction\",\n",
    "        \"Memo\": {\n",
    "          \"date\": \"2022-02-04\",\n",
    "          \"note\": \"Dual-chamber pacemaker was placed for sinus node dysfunction.\"\n",
    "        }\n",
    "      }},  \n",
    "      {\"Review\": {  \n",
    "        \"DX_Code\": \"I26.99\",\n",
    "        \"Description\": \"Pulmonary embolism\", \n",
    "        \"Memo\": {\n",
    "          \"date\": \"2023-07-22\",  \n",
    "          \"note\": \"Had unprovoked PE. Still on anticoagulation. Oncology note dated 07/05/2023: long term anticoagulation recommended. It can be primary hypercoagulability.\"\n",
    "        }\n",
    "      }},\n",
    "      {\"Review\": {\n",
    "        \"DX_Code\": \"E11.42\",  \n",
    "        \"Description\": \"Type 2 diabetes mellitus with diabetic polyneuropathy\",\n",
    "        \"Memo\": {\n",
    "          \"date\": \"2023-07-31\",\n",
    "          \"note\": \"Patient visited XXX DPM. Came in for foot care, upon neurology foot examination revealed reduced monofilament test and spontaneous. Suggested evaluation for Type 2 diabetes mellitus with diabetic polyneuropathy.\"\n",
    "        }\n",
    "      }},\n",
    "      {\"Review\": {\n",
    "        \"DX_Code\": \"E55.9\",\n",
    "        \"Description\": \"Vitamin D deficiency\",  \n",
    "        \"Memo\": {\n",
    "            \"date\": \"2023-09-01\",\n",
    "            \"note\": \"vitamin D 25-oh, total: 43 NG/mL\"\n",
    "          }\n",
    "        }}],\n",
    "      \"Inactive_Condition\": [\n",
    "        {\"Review\": {\n",
    "          \"DX_Code\": \"J06.9\",\n",
    "          \"Description\": \"Upper respiratory infection\",\n",
    "          \"Memo\": {\n",
    "            \"date\": \"2023-09-01\",\n",
    "            \"note\": \"Doctor visit. Patient no longer complained of cough. Patient is not taking Ibuprofen and cough suppressant anymore.\"\n",
    "          }\n",
    "        }}]\n",
    "      }\n",
    "    </recommendation>\n",
    "    </response>\n",
    "    </example>\"\"\"\n",
    "\n",
    "    ##### Prompt element 6: Input data to process\n",
    "    # If there is data that Claude needs to process within the prompt, include it here within relevant XML tags.\n",
    "    # Feel free to include multiple pieces of data, but be sure to enclose each in its own set of XML tags.\n",
    "    # This element may not be necessary depending on task. Ordering is also flexible.\n",
    "    INPUT_DATA = f\"\"\"Here are the patient notes: \n",
    "    <patient_notes>\n",
    "    {patient_notes}\n",
    "    </patient_notes>\n",
    "\n",
    "    Here are the initial recommendations: \n",
    "    <initial_recommendation>\n",
    "    {initial_recommendation}\n",
    "    </initial_recommendation>\n",
    "\n",
    "    Here are the guidelines: \n",
    "    <guidelines>\n",
    "    {guidelines}\n",
    "    </guidelines>\n",
    "\n",
    "    Here is the user's question:\n",
    "    <question>\n",
    "    {QUESTION}\n",
    "    </question>\"\"\"\n",
    "\n",
    "\n",
    "    ##### Prompt element 7: Immediate task description or request #####\n",
    "    # \"Remind\" Claude or tell Claude exactly what it's expected to immediately do to fulfill the prompt's task.\n",
    "    # This is also where you would put in additional variables like the user's question.\n",
    "    # It generally doesn't hurt to reiterate to Claude its immediate task. It's best to do this toward the end of a long prompt.\n",
    "    # This will yield better results than putting this at the beginning.\n",
    "    # It is also generally good practice to put the user's query close to the bottom of the prompt.\n",
    "    IMMEDIATE_TASK = \"How do you respond to the user's question?\"\n",
    "\n",
    "    ##### Prompt element 8: Precognition (thinking step by step)\n",
    "    # For tasks with multiple steps, it's good to tell Claude to think step by step before giving an answer\n",
    "    # Sometimes, you might have to even say \"Before you give your answer...\" just to make sure Claude does this first.\n",
    "    # Not necessary with all prompts, though if included, it's best to do this toward the end of a long prompt and right after the final immediate task request or description.\n",
    "    PRECOGNITION = \"Think step by step about your answer first before you respond. When you reply, first find all the medical conditions, corresponding ICD10 codes, explanation and write them down inside <thinking></thinking> XML tags.  This is a space for you to write down relevant content. Once you are done extracting relevant information, double check your work. Look back over the lab results and notes again with fresh eyes to make sure nothing was missed. Now answer the question. Put your recommendation inside <recommendation></recommendation> XML tag.\"\n",
    "\n",
    "\n",
    "    ##### Prompt element 9: Output formatting\n",
    "    # If there is a specific way you want Claude's response formatted, clearly tell Claude what that format is.\n",
    "    # This element may not be necessary depending on the task.\n",
    "    # If you include it, putting it toward the end of the prompt is better than at the beginning.\n",
    "    OUTPUT_FORMATTING = \"Put your response in <response></response> tags.\"\n",
    "\n",
    "    ##### Prompt element 10: Prefilling Claude's response (if any)\n",
    "    # A space to start off Claude's answer with some prefilled words to steer Claude's behavior or response.\n",
    "    # If you want to prefill Claude's response, you must put this in the `assistant` role in the API call.\n",
    "    # This element may not be necessary depending on the task.\n",
    "    PREFILL = \"[assistant] <response>\"\n",
    "\n",
    "\n",
    "\n",
    "    ######################################## COMBINE ELEMENTS ########################################\n",
    "\n",
    "    PROMPT = \"\"\n",
    "\n",
    "    if TASK_CONTEXT:\n",
    "        PROMPT += f\"\"\"{TASK_CONTEXT}\"\"\"\n",
    "\n",
    "    if TONE_CONTEXT:\n",
    "        PROMPT += f\"\"\"\\n\\n{TONE_CONTEXT}\"\"\"\n",
    "\n",
    "    if TASK_DESCRIPTION:\n",
    "        PROMPT += f\"\"\"\\n\\n{TASK_DESCRIPTION}\"\"\"\n",
    "\n",
    "    if EXAMPLES:\n",
    "        PROMPT += f\"\"\"\\n\\n{EXAMPLES}\"\"\"\n",
    "\n",
    "    if INPUT_DATA:\n",
    "        PROMPT += f\"\"\"\\n\\n{INPUT_DATA}\"\"\"\n",
    "\n",
    "    if IMMEDIATE_TASK:\n",
    "        PROMPT += f\"\"\"\\n\\n{IMMEDIATE_TASK}\"\"\"\n",
    "\n",
    "    if PRECOGNITION:\n",
    "        PROMPT += f\"\"\"\\n\\n{PRECOGNITION}\"\"\"\n",
    "\n",
    "    if OUTPUT_FORMATTING:\n",
    "        PROMPT += f\"\"\"\\n\\n{OUTPUT_FORMATTING}\"\"\"\n",
    "\n",
    "    # Print full prompt\n",
    "    print(\"-----------------------------------------------------------------------------------------------\")\n",
    "    print(\"--------------------------- Full prompt with variable substitutions ---------------------------\")\n",
    "    print(\"-----------------------------------------------------------------------------------------------\")\n",
    "    print(\"\\n\")\n",
    "    print(\"------USER TURN------\")\n",
    "    print(PROMPT)\n",
    "    print(\"\\n\")\n",
    "    print(\"------ASSISTANT TURN------\")\n",
    "    print(PREFILL)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ca6687e5-7b1c-4659-aba6-6ddcd9e0056f",
   "metadata": {},
   "source": [
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>\n",
    "## Call LLM\n",
    "Now let's run the prompt! Run the cell below to see LLM's output.\n",
    "\n",
    "<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "a37cf65d-eefa-409d-90cc-b90a5559ae24",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "------------------------------------------------------------------------------------------\n",
      "------------------------------------- LLM's response -------------------------------------\n",
      "------------------------------------------------------------------------------------------\n",
      "Input tokens: %s 35131\n",
      "Output tokens: %s 1951\n",
      "Total tokens: %s 37082\n",
      "Stop reason: %s end_turn\n",
      "\n",
      "<thinking>\n",
      "Date: 2016-01-21\n",
      "Condition: Cardiac murmur\n",
      "ICD10: R01.1\n",
      "Evidence: ICD10 diagnosis code R01.1\n",
      "\n",
      "Date: 2016-02-25\n",
      "Condition 1: Obesity\n",
      "ICD10: E66.9\n",
      "Evidence: Body mass index (BMI): 40 kilogram / (meter ^ 2)\n",
      "\n",
      "Condition 2: Hyperlipidemia\n",
      "ICD10: E78.5\n",
      "Evidence: cholesterol: 250 mg/dL, triglycerides: 111 mg/dL, HDL cholesterol: 73 mg/dL, Cholesterol in LDL [Mass/volume] in Serum or Plasma: 155 mg/dL (calc)\n",
      "\n",
      "Condition 3: Vitamin D deficiency\n",
      "ICD10: E55.9\n",
      "Evidence: vitamin D 25-oh, total: 29 NG/mL\n",
      "\n",
      "Condition 4: Hypertension\n",
      "ICD10: I10\n",
      "Evidence: \"Continue bisoprolol HCTZ and we will increase losartan to 100 mg daily. Continue to monitor BP at home with goal of 120/80\"\n",
      "\n",
      "Condition 5: Prediabetes\n",
      "ICD10: R73.03\n",
      "Evidence: Hemoglobin A1c/Hemoglobin.total in Blood: 6%, glucose: 119 mg/dL, estimated avg. glucose: 123 mg/dL (calc)\n",
      "\n",
      "Condition 6: Chronic kidney disease, stage 3\n",
      "ICD10: N18.3\n",
      "Evidence: GFR: 59\n",
      "\n",
      "Date: 2016-05-05\n",
      "Condition 1: Hypothyroidism\n",
      "ICD10: E03.9\n",
      "Evidence: TSH: 4 uIU/mL\n",
      "\n",
      "Condition 2: Abnormal electrocardiogram\n",
      "ICD10: R94.31\n",
      "Evidence: \"Mild changes with ST and lateral leads specifically 2 and V4 and V6 -we will refer to cardiology for further assessment due to history of mild aortic valve sclerosis and mild change with BP values.\"\n",
      "\n",
      "Condition 3: Aortic valve disorder\n",
      "ICD10: I35.8\n",
      "Evidence: \"Last echocardiogram DATE did display mild aortic valve sclerosis and stenosis.\"\n",
      "\n",
      "Date: 2016-07-04\n",
      "Condition: Herpes simplex\n",
      "ICD10: B00.9\n",
      "Evidence: \"Patient visited doctor for red rash on hands that begins a few days after the pain. Skin is sensitive to touch, itching. There are fluid-filled blisters that break open and crust over. Doctor prescribed Acyclovir\"\n",
      "\n",
      "Date: 2016-08-20\n",
      "Condition: Herpes simplex (inactive)\n",
      "ICD10: B00.9\n",
      "Evidence: \"Doctor visit. Patient no longer complained of skin rash. Physical check up confirmed no rash or redness in the hand. Doctor asked to stop taking Acyclovir.\"\n",
      "\n",
      "Inactive Conditions:\n",
      "- Herpes simplex (B00.9)\n",
      "\n",
      "Active Conditions:\n",
      "- Cardiac murmur (R01.1)\n",
      "- Obesity (E66.9)\n",
      "- Hyperlipidemia (E78.5)\n",
      "- Vitamin D deficiency (E55.9)\n",
      "- Hypertension (I10)\n",
      "- Prediabetes (R73.03)\n",
      "- Chronic kidney disease, stage 3 (N18.3)\n",
      "- Hypothyroidism (E03.9)\n",
      "- Abnormal electrocardiogram (R94.31)\n",
      "- Aortic valve disorder (I35.8)\n",
      "</thinking>\n",
      "\n",
      "<recommendation>\n",
      "{\n",
      "  \"Active_Condition\": [\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R01.1\",\n",
      "      \"Description\": \"Cardiac murmur\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-01-21\",\n",
      "        \"note\": \"ICD10 diagnosis code R01.1\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E66.9\",\n",
      "      \"Description\": \"Obesity\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-02-25\",\n",
      "        \"note\": \"Body mass index (BMI): 40 kilogram / (meter ^ 2)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E78.5\",\n",
      "      \"Description\": \"Hyperlipidemia\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-02-25\",\n",
      "        \"note\": \"cholesterol: 250 mg/dL, triglycerides: 111 mg/dL, HDL cholesterol: 73 mg/dL, Cholesterol in LDL [Mass/volume] in Serum or Plasma: 155 mg/dL (calc)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E55.9\",\n",
      "      \"Description\": \"Vitamin D deficiency\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-02-25\",\n",
      "        \"note\": \"vitamin D 25-oh, total: 29 NG/mL\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"I10\",\n",
      "      \"Description\": \"Hypertension\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-02-25\",\n",
      "        \"note\": \"Continue bisoprolol HCTZ and we will increase losartan to 100 mg daily. Continue to monitor BP at home with goal of 120/80\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R73.03\",\n",
      "      \"Description\": \"Prediabetes\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-02-25\",\n",
      "        \"note\": \"Hemoglobin A1c/Hemoglobin.total in Blood: 6%, glucose: 119 mg/dL, estimated avg. glucose: 123 mg/dL (calc)\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"N18.3\",\n",
      "      \"Description\": \"Chronic kidney disease, stage 3\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-02-25\",\n",
      "        \"note\": \"GFR: 59\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"E03.9\",\n",
      "      \"Description\": \"Hypothyroidism\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"TSH: 4 uIU/mL\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"R94.31\",\n",
      "      \"Description\": \"Abnormal electrocardiogram\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Mild changes with ST and lateral leads specifically 2 and V4 and V6 -we will refer to cardiology for further assessment due to history of mild aortic valve sclerosis and mild change with BP values.\"\n",
      "      }\n",
      "    }},\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"I35.8\",\n",
      "      \"Description\": \"Aortic valve disorder\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-05-05\",\n",
      "        \"note\": \"Last echocardiogram DATE did display mild aortic valve sclerosis and stenosis.\"\n",
      "      }\n",
      "    }}\n",
      "  ],\n",
      "  \"Inactive_Condition\": [\n",
      "    {\"Review\": {\n",
      "      \"DX_Code\": \"B00.9\",\n",
      "      \"Description\": \"Herpes simplex\",\n",
      "      \"Memo\": {\n",
      "        \"date\": \"2016-08-20\",\n",
      "        \"note\": \"Doctor visit. Patient no longer complained of skin rash. Physical check up confirmed no rash or redness in the hand. Doctor asked to stop taking Acyclovir.\"\n",
      "      }\n",
      "    }}\n",
      "  ]\n",
      "}\n",
      "</recommendation>\n",
      "</response>\n"
     ]
    }
   ],
   "source": [
    "if use_knowledge_base == 'Y':\n",
    "    \n",
    "    print(\"------------------------------------------------------------------------------------------\")\n",
    "    print(\"------------------------------------- LLM's response -------------------------------------\")\n",
    "    print(\"------------------------------------------------------------------------------------------\")\n",
    "    llm_output_text = (get_completion(PROMPT, prefill=PREFILL))\n",
    "    print(llm_output_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "80ca7b33-24e9-47f2-815a-c3e71ee18642",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'ResponseMetadata': {'RequestId': 'K23SX9ER4AK6QAY8', 'HostId': 'Zx6hBSQa+5pp5QaMOKt9tD0hJ238it+d/KzCV05qQtjDG6DMoPlhKSBzk4J8RdbKUtHs/2gkqfQ=', 'HTTPStatusCode': 200, 'HTTPHeaders': {'x-amz-id-2': 'Zx6hBSQa+5pp5QaMOKt9tD0hJ238it+d/KzCV05qQtjDG6DMoPlhKSBzk4J8RdbKUtHs/2gkqfQ=', 'x-amz-request-id': 'K23SX9ER4AK6QAY8', 'date': 'Sat, 05 Oct 2024 14:01:13 GMT', 'x-amz-server-side-encryption': 'AES256', 'etag': '\"c9959005bf85453ead8667f47ba50d52\"', 'content-length': '0', 'server': 'AmazonS3'}, 'RetryAttempts': 0}, 'ETag': '\"c9959005bf85453ead8667f47ba50d52\"', 'ServerSideEncryption': 'AES256'}\n"
     ]
    }
   ],
   "source": [
    "# Find text between <recommendation> tags using regex\n",
    "pattern = r'<recommendation>(.*?)</recommendation>'\n",
    "match = re.search(pattern, llm_output_text, re.DOTALL)\n",
    "extracted_recommendation = match.group(1)\n",
    "#print(extracted_recommendation)\n",
    "\n",
    "extracted_recommendation_bytes = extracted_recommendation.encode('utf-8')\n",
    "s3_response = s3_client.put_object(Body=extracted_recommendation_bytes, Bucket=s3_bucket, Key=s3_output_object_key)\n",
    "print(s3_response)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "29e3f484-80ab-480a-818c-f3cfd739395c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "availableInstances": [
   {
    "_defaultOrder": 0,
    "_isFastLaunch": true,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 4,
    "name": "ml.t3.medium",
    "vcpuNum": 2
   },
   {
    "_defaultOrder": 1,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 8,
    "name": "ml.t3.large",
    "vcpuNum": 2
   },
   {
    "_defaultOrder": 2,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 16,
    "name": "ml.t3.xlarge",
    "vcpuNum": 4
   },
   {
    "_defaultOrder": 3,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 32,
    "name": "ml.t3.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 4,
    "_isFastLaunch": true,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 8,
    "name": "ml.m5.large",
    "vcpuNum": 2
   },
   {
    "_defaultOrder": 5,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 16,
    "name": "ml.m5.xlarge",
    "vcpuNum": 4
   },
   {
    "_defaultOrder": 6,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 32,
    "name": "ml.m5.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 7,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 64,
    "name": "ml.m5.4xlarge",
    "vcpuNum": 16
   },
   {
    "_defaultOrder": 8,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 128,
    "name": "ml.m5.8xlarge",
    "vcpuNum": 32
   },
   {
    "_defaultOrder": 9,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 192,
    "name": "ml.m5.12xlarge",
    "vcpuNum": 48
   },
   {
    "_defaultOrder": 10,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 256,
    "name": "ml.m5.16xlarge",
    "vcpuNum": 64
   },
   {
    "_defaultOrder": 11,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 384,
    "name": "ml.m5.24xlarge",
    "vcpuNum": 96
   },
   {
    "_defaultOrder": 12,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 8,
    "name": "ml.m5d.large",
    "vcpuNum": 2
   },
   {
    "_defaultOrder": 13,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 16,
    "name": "ml.m5d.xlarge",
    "vcpuNum": 4
   },
   {
    "_defaultOrder": 14,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 32,
    "name": "ml.m5d.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 15,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 64,
    "name": "ml.m5d.4xlarge",
    "vcpuNum": 16
   },
   {
    "_defaultOrder": 16,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 128,
    "name": "ml.m5d.8xlarge",
    "vcpuNum": 32
   },
   {
    "_defaultOrder": 17,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 192,
    "name": "ml.m5d.12xlarge",
    "vcpuNum": 48
   },
   {
    "_defaultOrder": 18,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 256,
    "name": "ml.m5d.16xlarge",
    "vcpuNum": 64
   },
   {
    "_defaultOrder": 19,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 384,
    "name": "ml.m5d.24xlarge",
    "vcpuNum": 96
   },
   {
    "_defaultOrder": 20,
    "_isFastLaunch": false,
    "category": "General purpose",
    "gpuNum": 0,
    "hideHardwareSpecs": true,
    "memoryGiB": 0,
    "name": "ml.geospatial.interactive",
    "supportedImageNames": [
     "sagemaker-geospatial-v1-0"
    ],
    "vcpuNum": 0
   },
   {
    "_defaultOrder": 21,
    "_isFastLaunch": true,
    "category": "Compute optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 4,
    "name": "ml.c5.large",
    "vcpuNum": 2
   },
   {
    "_defaultOrder": 22,
    "_isFastLaunch": false,
    "category": "Compute optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 8,
    "name": "ml.c5.xlarge",
    "vcpuNum": 4
   },
   {
    "_defaultOrder": 23,
    "_isFastLaunch": false,
    "category": "Compute optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 16,
    "name": "ml.c5.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 24,
    "_isFastLaunch": false,
    "category": "Compute optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 32,
    "name": "ml.c5.4xlarge",
    "vcpuNum": 16
   },
   {
    "_defaultOrder": 25,
    "_isFastLaunch": false,
    "category": "Compute optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 72,
    "name": "ml.c5.9xlarge",
    "vcpuNum": 36
   },
   {
    "_defaultOrder": 26,
    "_isFastLaunch": false,
    "category": "Compute optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 96,
    "name": "ml.c5.12xlarge",
    "vcpuNum": 48
   },
   {
    "_defaultOrder": 27,
    "_isFastLaunch": false,
    "category": "Compute optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 144,
    "name": "ml.c5.18xlarge",
    "vcpuNum": 72
   },
   {
    "_defaultOrder": 28,
    "_isFastLaunch": false,
    "category": "Compute optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 192,
    "name": "ml.c5.24xlarge",
    "vcpuNum": 96
   },
   {
    "_defaultOrder": 29,
    "_isFastLaunch": true,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 16,
    "name": "ml.g4dn.xlarge",
    "vcpuNum": 4
   },
   {
    "_defaultOrder": 30,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 32,
    "name": "ml.g4dn.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 31,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 64,
    "name": "ml.g4dn.4xlarge",
    "vcpuNum": 16
   },
   {
    "_defaultOrder": 32,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 128,
    "name": "ml.g4dn.8xlarge",
    "vcpuNum": 32
   },
   {
    "_defaultOrder": 33,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 4,
    "hideHardwareSpecs": false,
    "memoryGiB": 192,
    "name": "ml.g4dn.12xlarge",
    "vcpuNum": 48
   },
   {
    "_defaultOrder": 34,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 256,
    "name": "ml.g4dn.16xlarge",
    "vcpuNum": 64
   },
   {
    "_defaultOrder": 35,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 61,
    "name": "ml.p3.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 36,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 4,
    "hideHardwareSpecs": false,
    "memoryGiB": 244,
    "name": "ml.p3.8xlarge",
    "vcpuNum": 32
   },
   {
    "_defaultOrder": 37,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 8,
    "hideHardwareSpecs": false,
    "memoryGiB": 488,
    "name": "ml.p3.16xlarge",
    "vcpuNum": 64
   },
   {
    "_defaultOrder": 38,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 8,
    "hideHardwareSpecs": false,
    "memoryGiB": 768,
    "name": "ml.p3dn.24xlarge",
    "vcpuNum": 96
   },
   {
    "_defaultOrder": 39,
    "_isFastLaunch": false,
    "category": "Memory Optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 16,
    "name": "ml.r5.large",
    "vcpuNum": 2
   },
   {
    "_defaultOrder": 40,
    "_isFastLaunch": false,
    "category": "Memory Optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 32,
    "name": "ml.r5.xlarge",
    "vcpuNum": 4
   },
   {
    "_defaultOrder": 41,
    "_isFastLaunch": false,
    "category": "Memory Optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 64,
    "name": "ml.r5.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 42,
    "_isFastLaunch": false,
    "category": "Memory Optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 128,
    "name": "ml.r5.4xlarge",
    "vcpuNum": 16
   },
   {
    "_defaultOrder": 43,
    "_isFastLaunch": false,
    "category": "Memory Optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 256,
    "name": "ml.r5.8xlarge",
    "vcpuNum": 32
   },
   {
    "_defaultOrder": 44,
    "_isFastLaunch": false,
    "category": "Memory Optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 384,
    "name": "ml.r5.12xlarge",
    "vcpuNum": 48
   },
   {
    "_defaultOrder": 45,
    "_isFastLaunch": false,
    "category": "Memory Optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 512,
    "name": "ml.r5.16xlarge",
    "vcpuNum": 64
   },
   {
    "_defaultOrder": 46,
    "_isFastLaunch": false,
    "category": "Memory Optimized",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 768,
    "name": "ml.r5.24xlarge",
    "vcpuNum": 96
   },
   {
    "_defaultOrder": 47,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 16,
    "name": "ml.g5.xlarge",
    "vcpuNum": 4
   },
   {
    "_defaultOrder": 48,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 32,
    "name": "ml.g5.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 49,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 64,
    "name": "ml.g5.4xlarge",
    "vcpuNum": 16
   },
   {
    "_defaultOrder": 50,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 128,
    "name": "ml.g5.8xlarge",
    "vcpuNum": 32
   },
   {
    "_defaultOrder": 51,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 1,
    "hideHardwareSpecs": false,
    "memoryGiB": 256,
    "name": "ml.g5.16xlarge",
    "vcpuNum": 64
   },
   {
    "_defaultOrder": 52,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 4,
    "hideHardwareSpecs": false,
    "memoryGiB": 192,
    "name": "ml.g5.12xlarge",
    "vcpuNum": 48
   },
   {
    "_defaultOrder": 53,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 4,
    "hideHardwareSpecs": false,
    "memoryGiB": 384,
    "name": "ml.g5.24xlarge",
    "vcpuNum": 96
   },
   {
    "_defaultOrder": 54,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 8,
    "hideHardwareSpecs": false,
    "memoryGiB": 768,
    "name": "ml.g5.48xlarge",
    "vcpuNum": 192
   },
   {
    "_defaultOrder": 55,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 8,
    "hideHardwareSpecs": false,
    "memoryGiB": 1152,
    "name": "ml.p4d.24xlarge",
    "vcpuNum": 96
   },
   {
    "_defaultOrder": 56,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 8,
    "hideHardwareSpecs": false,
    "memoryGiB": 1152,
    "name": "ml.p4de.24xlarge",
    "vcpuNum": 96
   },
   {
    "_defaultOrder": 57,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 32,
    "name": "ml.trn1.2xlarge",
    "vcpuNum": 8
   },
   {
    "_defaultOrder": 58,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 512,
    "name": "ml.trn1.32xlarge",
    "vcpuNum": 128
   },
   {
    "_defaultOrder": 59,
    "_isFastLaunch": false,
    "category": "Accelerated computing",
    "gpuNum": 0,
    "hideHardwareSpecs": false,
    "memoryGiB": 512,
    "name": "ml.trn1n.32xlarge",
    "vcpuNum": 128
   }
  ],
  "instance_type": "ml.t3.medium",
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
